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The malaria parasite detoxifies host red blood cell derived haem by conversion 
into the inert biocrystal haemozoin. Inhibiting this critical pathway is proposed to 
be the mechanism of action of chloroquine and related antimalarials and several 
studies have linked inhibition of the formation of synthetic haemozoin, β-
haematin, to parasite survival. However, haemozoin inhibition with a dose related 
increase in “free” haem correlated to decreased survival has not been 
demonstrated in the parasite. This project investigated the role of haem in the 
mechanism of action of several clinically relevant and novel antimalarials in the 
malaria parasite, Plasmodium falciparum.  
A pyridine-haem cellular fractionation assay was developed to directly determine 
all major haem species in drug treated chloroquine sensitive Plasmodium 
falciparum. Originally applied to chloroquine treated cells, the percentages of 
aqueous soluble Hb, “free” haem corresponding to haem that is labile and 
detergent soluble and finally base soluble Hz was determined through a series of 
fractionation steps in isolated trophozoites. Based on a method developed by 
Ncokazi and Egan, each haem species was spectrophotometrically determined as a 
low spin complex with aqueous pyridine (5% v/v, pH 7.5). Chloroquine inhibited 
haemozoin formation, causing a dose-dependent increase in toxic cellular “free” 
haem correlated with decreased parasite survival. The assay was extended to 
artesunate, amodiaquine, quinine, mefloquine, lumefantrine, and the antifolates 
pyrimethamine and a pyrimethamine sulfadoxine combination, at a single dose 
corresponding to 2.5⨯ the parasite growth IC50. Excluding the antifolates, all drugs 
exhibited inhibition of haemozoin in comparison to the control, but none to the 
degree which chloroquine inhibited haemozoin formation in Plasmodium 
falciparum. The results suggested that in addition to haemozoin inhibition, some of 
the antimalarials tested possess an alternative or additional mechanism of action. 
A comprehensive haem species dose response profile was required for each 
compound, however low throughput limited the application of the haem cellular 
fractionation assay. The method was subsequently modified to a higher 
throughput process performed in 24-well plates, providing a significant 
improvement in productivity and reduction in starting material volume. The 
modified method was validated against the original pyridine-haem fractionation 
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assay using chloroquine. A fluorescent flow cytometry-based technique was 
developed for the determination of cell counts of isolated trophozoites, allowing 
results to be expressed in terms of the amount of each haem species per cell rather 
than percentages. Flow cytometry of isolated trophozoites also provided 
information describing the change in morphology of drug treated cells. This 
modified method was applied to the previously mentioned antimalarials 
(excluding the pyrimethamine sulfadoxine combination) as well as quinidine, 
atovaquone and primaquine and an experimental artemisinin, 10-
deoxoartimisinin. The results showed that atovaquone, primaquine, artesunate 
and 10-deoxoartimisinin did not inhibit haemozoin formation. Among the 
quinolines tested, only amodiaquine displayed direct haemozoin inhibition in a 
manner which resembled chloroquine. Quinine and quinidine both showed 
evidence of haemozoin inhibition, however neither to the same degree exhibited 
by chloroquine and amodiaquine. This was accompanied by a reduction in total 
haem Fe attributed to interference with haemoglobin uptake. Despite being 
inhibitors of β-haematin formation, neither mefloquine nor lumefantrine showed 
evidence of direct haemozoin inhibition. Both compounds showed dose related 
decreases in total haem Fe attributed to a possible interference with haemoglobin 
uptake upon drug treatment. Finally, the technique was applied to six novel 
compounds active against Plasmodium falciparum, derived from benzamide and 
triarylimidazole scaffolds, identified through a high throughput screening 
campaign to inhibit β-haematin formation twice as effectively as chloroquine. All 
novel compounds capable of inhibiting β-haematin formation were found to inhibit 
haemozoin formation. Interestingly, these compounds produced levels of “free” 
haem higher than any compound previously tested, up to 5.5⨯ greater than the 
maximum level of “free” haem reached with chloroquine treatment. Transmission 
electron microscopy images performed on cells treated with one of these 
compounds revealed a significantly enlarged digestive vacuole containing a large 
number of vesicles with evidence of disrupted haemozoin formation.  
Application of the haem cellular fractionation assay to a diverse group of 
compounds confirmed or excluded haemozoin inhibition as a mechanism of action. 
The method identified varying degrees of Hz inhibition, possibly attributed to the 
attenuated toxicity of “free” haem amongst certain scaffolds, while others exhibited 
The Role of Haem in the Mechanism of Action of Antimalarials in Plasmodium falciparum 
  Jill Michelle Combrinck -November 2016  
iv 
alternative mechanisms in addition to haemozoin inhibition possibly as a 
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1.1 Malaria in 2016 
 
Malaria continues to be one of the leading causes of death worldwide, despite 
decades of strategic interventions aimed at reducing the incidence of malaria and 
malaria related deaths. The disease continues to have a heavy impact on global 
heath and the economy, most severely in countries with a high incidence of 
poverty.1  The most recent World Malaria report published at the end of 2015 
coincided with the end of the 15 year period assigned to the Millennium 
Development Goals. As part of goal number 6 pertaining to malaria, the aim was 
not only to halt, but reverse the global incidence of malaria by 2015. In keeping 
with this goal, 57 countries have managed to reduce their malaria burden by more 
than 75%, with 1 billion fewer cases of malaria and 6.2 million fewer malaria 
deaths occurring between 2001 and 2015, than if rates had remained unchanged 
since 2000 (Figure 1-1a, b). 2 One area of notable success during this 15 year 
period has been the substantial reduction in child mortality, falling by 48% in 
malaria endemic areas of sub-Saharan Africa. As shown in Figure 1-2, malaria is no 
longer the leading cause of death among children in sub-Saharan Africa. The 
disease has largely been eliminated in North America and in 2015, the World 
Health Organisation (WHO) for the first time reported no new indigenous cases of 
malaria in the WHO European region. 3 2 4 These successes have largely been 
achieved through an increased use of insecticide-treated mosquito nets and 
treatment in the form of artemisinin (AMN) based combination therapies. AMN 
based combination therapies have been shown to effectively reduce malaria 
mortality in the treatment of uncomplicated malaria in children younger than 2 
years by more than 97%.5 
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Figure 1-1: The percentage decrease in the estimated number of malaria cases and 
the malaria death rate are shown in Figures 1-1a and 1-1b respectively for each 
WHO region from the year 2000 to 2015. Figure 1-2 shows that the number of 
deaths caused by malaria in children younger than five years of age has decreased 
over the fifteen year period. Malaria is no longer the leading cause of death among 
children younger than five years of age in sub-Saharan Africa. All figures 
reproduced from the WHO World Malaria Report 2015.2 
 
However, in the face of these successes, Africa continues to carry the heaviest 
malaria disease burden. Of the 214 million new cases of malaria and 438 000 
deaths reported in 2015, more than 90% of deaths occurred in the WHO African 
region.  It is of critical concern that the rates of decline in malaria related incidence 
and mortality are the slowest in these higher burden countries which include 
several African countries. To address this, the WHO has rolled out another fifteen 
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year plan, “Global Technical Strategy for Malaria 2016 – 2030”. The goal of this 
new strategy is to reduce the global incidence of malaria and mortality by 90% and 
eventually have a world free of malaria. 2 In addition to vector control measures 
and improved surveillance, chemoprevention remains an essential tool in the 
implementation of this new technical strategy. AMN combination therapy is our 
current first line therapy for the treatment of malaria. However, reduced 
sensitivity to the AMNs threaten the continued success of this drug class.6 It is 
therefore imperative to continue exploring malaria parasite biology to improve our 
understanding of current drug targets, identify new drug targets and aid in the 
development of new effective antimalarials to help achieve the goal of a world free 
of malaria. 
1.2 A brief history of the disease 
For centuries, the theories regarding the transmission of malaria have been widely 
debated. From Hippocrates theory in the 5th century BCE of bad air to our current 
day understanding of insect vectors.7 During the 1800s malaria was endemic in all 
parts of Europe with the exception of Lichtenstein. The organs of patients who had 
succumbed to the disease were characterised by black deposits, originally 
attributed to bile. In 1846, Adelheid B at the age of 43 and after 24 years of 
hospitalisation as a mentally ill patient died from malaria, although malaria had 
not been identified as the cause of death. Her brain was found to be dark brown, 
her spleen enlarged and dark brown and her capillaries filled with brown particles. 
Several years later the association between the brown pigment found in her organs 
and malaria was made by the instructor in pathological anatomy at the University 
of Berlin, Virchow. Virchow associated the pigment with haematin crystals and 
today we know its formation is as a result of haemoglobin (Hb) digestion and 
consequent formation of the malaria pigment, haemozoin (Hz), an essential 
process in the malaria parasite.7 
In the 19th century, while on assignment in Secunderabad, India the British army 
surgeon, Ronald Ross made a Nobel Prize winning discovery when he conclusively 
identified the mosquito as the vector for malaria.8 He fed mosquitoes with spotted 
wings blood containing crescent shaped cells from patient Hussein Khan and 
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detected brown pigment in the stomach wall of the mosquito, now identified as the 
Anopheles mosquito.9  Further evidence for the involvement of the mosquito was 
provided by Patrick Manson in 1900 who allowed Anopheles mosquitoes imported 
from Rome to London to bite the fingers of his healthy 23 year old son who had 
never previously suffered from malaria and had not been out of the country since 
the age of three. Approximately fourteen days after being bitten, his son suffered 
from malaria characteristic intermittent fevers and recovered after being 
administered quinine (QN).10  
 
1.3 The lifecycle of P. falciparum 
 
Currently five Plasmodium species which commonly infect humans have been 
identified. Plasmodium falciparum, P. vivax, P. ovale, P. malariae and more recently 
P. knowlesi.11 12 Current information suggests that although P. knowlesi malaria 
infects humans it is largely transmitted through zoonotic transmission, when an 
anopheles mosquito infected by a macaque monkey bites and infects a human.13 
The malaria parasite, Plasmodium falciparum is responsible for the most virulent 
form of malaria. This species predominates in Africa affecting young children and 
pregnant women most severely.2 P. falciparum has a complicated lifecycle which 
can be divided into two parts. The sexual lifecycle within the female Anopheles 
mosquito and the asexual lifecycle in a vertebrate host. The asexual stage can be 
further subdivided in to two parts during which the parasite resides within 
hepatocytes and erythrocytes as displayed in Figure 1-2. The latter stage is 
responsible for most of the clinical symptoms associated with malaria, and is 
characterised by the adhesion of infected erythrocytes to endothelial cells, 
reducing the clearance of infected cells by the spleen, resulting in potentially fatal 
cerebral and placental malaria.3 6 
The sexual lifecycle begins when a female Anopheles mosquito feeds from a 
vertebrate host infected with malaria, picking up mature gametocytes circulating 
in the blood stream of the host. The transition from vertebrate to mosquito host 
initiates gametogenesis in the stomach of the mosquito. Male and female gametes 
fuse to form a zygote. Zygotes undergo meiosis and transform into motile 
ookinetes. The ookinete moves through the mosquito gut wall and matures into an 
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oocyst and eventually into sporozoites. After a period of 10-22 days, the 
sporozoites migrate to the lobes of the mosquito salivary glands.4 8 When an 
infected female Anopheles mosquito bites a vertebrate host, motile sporozoites in 
the mosquito’s saliva enter the host bloodstream via the dermal tissue and then 
the liver where they invade hepatocytes. This liver stage within the human host is 
asymptomatic and lasts approximately six days. During this time the parasites 
flourish and each sporozoite multiplies to produce thousands of merozoites that 
are released into the blood stream. This signifies the beginning of the asexual 
lifecycle, when one merozoite invades a host erythrocyte. Within the host red 
blood cell (RBC) three distinct phases are observed within a single 48 h cycle, the 
ring stage, trophozoite stage and the schizont stage. Each schizont will give rise to 
between eight and twenty daughter merozoites in each cycle, which burst from the 
host RBC and invade new erythrocytes, perpetuating the cycle of infection.4 After 
several asexual cycles some parasites develop into gametocyte forms which are 
taken up by a mosquito with its next blood meal and after approximately 2 weeks 
the mosquito is infectious to its next host and the cycle of infection is preserved.3  
Each point in the lifecycle of P. falciparum can be seen as a potential drug target. In 
the past drug discovery focussed on the asexual stage as it presents the most 
accessible laboratory model to study. Several distinct processes and organelles in 
the asexual lifecycle of the parasite including Hb degradation, Hz formation, folate 
synthesis, the mitochondrial electron transport system and the apicoplast have 
been used as drug targets. 1 14 15 Recently, more reliable and accessible tools for the 
study of gametocytes and improved gametocyte activity screening assays has 
resulted in the study and identification of promising chemotherapies which have 
the added benefit of blocking transmission of malaria. 16-18 This literature review 
focusses on the asexual blood stage of the parasite lifecycle and the drugs which 
target this stage of the lifecycle. 
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.  
Figure 1-2: The lifecycle of the malaria parasite Plasmodium falciparum. The 
sexual cycle is shown in the female anopheles vector and the asexual cycle within 
the hepatocytes and erythrocytes of its vertebrate host. This image has been 
reproduced with permission from the American Society for Clinical Investigation.3 
Republished with permission of American Society for Clinical Investigation, from 
Greenwood, B. M., Fidock, D. A., Kyle, D. E., Kappe, S. H., Alonso, P. L., Collins, F. H., 
and Duffy, P. E. (2008) Malaria: progress, perils, and prospects for eradication, J. 
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1.4 The asexual blood stages of Plasmodium falciparum 
 
The apicomplexan malaria parasite is a unicellular, largely intracellular eukaryote. 
The merozoite, the ring, the trophozoite and the schizont are identified as four 
distinct stages in the asexual lifecycle of the parasite.  
 
1.4.1 The Merozoite 
 
The merozoite is the smallest of all Plasmodium stages, specialised for its role of 
capturing and invading a host RBC (Figure 1-3a). This stage represents a moment 
of vulnerability for the parasite as the merozoite is briefly extracellular between 
escaping the remnants of its previous host RBC and invading a new host RBC. At its 
apex, the merozoite has a cluster of several secretory organelles, rhoptries, dense 
granules, micronemes and mononemes used during invasion of the host RBC.19 
These organelles discharge a mix of proteins and lipids, during invasion and 
change the shape and composition of the RBC, forming an invagination pit on the 
surface of the RBC which eventually forms the parasitophorous vacuole (PV).  The 
PV encloses the merozoite within a membrane lined cavity, separating and 
shielding the parasite from the host RBC cytoplasm cavity where it develops and 




The merozoite matures and flattens into a thin cup shape with a thicker rim 
identified as the ring-form of a trophozoite (Figure 1-3b). The structure appears as 
a ring or signet shape when viewed as a Giemsa stained slide under a light 
microscope as the nucleus, plastids and ribosomes are all housed on the outer rim 
while very little else exists at its centre. 21 The parasite feeds through its 
cytostome, a mouth like structure at the parasite surface, pulling through RBC 
cytosol as well as bits of PV. Host RBC cytosol, composed essentially of Hb is 
transported in vesicles to the parasite digestive vacuole (DV) where Hb is digested 
by a series of proteases. Initially several small vacuoles exist and fuse later to form 
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one large DV. 4 22 The processes of Hb digestion within the parasite DV is discussed 




The trophozoite stage is distinguished from the ring stage by change in shape and 
size rather than function. This stage is defined by high metabolic activity during 
which copious amounts of host RBC cytosol are digested within the acidic DV by a 
series of proteases.23 A portion of the resulting amino acids are used by the 
parasite and the rest are exported to the extracellular medium. Toxic haematin 
(Fe(III)protoporphyrin IX) produced as a consequence of Hb metabolism is 
transformed into non-toxic crystalline Hz inside the single large parasite DV 
(Figure 1-3c).24 6 The RBC physiology is altered dramatically during the 
trophozoite stage as a result of large amounts of parasite proteins being exported 
into the RBC cytoplasm and surface as well as the interaction of specific malarial 
antigens with the host RBC.25 21 Ribosomes, the endoplasmic reticulum (ER) and 
the Golgi-body increase in number and complexity to meet the increased demand 
for protein synthesis. The trophozoite establishes an exo-membrane system within 
its host RBC arising from the PV membrane (PVM) which functions as a highway 
for the trafficking of proteins. 26 The surface area of the trophozoite becomes 
considerably larger and several ultrastructural changes at its surface 
corresponding to irregular bulges and invaginations are identified as surface knobs 
(SK) and Maurer’s clefts in Figure 1-3c. These structures are speculated to be 
involved in trafficking of substances and are associated with adhesins, proteins 
which facilitate adhesion of parasitised RBCs (PRBCs) to blood vessel walls. 12 This 
prevents splenic clearance of PRBCs, as infected cells do not pass through the 
spleen where they would normally be identified by macrophages which remove 




The ingestion of host cell cytoplasm and consequent Hz formation in the acidic DV, 
continues into the schizont stage, virtually depleting the Hb content of the RBC. 
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Similarly, the formation and export of proteins into the RBC continues, distorting 
the RBC membrane and cytoskeleton and increasing permeability of the RBC 
membrane (Figure 1-3d).  According to Goldberg and Cowman, the parasite 
exports more than 400 proteins to the host cell throughout its asexual lifecycle to 
ensure survival, including kinases, lipases and adhesins. 27 28 Most notably, the 
schizont is defined by nuclear division, resulting in the formation of sixteen to 
twenty nuclei. As schizont development nears the end, individual nuclei formed 
move towards the surface of the parasite and the daughter merozoites are 
assembled in specific stages beginning with the apical organelles and ending with 
the rupture of the PVM and RBC membrane presumably triggered by secretions 
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Figure 1-3: The asexual stages of Plasmodium falciparum. (a) A lemon shaped 
merozoite with the secretory organelles specialised for host cell invasion located at 
its apex. The inset depicts merozoites invading a host RBC. (b) Cup shaped flat ring 
stage. The RBC and PVM are not shown in this image and the Golgi-body is not 
conclusively identified. The inset shows a host RBC invaded by 2 ring stage 
parasites. (c) A trophozoite with increased numbers of free ribosomes, ER and 
enlarged Golgi-body. Multiple cytostomes and a single large DV for the ingestion 
and digestion of RBC cytosol are easily identified.  The inset shows a trophozoite 
within an irregularly shaped RBC. (d) The schizont stage of the lifecycle with SK 
visible on the RBC surface and daughter merozoites budding at the schizont 
surface.  The inset shows a schizont invaded RBC with the schizont occupying the 
majority of the RBC volume. Reprinted from Parasitology Today, 16(10), Bannister, 
L.H., Hopkins, J.M., Fowler, R.E., Krishna, S. and Mitchell, G.H, A brief illustrated 
guide to the ultrastructure of Plasmodium falciparum asexual blood stages, 427-
433., Copyright (2000), with permission from Elsevier. 21 
 
 
The Role of Haem in the Mechanism of Action of Antimalarials in Plasmodium falciparum 
  Jill Michelle Combrinck -November 2016  
12 
1.5 Haemoglobin degradation 
 
Haemoglobin is a major component of RBCs, making up 95% of the cytosolic 
proteins and reaching concentrations of 5 mM within the RBC.4 The malaria 
parasite metabolises Hb in an essential process which dominates a large part of the 
48 h asexual parasite lifecycle. Occurring most prolifically during the metabolically 
active trophozoite stage, approximately 60% of the host RBC Hb is digested. 29 30 
Hb metabolism continues into the schizont stage where the parasite occupies most 
of the volume of the host RBC and approximately 80% of the host RBC Hb has been 
digested. 31 The process occurs within the acidic DV, driven by a series of proteases 
and several peptidases resulting in the formation of amino acids, oxygen radicals 
and haem (Figure 1-4). Hb metabolism and the formation of Hz is a massive 
process in the asexual parasite and represents a pathway exclusive to the parasite, 
differing significantly to its host. Full understanding and consequent manipulation 
of the processes involved can open doors to the discovery of new effective drug 
targets. The details of Hb metabolism, eventually leading to the formation of Hz are 
discussed below. 
 
1.5.1 Hb ingestion 
 
Malaria parasites endocytose large amounts of host cell Hb primarily during the 
trophozoite stage via a cytostomal system. 32 Several of these double membraned 
pear shaped cytostomes can be found inside one parasite. The cytostome 
originates from an invagination of the PVM and parasite plasma membrane (PPM) 
forming a bridge between the two membranes separating the parasite and host 
RBC cytoplasm.33 Although most prolific at the trophozoite stage, recent evidence 
of an inactive cytostomal ring, indicative of a feeding apparatus, was seen at the 
periphery of merozoites suggesting that Hb uptake occurs very early in the 
parasite lifecycle. 34 33 Host RBC cytosol is ingested by the cytostome and double 
membrane vesicles budding from the cytostome transport RBC Hb to the acidic DV. 
35 4 Baker et al have shown that the development of the DV and the degradation of 
Hb start at the ring stage of the P. falciparum lifecycle. Using fluorescence and 
electron tomography, “pre-DV” acidified Hz containing compartments at the 
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periphery of mid ring stage parasites have been detected.36 As the parasites 
mature these peripheral acidic compartments coalesce into a single large DV.37 
Upon reaching the DV the outer membrane of the Hb containing vesicles fuse with 
the DV membrane. Once within the vacuole the single membrane of the vesicle 
lyses in a process specific to the vesicle membrane, hypothesized to be governed 
by phospholipases. Hb digestion ensues after the vesicle membrane has lysed. 36  
 
1.5.2 Hb metabolism  
 
Within the acidic DV, Hb is degraded in a stepwise manner by a series of proteases, 
beginning during the ring phase and peaking during the trophozoite stage. 38 36  In 
the presence of aspartic acid and cysteine protease inhibitors (Pepstatin and E62 
respectively) globin metabolism is completely blocked resulting in osmotic 
swelling, followed by the disruption of vacuolar processes and consequent parasite 
death.39 When administered individually, pepstatin inhibits digestion of Hb, while 
E-64 a specific cysteine protease inhibitor, has minimal effect on Hb degradation.40 
This suggests Hb metabolism follows a specific order. Cleavage of Hb into peptides 
is initiated by the aspartic acid proteases plasmepsin I and II (PM I and II), 
followed by plasmepsin IV (PM IV) and histoaspartic protease (HAP). 40 41 Peptides 
are further broken down by a family of cysteine proteases, falcipain II and III and 
the Zn-metalloprotease, falcilysin. 42 41 Aminopeptidases degrade short peptides 
into amino acids (Figure 1-4). 43  
Despite digesting up to 80% of the RBC Hb by the schizont stage, several studies 
have shown that P. falciparum only utilises approximately 16% of the amino acids 
released from Hb digestion. 31 29 P. falciparum has a limited capacity for the de novo 
synthesis of amino acids. 29 Haemoglobin contains no isoleucine and is lacking in 
methionine, cysteine, glutamine and glutamate. 44 The parasite therefore relies on 
exogenous sources as well as Hb digestion to fulfil its amino acid quota. Despite 
being grown in cultures containing all 20 essential amino acids, parasites will 
continue to digest Hb. 45 Further studies have shown that parasites grown in the 
presence of protease inhibitors in medium supplemented with all the essential 
amino acids resulted in inhibition of parasite growth. 46 47 48 Therefore the 
provision of essential nutrients is not the only motivation behind Hb metabolism. 
It has been suggested that in addition to providing a protein source, Hb is broken 
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down to “make room” for parasite growth by digesting RBC cytoplasm to prevent 
premature host RBC lysis. 49  
 
 
Figure 1-4: The process of Hb degradation and Hz formation with the trophozoite. 
RBC = red blood cell, PVM = parasitophorous vacuole membrane, PPM = parasite 
plasma membrane, DV = digestive vacuole, C = cytostome, T = troph, PM I, II, IV = 
plasmepsin I, II, IV, HAP = histoaspartic protease. 
 
1.6 Haemozoin in Plasmodium falciparum 
 
The detoxification of haem to inert Hz crystals is one of the final stages in the 
process of Hb degradation in the malaria parasite. In addition to providing amino 
acids as a nutrient source for the parasite, Hb metabolism results in the release of 
four haem (Fe(II)PPIX) units. Lacking haem oxygenase required for haem 
catabolism, the parasite sequesters it into inert Hz crystals.50 51 The activity of 
several important current antimalarials, including chloroquine (CQ), is attributed 
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1.6.1 The toxicity of Haem 
 
 Haemoglobin degradation is a major source of oxidative stress for the parasite. As 
a consequence of Hb digestion, haem (Fe(II)PPIX) is released and immediately 
autooxidised to haematin (Fe(III)PPIX) resulting in the formation of reactive 
oxygen species (ROS) within the acidic environment of the DV.53 The terms haem 
(Fe(II)PPIX) and haematin (Fe(III)PPIX) are used interchangeably, however all 
haem in the parasite DV is technically in the oxidised form, haematin.    
In the 4 fL volume DV, haematin can reach concentrations of up to 0.4 M.54 
Micromolar concentrations of free haem have been shown to be toxic by causing 
oxidative stress, membrane destabilisation and cell lysis. 40 51 55 Although it has 
been shown that more than 95% of toxic haem is sequestered as inert Hz in the 
parasite DV, even a small amount of free haem is capable of damaging the parasite. 
30 Haem has a lipophilic nature and has been shown to accumulate in membranes. 
56 57 This most likely results in impairment of membrane functioning which 
possibly manifest as interference with endocytosis and vesicle fusion required for 
the uptake and degradation of Hb in the parasite. 58 Both haemin (Fe(III)PPIX-Cl) 
and complexes of CQ-Fe(III)PPIX have been shown to cause swelling and eventual 
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Figure 1-5: Haemin lyses malaria parasite (×1100). Isolated P. berghei 
trophozoites suspended in culture medium as control (A) and incubated in the 
presence of 20 µM haemin (B). Cells treated with a complex formed from 20 µM 
haemin and 5 µM CQ produced similar results to B, while cells incubated with CQ 
alone showed no effect. From: Orjih, A. U., Banyal, H., Chevli, R., and Fitch, C. D. 
(1981) Hemin lyses malaria parasites, Science 214, 667. Reprinted with permission 
from The American Association for the Advancement of Science. 55  
 
While the toxicity of haem is prevented through Hz formation, auto-oxidation of 
haem to haematin within the DV liberates electrons which combine with oxygen to 
form several ROS, including superoxide anions (O2-), hydroxyl radicals (OH∙) and 
hydrogen peroxide (H2O2).50 59 The presence of ROS is kept to a minimum by the 
antioxidant and redox systems within the parasite (Figure 1-6). A family of 
superoxide dismutases catalyse the dismutation of O2- to H2O2 and O2, Thioredoxin 
peroxidases then reduce H2O2 to H2O and O2.60 Highly reactive OH˗ radicals, known 
to cause lipid peroxidation are generated through the spontaneous reaction of O2- 
and H2O2 or via the Fenton reaction.60 61 
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Figure 1-6: The generation of reactive oxygen species in P. falciparum.                             
From: Müller, Sylke, 2004. Image reprinted with permission from Wiley Online. 
Copyright © 2004, John Wiley and Sons Library. 60  FP IX = 
ferri/ferroprotoporphyrin IX; HbO‐Fe2+ = oxy‐haemoglobin containing 
ferriprotoporphyrin IX; MetHb‐Fe3+ = methaemoglobin containing 
ferriprotoporhpyrin IX; SOD = superoxide dismutase. 
 
1.6.2 The structure of haemozoin 
 
As mentioned above, in 1846 dark brown pigment was found in the organs of a 
mental patient who had succumbed to malaria. The pigment was originally 
attributed to bile until several years later when the connection between the dark 
brown malaria pigment we know today as Hz, and malaria was made. 62 The 
association between malaria and haematin was made by Brown in 1911, when 
dark brown pigment was identified as a haematin-protein complex. 63 Chemical 
analysis of purified Hz extracted from P. falciparum by Slater et al, showed that Hz 
was identical to haematin and without a protein component. Further analysis using 
Fourier-transform IR spectroscopy, extended X-ray absorption fine structure 
spectroscopy (EXAFS) and X-ray powder diffraction revealed that purified Hz was 
structurally identical to synthetic Hz, β-haematin (βH). The structure of βH (and 
hence Hz) was proposed to be a polymer of Fe(III)PPIX units linked by co-
ordination of the propionate group of one Fe(III)PPIX molecule to the Fe(III) 
centre of the next. 64 Hz was referred to as a polymer until 2000 when this model 
was invalidated by Pagola et al. Having first established that the powder X-ray 
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diffraction pattern of βH was identical to that of whole dried PRBCs, the crystal 
structure of βH was determined from the powder diffraction data obtained with 
synchrotron radiation using Rietveldt refinement (Figure 1-7). Hz was determined 
to be made up of cyclic dimers of Fe(III)PPIX, with the propionate of one 
Fe(III)PPIX co-ordinated to the Fe(III) centre of the other.  Dimers are linked to 
each other by hydrogen bonding of propionate groups. 65 24  
 
 
Figure 1-7: Two unit cells of the crystal structure of Hz as determined by Pagola et 
al. Reprinted by permission from Macmillan Publishers Ltd: [Nature Publishing 
Proup], Copyright (2000). 24  
 
1.6.3 Haemozoin formation in Plasmodium falciparum 
 
The exact mechanism by which Hz is formed in the acidic DV of the parasite is not 
conclusively known, however, several theories have been proposed to explain the 
mechanism.  
Slater and Cerami suggested that a “haem polymerase” enzyme (HPE) catalysed Hz 
formation after showing that βH formation was promoted in the presence of 
extracts of PRBCs. 66 The theory was discredited when it was shown the “enzyme” 
remained active after extensive boiling and protease treatment. Hz itself was 
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proposed to be a nucleation site for further crystal formation when it was shown 
that both Hz and βH, promoted βH formation. 67 68 However this theory does not 
account for the formation of Hz in the absence of pre-existing Hz such as in the ring 
stage when Hb degradation is only beginning. Egan et al in 1994 showed that βH 
could be formed spontaneously from haematin in acid acetate solutions (pH 4.2 – 
5.0, 6°C – 65°C). 69 The reaction was inhibited in the presence of antimalarials CQ, 
AQ and QN but not primaquine (PQ), an antimalarial active against hypnozoites in 
the liver stage in P. vivax and also shown to have potent activity against stage V 
gametocytes in P. falciparum. 70 The antimalarially inactive compounds 9-
epiquinine and 8-hydroxy quinoline had no effect on βH formation. 
In 1996, Sullivan et al associated two histidine rich proteins (HRP II and HRP III) 
with the initiation of Hz formation. It was found that HRP II was able to bind more 
than 17 mol equivalents of haem under acidic conditions. Both HRP II and HRP III 
were shown to accumulate in the DV and bind haem in a process that was inhibited 
by CQ. 71  However when it was found that a P. falciparum clone of the CQ sensitive 
(CQS) HB3 and CQ resistant (CQR) Dd2 strains lack both HRP II and HRP III but still 
forms Hz, the significance of the role played by HRP in Hz formation was 
questioned. 72  Another protein speculated to be involved in Hz formation was 
identified by Jani et al in 2008. The haem detoxification protein (HDP) was found 
to rapidly convert haem into Hz within the DV. Unlike HRP II and III, HDP has been 
found in all species of Plasmodium. It is speculated that HDP specifically catalyses 
the formation of haem dimers and acts as a chaperone of dimers, delivering them 
to lipid bodies where Hz is assembled. 73  
The theory of lipid mediated Hz formation was popularised in a study by Fitch et al 
where it was found that lipid extracted from PRBC membranes promoted βH 
formation from Fe(III)PPIX under conditions mimicking the environment of the 
DV. 74 In 2007, Pisciotta et al demonstrated the presence of Hz crystals within lipid 
droplets in transmission electron microscopy (TEM) images of malachite green 
stained PRBCs, supporting the theory of lipid mediated formation of Hz (Figure 1-
8). Isolation and characterisation of the lipid droplets from P. falciparum via mass 
spectrometry found the composition to be a 4:2:1:1:1 ratio of monostearic: 
monopalmitic: dipalmitic: dioleic and dilinoleic glycerols. The lipid blend was 
capable of initiating haem crystallisation. 75 Recently, Ambele and Egan 
demonstrated that the neutral lipids associated with Hz formation mediate the 
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formation of βH under physiological conditions at rates analogous to the parasite. 
Confocal microscopy performed on samples of laboratory formed H, directly 
demonstrated that H was formed in close association with the neutral lipid blend. 
76   
 
 
Figure 1-8: TEM of trophozoites stained with malachite green. (A) An early 
trophozoite with small Hz crystals surrounded by neutral lipid spheres inside the 
DV. The inset clearly shows the crystals embedded within a lipid droplet and the 
lack of bilayer membrane at the periphery of lipid sphere. (B) A more mature 
trophozoite with larger haem crystals within the lipid. This image was originally 
published in: http://www.biochemj.org/content/402/1/197, Pisciotta, J.M et al, 
2007 with permission from the Biochemical Society. 75  
 
1.7 Chloroquine and related antimalarials 
 
The quinolines represent one of the world’s most successful drug classes (Figure 1-
9).77 QN was the first quinoline to be isolated from extracts of the bark of the 
Cinchona tree in 1820 by Pelletier and Caventou. 78 QN was used extensively 
during WWI and when demand for the drug exceeded supply, research into the 
production of synthetic alternatives was pursued. This led to the development of 
CQ and pyrimethamine (PYR).79 In 1943, CQ was taken into clinical trials and was 
subsequently widely used due to its effectiveness and low risk side effect profile.80 
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Following the success of CQ, the closely related 4-aminoquinoline, amodiaquine 
(AQ) was synthesized followed by the 8-aminoquinoline primaquine (PQ). Both 
were introduced as alternatives to CQ at the end of WWII.81 However, misuse of CQ 
led to the development of resistance in the 1960’s and although CQ is no longer 
recommended as a first line therapy for the treatment of malaria, this 4-
aminoquinoline still holds the record as the world’s most successful antimalarial.82 
In response to CQ resistance, the quinoline methanols, mefloquine (MQ) and the 
aryl methanol  halofantrine (HF) were developed by the Walter Reed Army 
Institute of Research in 1963.83  
 
Figure 1-9: Structures of some quinoline and related antimalarials discussed in 
this literature review. 
 
1.7.1 Mechanism of action of chloroquine and related antimalarials 
 
Chloroquine has been shown to be active only against the intraerythrocytic stage 
of the parasite lifecycle where Hb is actively degraded, providing the first clue that 
its mechanism must be related to processes which occur during this stage of the 
parasite lifecycle. 84  Further clues towards the mechanism of action of CQ were 
provided when treatment of parasites with pharmacologically relevant 
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concentrations of CQ, produced swelling of the DV and the accumulation of Hb. 35 85 
The evidence above suggested that CQ acts on the Hb degradation pathway. 
Several theories for the mechanism of action of CQ have been proposed including 
the inhibition of haemoglobin proteases, inhibition of the peroxidative degradation 
of haem, inhibition of glutathione dependent degradation of haem in the parasite 
cytosol and direct inhibition of Hz formation. 40 31 86 66 
1.7.1.1 Accumulation in the digestive vacuole 
A weak diprotic base, CQ has been shown to accumulate several thousand fold 
within the acidic DV of the malaria parasite by ion-trapping. 87 88 In its 
unprotonated form CQ moves down the pH gradient to the acidic DV, where once 
protonated becomes trapped as result of its membrane impermeability. 89 90 
Chloroquine is thus able to concentrate from nanomolar to almost millimolar 
concentrations in the DV. The pH gradient is important in determining the level of 
CQ accumulation and has received significant attention, especially in light of CQ 
resistance. Decreasing the pH gradient by increasing the pH of the DV would 
results in decreased CQ accumulation. However there is little evidence of this and 
indeed, several studies even went so far as to claim that the pH of the DV in CQR 
strains is more acidic, reducing the solubility of haem in the DV and hence reducing 
the availability of the prosed drug target for CQ rather than the accumulation of CQ 
itself. 91 92
 Establishing the exact pH of the DV has been an area of significant debate, with pH 
values ranging from 4.2 to 5.9. The variation being largely dependent on the 
method of measurement used. 92 90 93 94 91 Klonis et al measured the DV pH to be 5.4 
– 5.5 using a flow cytometry based method based on the pH sensitivity of green
fluorescent protein (GFP). Furthermore they found no difference in the pH of 
between CQS and CQR strains. 95 In addition to pH trapping, CQ has been shown to 
accumulate in the DV as a result of interaction with free haem in the DV which acts 
as a CQ receptor. 96 The accumulation of CQ in the DV supports the theory that the 
mechanism of action of CQ and related antimalarials is related to the process of Hb 
degradation which occurs in the parasite DV. 
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1.7.1.2 Measuring inhibition of Hz formation 
 
The determination of the ability of a compound to inhibit Hz formation within the 
malaria parasite is routinely carried by measuring the formation of synthetic Hz, 
βH, within a cell-free environment mimicking conditions of Hz formation within 
the DV.  Several methods have been developed to achieve this (Table 1-1). 
The evolution of the βH inhibition assay can be traced back to the experiments by 
Slater and Cerami where it was demonstrated that CQ and QN inhibited the 
formation of Hz under physiological conditions and in the presence of PRBC 
extracts. 64 66 Quantitative spectroscopic measurement was first reported by 
Basilico et al. Based on the solubility of haem but not βH in aqueous mildly alkali 
solutions, haem could be measured in mixtures of haem and βH. 97 The method was 
subsequently modified to a higher throughput 96-well plate method used for 
screening larger volumes of compounds for βH inhibitory activity. In this method, 
test compounds were incubated overnight in 4.5 M acetic acid. Unreacted haem 
solubilised in DMSO was measured spectroscopically. 98 The method, referred to as 
the haem polymerisation inhibitory activity (HPIA) assay was subsequently 
modified to eliminate the presence of interference by phosphates and chloride 
salts. Haemin rather than haematin was used as the starting material and sodium 
hydroxide as the solvent for unreacted haemin. 99 Ncokazi and Egan introduced 
further improvements for the measurement of βH inhibition with the development 
of the ferrihemochrome method, based on the pyridine hemochrome method 
published by Partos in 1922. 100 This modification improved the detection of the 
haem species by spectroscopically measuring haem as a low spin haem-pyridine 
complex. Additionally this method required only 60 min of incubation at 60 °C. 101 
Recently the assay has been adapted to a more physiologically relevant one, where 
inhibition of βH is measured in a lipid environment representing the site of Hz 
inhibition in the DV. Later, Carter et al reported the lipophilic detergent Nonidet P-
40 (NP-40) best mimicked results obtained when compared to the neutral lipid 
blend identified in the parasite DV (Section 1.6.3). 102 This method has been 
adapted to a high throughput screening method used to screening libraries of tens 
of thousands of compounds for the identification of novel βH inhibiting 
compounds. 103 104 105   
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Measurement of βH using several of the methods described above has been 
extensively performed on the quinolines and a strong relationship between the 
quinolines, βH inhibition and parasite growth inhibition has been demonstrated on 
several occasions. 106 107 52 69 101 72 108 109 Although most of the research surrounding 
Hz inhibition has been carried out in relation to CQ, the findings have been 
associated with related quinolines. The relationships established by these studies 
on βH formation supports the view that these quinolines share a mechanism of 
action involving Hz inhibition with CQ. 
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CQ = chloroquine, AQ = amodiaquine,  PQ = primaquine, QD = quinidine, QN = quinine, MQ = mefloquine, HF = 
halofantrine, AMN = artemisinin, DHA = dihydroartemisinin, PYR = pyrimethamine, ATV = atovaquone, 10-dO-
AMN = 10-deoxoartemisinin.  
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While measuring βH inhibition in a non-cellular system has been widely applied, 
demonstrating the effects of Hz inhibition within the parasite has not been as 
straight forward. A study by Asawamabasakda et al measured the effects of CQ and 
AMN on Hz production in three strains of P. falciparum, CQR, W2 and FCR3 and 
CQS, D6. Hz was extracted from drug treated (6 h) isolated trophozoites by 
filtration and spectrophotometrically quantified as pmol of Hz per 106 cells. 
Interestingly it was found that CQR strains contained more Hz than the CQS strain. 
The amount of Hz in treated cells was measured in conjunction with hypoxanthine 
content to determine if Hz formation occurs at or below concentrations which 
affect parasite viability. Hypoxanthine is known to be taken up by malaria 
parasites and incorporated into nucleic acids and was used to determine parasite 
viability. It was found Hz formation was inhibited only in cells treated with CQ 
concentrations at or greater than the parasite growth IC50. The authors deduced 
the effect of CQ on Hz formation was small in comparison to parasite survival and 
therefore a small effect of CQ on Hz formation is required to kill the parasite, or the 
drug is killing via a secondary mechanism affecting Hz production indirectly. 
Treatment with AMNs produced no change in Hz levels at any concentration 
tested. 111 Another study by Burgess et al examined the effects of Hz formation in a 
CQS strain D6 and CQR strain Dd2 of P. falciparum inoculated with 2 novel CQ 
analogues (compound 1 and 22) which contained CQ resistance reversal moieties. 
112 113 Both compounds inhibited the formation of βH and were derived from a 
series which demonstrated a favourable correlation between the parasite growth 
inhibition and the ability to inhibit the formation of βH. Trophozoites were isolated 
by saponin lysis 24 h after inoculation and Hz was extracted via centrifugation. The 
washed Hz was dissolved in 0.2 M sodium hydroxide and the amount of haem was 
spectroscopically determined. The results were examined in conjunction with 
microscopy images (Figure 1-10).  Haemozoin formation in cells treated with 
compound 22 was almost completely inhibited at 10 nM in D6 and 100 nM in Dd2. 
A similar effect was seen in Dd2 treated with CQ at 1000 nM. Results for compound 
1 were between compound 22 and CQ. Examination of the Hz crystals within the 
DV of microscopy slides confirmed the results obtained for measured Hz. The 
authors deduced that compounds 1 and 22 had a similar mechanism of action to 
CQ.  
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Figure 1-10: The effect of various concentrations of CQ, compound 1 and 22 on D6 
and Dd2 demonstrated via light microscopy images  (A) and Hz formation (B). The 
table (C) summarises the observations made from Figure A and B. Reprinted and 
adapted with permission Burgess, S.J., Kelly, J.X., Shomloo, S., Wittlin, S., Brun, R., 
Liebmann, K. and Peyton, D.H., 2010., Synthesis, Structure− Activity Relationship, 
and Mode-of-Action Studies of Antimalarial Reversed Chloroquine Compounds. J. 
Med. Chem., 53, 6477-6489 with permission from American Chemical Society 
(Copyright 2010). 112  
 
Although both studies were able to measure changes in Hz formation in P. 
falciparum in response to drug treatment, neither study demonstrated the result of 
Hz inhibition. The level of haem produced, if any, in response to changes in Hz 
formation was not determined. This is an important determination as this free 
haem is regarded as the route of toxicity attributed to Hz inhibition resulting in 
parasite death.  Furthermore decreased level of Hz formation could be as a result 
of secondary unrelated effects in the cell due to reduced Hb uptake, resulting in 
less Hz formation and interpreted as Hz inhibition. Although providing useful 
A B
C
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information neither method is able to directly attribute the mechanism of action of 
the compounds investigated to direct Hz inhibition.  
 
1.7.1.3 Hz inhibition as a drug target 
 
Evidence that the mechanism of action of several quinoline antimalarials do not 
directly interfere with Hb degradation was demonstrated using protease inhibitors 
which block the digestion of Hb. While inhibition of Hb digestion by protease 
inhibitors was reversed upon removal, this was not true for quinoline 
antimalarials suggesting a mechanism downstream from the inhibition of Hb 
degradation is involved. 114 115 Chou et al in 1980 reported than haematin was the 
receptor of CQ in P. falciparum.96 Several studies followed implicating Hz inhibition 
as the mechanism of action either through interaction with haem or with the Hz 
crystal itself. In 1992 Slater and Cerami showed that both CQ and QN inhibited the 
formation of Hz under physiological conditions and in the presence of PRBC 
extracts, suggesting that a subsequent increase in toxic free haem or haem-drug 
complexes killed the parasite. At the time Hz inhibition was attributed to the ability 
of CQ and QN to inhibit the functioning of HPE. 66 Sullivan et al demonstrated the 
association of Hz with quinolines using electron microscopy (EM) 
autoradiography. Parasites incubated in the presence of [3H] quinidine (QD) and 
[3H] CQ showed the signal arising from the labelled quinolines was almost 
exclusively over the Hz in the DV. Furthermore subcellular fractionation of 
parasites incubated in the presence of [3H] QD and [3H] CQ showed the quinolines 
were associated with recovered Hz. It was suggested that the quinolines bind haem 
and form a drug-haem complex which is incorporated into growing Hz, preventing 
the addition of further haem and terminating growth of Hz (Figure 1-11). The 
theory explains the hyper-concentration of CQ within the DV which cannot be fully 
accounted for by the effects of pH trapping alone. 116 Haem in RBC Hb is present at 
approximately 20 mM. If most of this is digested by the parasite within the 4 fL DV 
haem concentrations could theoretically reach 0.4 M. If a quinoline molecule were 
incorporated at every 400th haem, quinoline concentrations would reach 1mM 
within the DV. 54  
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Figure 1-11: Model of quinoline inhibition of Hz formation as proposed by 
Sullivan et al. Quinolines bind haem forming a drug-haem complex which is 
incorporated into growing Hz 54. From: Sullivan, D.J., Gluzman, I.Y., Russell, D.G. and 
Goldberg, D.E., 1996. On the molecular mechanism of chloroquine's antimalarial 
action. Proceedings of the National Academy of Sciences, 93(21), 11865-11870. 
Copyright (1996) National Academy of Sciences.  
 
Despite overwhelming evidence that CQ and related antimalarials inhibit Hz 
formation, it is not clear whether this is due to direct interaction of the drug with 
haematin or adsorption of the drug onto the fastest growing face of the Hz. 96 54 The 
structures of co-ordination complexes between Fe(III)PPIX and each of HF, QN and 
QD have previously successfully been determined using single X-ray diffraction, 
demonstrating direct interaction with Fe(III)PPIX. 117 118 An unsuccessful attempt 
to similarly grow and elucidate the crystal structures for the 4-aminoquinolines by 
Gildenhuys et al led to the discovery that in a lipid water system at low 
concentrations of CQ the rate of βH formation decreases. This outcome reproduces 
results obtained by Egan and Ncokazi, where it was shown that the formation of 
βH (4.5 M acetate, pH 4.5 at 60 °C) in the presence of CQ, AQ, QN and QD is not 
inhibited, but rather the rate at which βH forms is decreased. 52 Adsorption of the 
drug to the fastest growing face of the βH crystal, rather than the formation a 
complex with Fe(III)PPIX was used to explain the behaviour observed at lower, 
more biologically relevant drug concentrations. Modelling of the results showed 
that at higher drug concentrations, the βH yield decreased and an insoluble 
Fe(III)PPIX precipitate was formed.119   
The recent discovery that Hb metabolism and Hz formation take place in acidified 
“pre-DV” compartments during the early ring phase of the parasite lifecycle has 
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implications for antimalarials such as CQ which most likely act on the Hz formation 
pathway and accumulate in acidic compartments. 36 Ring stage parasites would 
therefore accumulate CQ and inhibit the early stages of Hz formation resulting in 
the formation of toxic haem and continue into the trophozoite stage. This would 
provide a rationale for previous studies have shown that ring stage parasites are 
more susceptible to CQ treatment. 120  
 
1.7.1.4 Inhibition of haemoglobin degradation 
 
Several quinolines, including CQ have in the past been shown to interfere with the 
process of Hb degradation. Treatment with CQ has been shown to increase the 
amount of undigested Hb in parasites. 121 122 Ginsburg et al in 1984 showed that 
increased Hb levels were accompanied by an accumulation of single membrane Hb 
laden transport vesicles in the DV of CQ treated cells. This was attributed to 
inhibition of phospholipases responsible for digesting the transport vesicle 
membranes and releasing the RBC cytosol contents into the DV for digestion of Hb. 
123 A subsequent study by Hoppe et al studied the effects of CQ, AMN and MQ on 
endocytosis in P. falciparum.  In this study increased levels of Hb in cells treated 
with CQ at the ring stage for 12 h was accompanied by the presence of double 
membrane transport vesicles outside the parasite DV (Figure 1-12 A, B). This was 
attributed to failure to deliver transport vesicles to the DV and the inability to fuse 
transport vesicles with the DV. Interestingly when cells were treated with CQ for a 
shorter time period (5 h), later in the lifecycle, an increase in undigested Hb levels 
was observed but no accumulation of transport vesicles. This observation suggests 
the parasite is more sensitive to the effects of CQ at the ring stage. 120 The 
downstream effect of inhibiting Hb degradation whether by preventing fusion of 
transport vesicles with the DV or inhibiting the lysis of transport vesicle 
membranes is that the parasite cannot access Hb. Although studies have shown 
that only a fraction of these amino acids are required, inhibiting the degradation of 
Hb also prevents parasite growth as Hb degradation will free up space in the cell 
for expansion and parasite growth. 29 49  Moderate increases in undigested Hb were 
also seen in cells treated with AMN, with no accompanying accumulation of 
transport vesicles. 124 Parasites treated with MQ showed a decrease in parasite Hb 
levels attributed to the inhibition of the process of endocytosis by the parasite 
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cytostomal system. 121 As in the case of AMN no accompanying evidence of 
accumulation of transport vesicles was observed in the MQ treated parasite. 124  
In a subsequent study by Roberts et al the effects of QN, HF and AQ were 
investigated and compared to CQ. 125 Parasites were inoculated at concentrations 
corresponding to 5× the parasite growth IC50 for 8 h. Cells treated with MQ, QN and 
HF reduced Hb content by 83%, 64% and 84% respectively and showed no 
evidence of increased accumulation of transport vesicles (Figure 1-12 C). Cells 
treated with CQ resulted in a 283% increase in Hb content and an accumulation of 
Hb transport vesicles as previously shown. 124 121 122 It was expected that the 4-
aminoquinoline AQ, closely related to CQ, would produce an effect similar to CQ in 
treated cells. However treatment with AQ produced no increase in levels of 
undigested Hb, but did show an increase in Hb laden transport vesicles in the 
parasite. Closer examination revealed that AQ treated cells exhibited a 
combination of behaviours seen in CQ treated cells and cells treated with MQ, QN 
and HF. Inhibition of endocytosis accompanied by an accumulation of Hb transport 
vesicles which  caused the net effect to show no change in Hb levels of AQ treated 
cells.125 Previous studies have shown that Hb antagonises the action of the 
quinolines. 126 The addition of protease inhibitors (PIs) increased Hb levels in the 
control and caused no real change in the Hb levels of both CQ and AQ treated cells. 
In cells treated with MQ, QN and HF, Hb levels were decreased by 66%, 31% and 
30% respectively, in comparison to decreases of 83%, 64% and 84% in the 
absence of PIs (Figure 1-12 D). This indicates that the presence of undigested Hb in 
cells treated with MQ, QN and HF in the presence of PIs antagonised the effect the 
drugs had on the inhibition of endocytosis, agreeing with previous work. 126 125   
The effects of the above mentioned drugs cannot exclusively be attributed to a 
direct effect of the drugs themselves, but could be due to a secondary downstream 
effect of the drug. In the case of CQ, treatment is postulated cause a build-up of 
toxic haem through inhibition of Hz formation. The increased levels of lipophilic 
toxic haem could very well interact with membranes and causing membrane 
damage preventing membrane fusion resulting in an accumulation of transport 
vesicles in the parasite cytosol as demonstrated by Hoppe et al. 57 124 However the 
evidence summarised above suggest the quinoline methanols differ in their 
mechanism of action in comparison to CQ. Further evidence that the quinoline 
methanols possess a different drug target is shown in the treatment of P. berghei 
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infected mice with a range of antimalarials. Whereas CQ and 4-aminoquinoline 
derivatives caused a decrease in the amount of Hz produced, QN, MQ and PQ 
showed no effect. 127  
 
 
Figure 1-12:  TEM of chloroquine-treated parasites in A, B showing accumulation 
of transport of vesicles outside the DV. infected red blood cell = RBC, parasite = 
PAR, parasite nucleus = NU, digestive vacuole = VAC, and transport vesicles 
(asterisks). Hb levels in drug-treated parasites in C, D. (C) Parasite cultures were 
untreated (control [Con]) or incubated with CQ, AQ, quinine (Q), halofantrine (H) 
and MQ. (D) In parallel cultures, the quinoline drugs were added in combination 
with the protease inhibitors. An asterisk (*) indicates a significant change from the 
results for the controls (P < 0.05; 95% confidence interval [CI]). Images A, B from 
Hoppe et al, 2004 124 and C, D from Roberts et al, 2008 125 reproduced with the 
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1.7.2 Resistance to chloroquine and related quinolines   
 
1.7.2.1 Chloroquine resistance 
 
Chloroquine was successfully used for the treatment of malaria throughout the 
1940s and 1950s. 128 Resistance to CQ emerged in the 1960s in S.E. Asia and South 
America and by the 1980s had spread across Africa. 82 The development and 
spread of resistance to CQ and related antimalarials has significantly increased the 
global cost of controlling malaria, as new drugs must be continually developed to 
replace ineffective treatments. 2   
The emergence of CQ resistance is attributed to mutations in the ‘Plasmodium 
falciparum CQ resistance transporter’ (PfCRT) and other DV membrane proteins 
resulting in reduced CQ accumulation. 129 130 In comparison to CQS strains, 
resistant parasites have been shown to accumulate up to ten times less CQ in the 
DV, falling outside the effective therapeutic range for CQ.131 PfCRT is a member of 
the Drug/Metabolite Transporter (DMT) superfamily (Figure 1-12). The 424 amino 
acid protein, encoded by the pfcrt gene on chromosome 7, localises to the parasite 
DV. 130 PfCRT has been found to be essential to the parasite and is assumed to play 
a role in the transport of amino acids and peptides out of the DV.132 Several 
mutations in PfCRT (PfCRTCQR) have been identified in CQR strains, most of which 
are located on the vacuolar side of the protein (Figure 1-13). However the 
substitution of positively charged lysine for neutral hydrophobic threonine at 
position 76 (K76T) has been shown to be essential in conferring resistance. As a 
consequence of this mutation, protonated CQ (CQH2+  or CQH+) previously trapped 
in the DV is able to efflux out of the DV. In its protonated state, CQ is unable to 
interact with the wild type K76 PfCRT, however protonated CQ can interact with 
PfCRTCQR allowing transport down the electrochemical gradient away from the DV. 
Resistance arises due to a reduced concentration of CQ at its site of action within 
the DV.133 The process has been shown to be saturable and temperature 
dependent. The effect of PfCRTCQR  can therefore be overcome by increasing the 
dose of CQ administered and in so doing saturate the transport process of CQ out 
of the DV allowing lethal concentrations of CQ to be reached within the DV.129 A 
recent study conducted in Guinea-Bissau on patients infected with CQR malaria 
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showed that at high doses, CQ treatment was as therapeutically effective as AMN-
lumefantrine (LF) combination therapy at curing infection. 134  
Resistance to CQ is reversed in the presence of the calcium channel blocker 
verapamil (VP) causing a decrease in the parasite growth IC50 value and increased 
accumulation in CQR strains. 135 136  However, the concentration of VP required to 
bring about this change is beyond its therapeutic concentrations. 137 It has been 
suggested that some resistance reversers are themselves substrates for PfCRTCQR 
and therefore compete with CQ for transport out of DV. 138 These substrates 
therefore represent a possible class of effective antimalarials which could possibly 
block functioning of normal PfCRT. Although the K76T mutation is essential for 
resistance, the mutation alone is not sufficient for resistance. The CQR strain Dd2 
for example, contains eight mutations in PfCRTCQR not found in the wild type. 129 
This suggests that one or more additional mutations work together to transport CQ 
out of the DV. 
 
 
Figure 1-13: Arrangement of known polymorphic residues in PfCRT. PfCRT is 
predicted to contain 10 α-helical transmembrane domains (TMDs) and to be 
orientated in the DV membrane with the N- and C-termini extending into the 
parasite cytosol. The positions of the polymorphic residues are indicated 
with black circles. The key CQ resistance-associated mutation (K76T) is 
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represented as a red square. The box attached to each polymorphic residue lists 
the (non-wild-type) amino acid(s) known to occur at that position. The predicted 
roles of the TMDs are as follows: 4 and 9 (outlined in dark green) are implicated in 
the binding and translocation of substrates, TMDs 3 and 8 (boxed in light green) 
are thought to assist in the binding and translocation of the substrate and may also 
influence the substrate-specificity of the transporter, TMDs 1, 2, 6, and 7 (boxed in 
black) are involved in recognising and discriminating between substrates, and 
TMDs 5 and 10 (outlined in mid-green) play a role in the formation of homo-
dimers. 129 Cellular and Molecular Life Sciences, Know your enemy: understanding 
the role of PfCRT in drug resistance could lead to new antimalarial tactics, 69, 
2012, 1967 – 1995, Summers, Robert L., Megan N. Nash, and Rowena E. Martin, 
(Springer Basel AG 2012). With permission of Springer. 
 
Mutations in proteins other than PfCRT have also been identified in relation to CQ 
resistance. A homologue of eukaryotic ATP-binding cassette (ABC) protein, the 
Plasmodium falciparum multidrug resistance transporter 1 (PfMDR1) has been 
linked to CQ resistance. Expressed at the DV membrane, PfMDR1 is thought to be 
involved in the transport of substrates from the cytosol into the DV.139 Indeed it 
has been shown that wild type PfMDR1 expressed in oocytes mediates CQ 
transport. 140 Alone, mutations in PfMDR1 do not confer resistance, but can 
modulate resistance to CQ in parasites with PfCRTCQR. Mammalian Chinese hamster 
ovarian cells modified to express PfMDR1 showed an increase in CQ accumulation 
and increased sensitivity to CQ toxicity. 141 Therefore it is likely that while in wild 
type parasites PfMDR1 may transport CQ into the DV, in resistant parasites the 
ability of PfMDR1 to transport CQ into the DV is compromised. In CQR strains, 
PfMDR1 works synergistically with PfCRTCQR to reduce the concentration of CQ in 
the DV. 140  
 
1.7.2.2 Resistance to other quinolines 
 
Based on their ability to inhibit βH formation, the more hydrophobic aryl 
methanols including, QN, QD, MF, lumefantrine (LF) and HF are postulated to share 
the mechanism of Hz inhibition of CQ. However as discussed in Section 1.7.1.4 it is 
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also possible that QN, Mef and HF have drug targets other than the inhibition of Hz 
formation. Similarly mechanisms of resistance in these quinolines share 
similarities, but also differ in several aspects. 
Resistance to MQ has been related to increase copies of the pfmdr1 gene resulting 
in the increased expression of PfMDR1. 142 143 144 145 It has been shown that parasite 
strains which are resistant to MQ also show reduced susceptibilities to HF, LF as 
well as QN. 143 146 147 However, resistance to MQ has been associated with increased 
CQ sensitivity. 144 148 Cowman et al showed that two CQR strains of P. falciparum 
cultured under MQ drug pressure had an amplification of the pfmdr1 gene which 
resulted in an overexpression of the protein PfMDR1. The strains showed an 
increase in resistance to MQ, as well as HF and QN and a decrease in resistance to 
CQ.143  When the CQR strain K1 was cultured under HF drug pressure, the resulting 
strain (K1HF) demonstrated increased susceptibility to CQ and reduced 
susceptibility to HF and MF. Three novel PfCRT mutations were identified in K1HF 
one of which (S163R) reintroduced a positive charge to PfCRTCQR. 132 This novel 
mutation was postulated to increase sensitivity to CQ by reinstating the ability of 
CQ to accumulate in the DV. 149 An inverse relationship was established between 
CQ resistance and MQ resistance, related to the accumulation via PfMDR1. The 
relationship suggests that as the function of PfMDR1 is to transport substrates into 
the DV and the amplification of PfMDR1 results in resistance to MQ, HF, LF and QN. 
These drugs may have targets outside the DV in the parasite cytosol. The reverse is 
true for CQ. Amplification of PfMDR1 results in increased CQ susceptibility as a 
result of increased transport into the DV, the site of action of CQ. It has also been 
postulated PfCRTCQR effluxes MQ out of DV as in the case of CQ and if indeed MQ 
has a drug target in the cytosol, this explains why PfCRTCQR increases susceptibility 
to MQ.  
Parasites resistant to CQ often share a reduced sensitivity to QN, implicating PfCRT 
in the mechanism of resistance of QN. 150 151 It has been shown that CQR parasites 
efflux QN out of the DV at a rate greater than that of a CQS strain. 152 Additionally 
QN, like CQ has been shown to induce a proton pump leak from CQR parasites, 
consistent with the theory that resistance is a result of efflux of drug out of the DV 
in the presence of PfCRTCQR. 138 Evidence that QN, like CQ is effluxed out of the DV, 
re-affirms Hz inhibition is the likely target for QN. However, parasite strains which 
are resistant to MQ also show reduced susceptibilities to HF, LF and QN. 143 146 147 
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The replacement of PfCRT by PfCRTCQR in a CQS strain, GCO3 increased 
susceptibility to both MQ and QN, suggesting that QN, as in the case of MQ, has a 
cytosolic target.153 QN resistance does not seem to arise from a single cause.  It is 
suggested that this is due to a mechanism of action which has more than one target 
in the cell in the case of QN. 58 125   
Given the structural similarity of AQ to CQ it is expected that the mechanism of 
resistance would be similar. As is the case for CQ, AQ resistance is associated with 
changes in both PfCRT and PfMDR1 translating into efflux out of the DV and 
reduced transport into the DV respectively. 154 129 However the more hydrophobic, 
AQ retains some activity against CQR parasites.155 This has been partly attributed 
to their retention in the hydrophobic lining of CQR-PfCRT channel. 135 156 
Furthermore, resistance to AQ has been associated with different haplotypes in 
PfCRT compared to CQ resistance. 157  
 
1.8 The Artemisinins 
 
AMNs in combination with a partner drug are currently recommended by the WHO 
as a first-line treatment of P. falciparum malaria.158 Derived from ancient Chinese 
herbal medicines, the AMNs are effective against both CQR and multi-drug 
resistant strains of malaria. They are fast acting and effective against all asexual 
stages of P. falciparum, from recently formed rings to schizonts and possess anti-
gametocyte activity imparting the added benefit of transmission prevention. 159 160   
 
1.8.1 Resistance to the artemisinins 
 
Reports of emerging resistance to the AMNs have been increasing, with cases first 
recorded in Western Cambodia. 161 162 Resistance is defined as a decline in the 
efficacy of treatment characterised by slow parasite clearance. Dondorp et al in 
2009 conducted a clinical study in Pailin, Western Cambodia and Wang Pha, 
Thailand where the effects of oral artesunate (ART) and ART-MQ combination 
therapy were evaluated. Median parasite clearance in Thailand was determined to 
be 48 h, compared to 84 h in Cambodia. In a subsequent study published by Ashley 
et al in 2014 it was found that AMN resistance to P. falciparum was prevalent 
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across most of South East Asia (Figure 1-14). The study was conducted on patients 
with acute, uncomplicated P. falciparum malaria, treated with ART from May 2011 
to April 2013 at fifteen different sites in ten countries. Parasite clearance half-life 
at the Thailand-Cambodia border was found to be 7 h, 5 h longer than in the 
Democratic Republic of Congo, with resistance defined as a parasite clearance with 
half-life of 5 h or longer.  These resistant strains were strongly associated with 
single point mutations on chromosome 13 (kelch13 polymorphism), which 
encodes a kelch protein. The mutation has been detected throughout mainland 
Southeast Asia where prolonged courses of AMN-based combination therapies are 
required for effective treatment.163 Novel antimalarial treatments currently in 
development will not be available for several years. It is therefore imperative to 
curb the spread of resistance to AMN combination therapies.  
 
Figure 1-14: The location of patient study sites described by Ashley et al is shown 
in Figure A with insets indicating the proportions of patients with AMN resistance 
(parasite clearance half-life > 5 h). Parasite clearance curves for groups of 20 
patients from Pailin, Cambodia (red and purple lines) and Wang Pha, Thailand 
(orange and blue lines) are shown in figure B. Graphs representing ART 
monotherapy at a dose of 2 mg/ml (red and orange) and ART-MQ combination 
therapy at 4 mg/kg of ART for 3 days followed by MQ at 15 mg/kg on day 3 and 10 
mg/kg on day 4 (purple and blue) are shown. Image A was reproduced with 
permission from Ashley et al 163, Copyright Massachusetts Medical Society. Image B 
was reproduced with permission from Dondorp et al 162, Copyright Massachusetts 
Medical Society.  
A
B
Parasite clearance half-life ≤ 5 h
Parasite clearance half-life > 5 h,  kelch 13 polymorpisisms at or 
beyond amino acid position 441
Parasite clearance half-life > 5 h,  no kelch 13 polymorpisisms at or 
beyond amino acid position 441
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The AMNs are characterised by a peroxide group in a 1,2,4-trioxane system, 
proved to be essential for antimalarial activity.160 These drugs require activation 
by cleavage of the endoperoxide ring creating reactive intermediates which, 
through various cellular interactions including interaction with parasite protein 
nucleophilic groups, result in parasite death.164 The mechanism of action of AMNs 
has not been fully elucidated and the role of haem in the mechanism of action of 
this drug class remains a widely debated topic.2 110 98 Reduced haem and ferrous 
iron have been suggested as activators. Ferrous iron derived from a small labile 
pool of intracellular iron released by haem degradation in the DV and haem as a 
by-product of Hb digestion occurs most abundantly in the trophozoite phase. 31 36 
165 166 167 168 Given the abundance of haem as a consequence of parasite Hb 
digestion during the trophozoite stage, it seems an obvious choice as a preferred 
activator. However, the presence of Fe chelators were shown to antagonise the 
effect of the AMNs, demonstrating that non haem sources of Fe were required for 
activation.169 Recently, Xie et al demonstrated that the presence of Fe chelators at 
the early ring stage attenuated AMN activity, while at the troph stage PIs 
effectively reduced the activity of the AMNs, proposing that both ferrous haem and 
Fe2+ are involved in activation at different stages of the lifecycle depending on 
abundance.170 Since Fe chelators antagonised but did not eliminate AMN activity 
and haem reacts with AMNs much more efficiently than other Fe containing 
molecules, haem activation of the AMNs remains a feasible option. However, haem 
dependent AMN activation conflicts with the fact that AMN maintain activity at all 
stages of the P. falciparum lifecycle, with very high activity against very early ring 
stages (2 – 4 h post invasion) believed to possess little or no free haem. 171 111 
Recent research has shown that down modulating the expression of falcipain II and 
III rendered early rings resistant to AMNs, implicating Hb derived haem in the 
activation and activity of AMNs and indirectly demonstrating that Hb degradation 
does to some degree occur even in early rings.170 As discussed in Section 1.5.1, 
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fluorescence and electron tomography of mid ring stage parasites showed a 
detectable “pre-DV” acidified Hz containing compartment signifying that Hb 
degradation does occur at the early ring stage.36 Furthermore an inactive 
cytostomal ring indicative of feeding apparatus was seen at the periphery of 
merozoites suggesting that Hb uptake and degradation does occur very early in the 
parasite lifecycle, making the presence of haem in early ring stages a possibility. 34 
33  
 
1.8.2.2 Haemozoin inhibition 
 
The AMNs are known to interact with haem and several studies have identified the 
formation of haem-AMN adducts through the alkylation of ferrous haem by AMNs. 
Evidence of AMN haem association was found as haem-AMN adducts in the spleen 
and urine of Plasmodium vinckei infected mice treated with AMNs. 172 173 174 
Although this finding does suggest that AMNs interfere with Hz formation, 
accumulation of haem in organs could also just be associated with disease 
progression. The adduct has been isolated and identified in several chemical 
studies, however the role of these adducts in the mechanism of action of the AMNs 
is not defined. Nonetheless it has been proposed that formation of this adduct 
inhibits haemozoin formation causing toxic build up of haem eventually killing the 
parasite through oxidative stress or inhibition of essential cellular processes. 51 175 
176 177 Loup et al showed that haem-AMN adducts were able to inhibit the 
formation of βH from haemin in acetate at pH 5 (37 °C, 18 h incubation).178 
However evidence against AMN inhibition of haemozoin in the parasites was 
shown when AMN treatment of PRBCs at both the ring (12 – 16 h into cycle) and 
troph stage did not diminish Hz content, while treatment with CQ inhibited Hz 
formation.111 Further evidence against AMN driven Hz inhibition provided by 
Eckstein, Ludwig et al, showed AMN in parasites does not accumulate in the DV 
and Asawamahasakda et al, showed that only 13-15% of radiolabelled AMN was 
found in the isolated Hz fraction. 179 111 AMNs are also effective against parasites 
that do not degrade Hb, such as Toxoplasma gondii and Babesia spp, while CQ, 
known to inhibit Hz formation has been shown to be almost 200 fold less potent 
against Babesia Gibsoni. 180 181 182  Therefore, although Hz inhibition has been 
implicated as a target for this drug class, it remains a controversial topic.98 111 183 In 
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2003, Haynes et al published an article which showed two potent AMN derivatives, 
10-deoxoartemisinin (10-dO-AMN) and dihydroartemisinin (DHA) do not inhibit 
the formation of the synthetic Hz analogue, βH.110 The drugs were screened for βH 
inhibition using two alternative methods, the haem polymerisation inhibitory 
activity assay (HPIA, acetic acid at pH 2.7 for 18 h at 37 °C) and the β-haematin 
inhibitory activity assay (βHIA, DMSO-acetate buffer at pH 5.0 for 18 h at 37 °C). 98 
99 DHA showed a dose dependent inhibition in the HPIA assay only, while no 
activity was seen with 10-dO-AMN in either assay, contrary to positive results 
previously obtained for several quinolines, including CQ, AQ, QN and MQ. 105 184 101 
In a separate study AMN, like DHA showed activity in the HPIA.98 The activity of 
AMN and DHA in the HPIA can be attributed the unstable nature of these 
compounds under the aqueous conditions used in the HPIA resulting in an opening 
of the ring and consequent binding to free haem. 10-dO-AMN is more stable than 
both AMN and DHA under aqueous condition therefore less likely to interact with 
haem. With no oxygen at C-10, 10-dO-AMN is not prone to ring opening under 
aqueous condition and therefore cannot bind Fe(III)PPIX. Despite lack of activity in 
the HPIA and the βHIA, 10-dO-AMN remains a potent antimalarial indicating that 
βH inhibition and binding to Fe(III)PPIX is not required for antimalarial action.  
Several other drug targets of the AMNs, other than Hz inhibition have also been 
explored; however, a single target resulting in cell death has not yet been 
identified. Radiolabelled AMN derivatives incubated at physiological drug 
concentrations with PRBCs at various stages of the parasite lifecycle were found to 
be covalently bound to six parasite proteins indicating a possible drug target. 185 186 
AMNs have also been shown to accumulate in neutral lipids causing membrane 
damage and have been shown to affect the mitochondrial electron transport chain 
in yeast. 187 188 189   
 
1.9 Non-haemozoin inhibiting antimalarials 
 
The structure of the non-βH inhibiting antimalarials PQ, PYR, Sulfadoxine (S) and 
atovaquone (ATV) are shown in Figure 1-15. The 8-aminoquinoline, PQ is known 
to have a distinctly different target in P. falciparum, acting on the liver stage rather 
than the asexual stage of the malaria lifecycle.190 79 PQ has also been shown to have 
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potent gametocytocidal activity in P. falciparum.191 70 Methylene blue, was the first 
synthetic compound to be used for the clinical treatment of malaria in the 19th 
century, however its toxicity led to the synthesis of PQ.192 As previously mentioned 
PQ, like QN and MQ, when used to treat P. berghei infected mice showed no effect 
on Hz formation while CQ treatment showed a decrease in Hz production.127 PQ 
has also been shown not to produce any evidence of βH inhibition and unlike CQ, 
MQ and QN was shown not to complex with haem. 99 69 193   
PYR and S are two antifolates most frequently used for the treatment of malaria. 
Both compounds act on the folate synthesis pathway, required for nucleotide 
synthesis and amino acid metabolism. PYR inhibits the enzyme dihydrofolate 
reductase and S interferes with dihydroopteroate synthase.1 194 195 Administered as 
a combination therapy (SP), the two antifolates have a synergistic effect, however, 
widespread use of the combination has led to resistance. 196 197 Neither PYR or S 
have an effect the formation of βH and are often used as negative controls in assays 
which screen for  βH  inhibiting antimalarials.105 
ATV interferes with the mitochondrial electron transport chain in the malaria 
parasite through inhibition of the respiratory enzyme complex, cytochrome bc1.198 
199 ATV resistance coincides with mutations in the cytochrome bc1 gene, 
confirming the mechanism of action of ATV.200 The use of ATV as a monotherapy is 
associated with a high rate of recrudescent parasitemia and high rate of resistance 
and is limited in developing countries due to the high cost associated with the 
production of the drug.29  
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Figure 1-15: Structures of non-βH inhibiting antimalarials discussed in this 
literature review 
 
1.10 The relevance of investigating the role of haem in the 
mechanism of action in antimalarials 
 
An effective vaccine is seen by many as the only solution for the elimination of 
malaria. A malaria vaccine currently in phase 3 clinical trials has been found to 
reduce clinical malaria by 39% and severe malaria by 31.5% in children aged 5 – 
17 months who received four doses of the vaccine. Chemoprophylaxis, certainly for 
the near future remains our only viable option in combatting malaria and in light of 
emerging AMN resistance we have a limited supply of effective available 
antimalarials to choose from. In recent years there has been a marked reduction in 
the global incidence of malaria. The disease is no longer the leading cause of death 
in children younger than five. However the rates of decline in Africa have been 
among the slowest. 2    
An overwhelming amount of evidence suggests that CQ and related antimalarials 
target Hz formation, resulting in increased levels of toxic haem (or haem-drug 
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complexes) eventually leading to cell death most likely through inhibition of 
proteases, oxidative stress and membrane damage. 201 202 51 57 However, prior to 
this report, a decrease in Hz, accompanied by an increase in free haem, confirming 
that this is the killing mechanism had never been demonstrated in the malaria 
parasite. Recently, several HTS campaigns of thousands of compounds to identify 
βH inhibitors have been carried out. 103 104 Demonstration of inhibition of Hz would 
be a valuable validation step.  The application of such a method could provide 
insight into the mechanism of Hz inhibition. Although widely studied, the details 
behind the mechanism of Hz formation and consequent inhibition of this process 
remain unclear.   
The long running success of CQ as antimalarial and the slow rate at which 
resistance emerged to this drug warrants further study into the mechanism of 
action behind this drug and related quinolines.  
 




To develop a method to measure whether CQ causes a dose related decrease in Hz 
and increase in ‘free” haem within treated P. falciparum that can be correlated to 




The aim was accomplished by fulfilling the following objectives: 
 
 Developing a method, the haem cellular fractionation assay, capable of 
determining the quantities of each of the haem species corresponding to Hb, 
“free” haem and Hz in CQ treated P. falciparum. 
 
 Modifying the haem cellular fractionation assay to a higher throughput 
technique and validate the new method using CQ. 
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 Applying the higher throughput method to several clinically relevant 
antimalarials of various mechanisms of action to confirm or exclude Hz 
inhibition as the mechanism of action. 
  
 Applying the method to several novel antimalarials which show promising 
activity to aid in understanding their mechanism of action and the process 
of Hz inhibition in non-quinoline scaffolds. 
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Chapter 2: General materials, instrumentation and methods 




All materials used were of AR grade or higher and unless specified used without 
further purification. The materials are listed according to the methods for which 
they were needed. Where materials are common to more than one method, they 
are mentioned where first used unless sourced from a different supplier. All 
consumables were purchased from Lasec, Millipore, Merck South Africa and Sigma 
Aldrich. The water used throughout this work was double distilled deionised 
Millipore® Direct-Q water. 
 
Table 2-1: List of materials used for the tissue culture of Plasmodium falciparum 
Materials for tissue culture of Plasmodium falciparum Supplier 
RPMI 1640 with glutamine but without  
sodium bicarbonate (R6504) 
Sigma Life Science 
D-(+)-Glucose Sigma Life Science 
 (N-2-[hydroxyethyl]piperizine-N’-2-[ethanesulfonic acid]) 
 HEPES  
Sigma Life Science 
Hypoxanthine Sigma Life Science 
Albumax II Gibco 
Gentamicin solution Sigma Life Science 
Sodium bicarbonate  Sigma Life Science 
Sodium chloride  Sigma Aldrich 
Sodium L-lactate Sigma Life Science 
Potassium chloride  Sigma 
Sodium dihydrogen phosphate  Merck 
Glycerine (1,2,3 – propantriol) Sigma Aldrich 
D- Sorbitol Sigma Life Science 
Oil for immersion lenses Merck 
Giemsa’s azur eosin methylene blue solution Merck 
Phosphate buffered saline (PBS) tablet  Sigma Life Science 
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Table 2-2: List of materials used for the antiplasmodial assays 
Materials for antiplasmodial assays Supplier 
Dimethyl sulfoxide (DMSO) Merck 
Triton X 100 Merck 
3-Acetylpyridine adenine dinucleotide (APAD) Sigma Life Sciences 
Calcium L-lactate hydrate Sigma Life Sciences 
Trizma base (Tris) Sigma Life Sciences 
Nitro blue tetrazolium salt (NBT) Sigma Aldrich 
Phenazine ethosulphate Sigma Aldrich 
Hydrochloric acid 32% Sigma Aldrich 
SYBR Green I nucleic acid gel stain (10 000 × in DMSO) Sigma Aldrich  
Ethylenediaminetetraacetic acid (EDTA) 
Saponin 
BDH 
Sigma Life Science 
 
Table 2-3: List of materials used for the detergent mediated assay for β-haematin 
inhibitors 




Sodium acetate trihydrate 
Sigma Aldrich 
Sigma Aldrich 
Acetic acid Sigma Aldrich 
Haemin (> 98%) Fluka 
Acetone Sigma Aldrich 
Pyridine Sigma Aldrich 
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Table 2-4: List of materials used for transmission electron microscopy 
Materials for transmission electron microscopy (TEM) Supplier 
Percoll® Sigma Life Science 
Gluteraldehyde (50% in H2O) Sigma Aldrich 
Osmium tetroxide  SPI CHEM 
Agarose (low gelling temperature) Sigma Aldrich 
Ethanol Merck 
Acetone Saarchem 
Spurr’s epoxy resin Agar Scientific 
Uranyl acetate BDH 
Lead citrate Merck 



















The Role of Haem in the Mechanism of Action of Antimalarials in Plasmodium falciparum 
  Jill Michelle Combrinck -November 2016  
50 
Table 2-5: A List of materials used for the pyridine haem fractionation study and 
the suppliers they were purchased from. The empirical formula and Mw are listed 
for antimalarials. 




(C18H26ClN3.2H3PO4, Mw = 515.87 g/mol) 
Sigma Life Sciences 
Pyrimethamine  
(C12H13ClN4, Mw = 248.71 g/mol) 
Fluka Analytical 
Sulfadoxine 
(C12H14N4O4S, Mw = 310.33 g/mol) 
Sigma Aldrich 
Amodiaquine  
(C20H22ClN3O.2HCl.2H2O, Mw = 464.8 g/mol) 
Sigma 
Quinine 
(C20H24N2O2.HCl, Mw = 369.9 g/mol) 
Sigma 
Mefloquine 
(C17H16F6N2O.HCl, Mw = 414.77 g/mol) 
Sigma Life Sciences 
Artesunate 
(C19H28O8, Mw = 384.42 g/mol) 
Sigma Life Sciences 
Lumefantrine 
(C30H32Cl3NO, Mw = 528.94 g/mol) 
Sigma 
Saponin Sigma Life Science 
Magnesium sulphate  Merck 
Phosphate buffered saline tablet Sigma Life Science 
Sodium Dodecyl Sulfate (SDS) Sigma Aldrich 
Haematin porcine  Sigma Aldrich 
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Table 2-6: A List of materials used for the ferrozine assay and the suppliers they 
were purchased from. 
Materials for ferrozine assay  Supplier 
Trichloroacetic acid (TCA) Fluka 
30 % Hydrogen peroxide  Sigma Aldrich 
Ascorbic acid Sigma Aldrich 
Ammonium acetate Saarchem 
Ferrozine (disodium salt of 3-(2-pyridyl-5, 6-bis-(4-phenyl-
sulphonic acid)-1, 2, 4-triazine) 
Sigma Aldrich 
Ferrous ammonium sulphate  
hexahydrate  
Hopkin and Williams 
Ltd. 
Neocuproine HCl hydrate Sigma 
Sulphuric acid KIMIX 
 
Table 2-7: A List of materials used for thin layer chromatography (TLC) of haemin 
and osmium tetroxide fixed haem and the suppliers they were purchased from. 
Materials for thin layer chromatography  
 of haem and osmium tetroxide fixed haem 
Supplier 
Haemin (from porcine) Sigma 
 
Table 2-8: A list of materials used for the 24 well plate haem fractionation assay 
and the supplier they were purchased from. The empirical formula and Mw is 
listed for antimalarials. 
Materials for 24 well plate haem fractionation assay Supplier 
Trucount™ beads Becton Dickonson 
Atovaquone 
(C22H15ClO3, Mw =366.84 g/mol) 
Sigma Aldrich 
Quinidine 
(C20O24.N2O2.HCl.H2O Mw = 378.89 g/mol) 
Sigma Aldrich 
10-deoxoartemisinin  
(C15H24O4, Mw = 268.3 g/mol) 
*Donated by Dr Liezl 
Gibhard 
*Division of Pharmacology, Department of Medicine, University of Cape Town 
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2.2 General Instrumentation  
 
The instrumentation detailed below refers to general instrumentation used 
throughout this study. Instrumentation specific to a technique is described where 




The centrifugation of suspensions was carried out using an Eppendorf Centrifuge 
5810R or 5804 in plastic Greiner Falcon tubes (15 and 50 mL). Suspensions in 24 
and 96 well assay plates were centrifuged using an Eppendorf deep well plate 
attachment (A-2-DWP). A Boeco Microspin12 centrifuge was used for the 





A Labcon 508IU incubator maintained at 37 °C was used to store all cultures of 
Plasmodium falciparum.  
 
2.2.3 Light microscope 
 
A Laborlux 12 Leitz Light microscope was used to view thin films of malaria 
parasites on glass microscope slides to determine the integrity of parasites in 
culture.  A Sigma bright-line hemacytometer (Z353, 962-9) was used to determine 
cell counts.  
 
2.2.4 pH meter 
 
The pH of all solutions was determined and adjusted to the required working pH 
value using a bench Jenway 3510 pH meter fitted with a 924 007 glass Jenway 
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electrode or a Crison MicropH 2000 pH meter and Crison 52 03 glass electrode. 
Both pH meters were calibrated before use with standard solutions at pH 4.00 ± 
0.01 (Buffer, reference standard, Sigma B5020) and 7.00 ± 0.01 (Buffer, reference 
standard, Sigma B4770) at room temperature of ~ 23 °C. Electrodes were stored 




A Bandelin Sonorex RK100H sonicator was used where required to ensure the 




A Scientific Industries Vortex Genie2 (G560E) was used where required to ensure 
all suspensions and solutions prepared were homogenous. 
 
2.2.7 Water bath 
 
A GRANT digital Y6 water bath or a YIH DER BL-710 water bath with the 
temperature of the water maintained at 37 °C and confirmed with an external 
thermometer was used throughout this study.  
 
2.2.8 Weighing balance  
 
A four decimal place Adventure™ OHAUS weighing balance or five decimal place 
Sartorius R200D balance was used to weigh out all materials. The balances were 
regularly calibrated with mass standards. 
 
2.2.9 UV-vis measurements 
 
All single UV-vis spectra were recorded on a Varian Cary 100 or Shimadzu UV1800 
UV-visible spectrophotometer. Measurements were conducted using a 1 cm 
pathlength Hellma® quartz cuvette. A SpectraMax 340PC, 96-well plate reader was 
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GraphPad Prism version 4 (GraphPad Software Inc.) for windows was used to 
analyse all data and calculate statistical significance. 203 ChemDraw Professional 
V15.0.0.0.16 (PerkinElmer) was used to generate chemical structures and figures. 
All flow cytometry data was analysed using FloJo software version 10 for which 
Tree Star Inc. donated a one year subscription (Tree Star Inc). The bibliography 
was created using EndNote X7.4 (Thomson Reuters).  
 
 
2.4 Sample Preparation 
 
2.4.1 Tissue culture of Plasmodium falciparum 
 
Incomplete culture medium 
Incomplete culture medium was prepared by dissolving 10.4 g RPMI 1640 (with 
glutamine but without sodium bicarbonate), 4 g D-(+)-glucose, 6 g HEPES, 0.088 g 
hypoxanthine, 5 g albumax II, and 1.2 ml (0.05 g/L) gentamicin in 1 L of distilled 
water.  The solution was pre-filtered through a 0.45 µm filter and then sterile 
filtered through a 0.22 µm membrane into autoclaved glass bottles. The incomplete 
medium was stored at 4 °C until further use. 
 
Sodium bicarbonate (5%) 
The solution was prepared by dissolving 50 g of NaHCO3 in 1 L of distilled water 
and sterile filtered through a 0.22 µm membrane into 100 ml autoclaved glass 
bottles.  The solution was stored at 4 °C until further use. 
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Complete culture medium 
Complete culture medium was prepared by adding 8.4 ml of 5% NaHCO3 to 200 ml 
of incomplete culture medium before use.  The complete medium was stored at      
4 °C until further use. 
 
Wash medium 
Wash medium was prepared in the same way as the complete culture medium but 
without albumax II.  
 
Washed O+ human red blood cells (RBCs) 
The human blood used in the experiments was obtained from the blood bank 
(Groote Schuur Hospital).  The blood was washed by adding wash medium to 
whole blood in a 1:1 ratio. The solution was centrifuged at 1200 rcf (relative 
centrifugal force) for 5 min and the supernatant was aspirated. This process was 
repeated a second time and the washed blood was stored at 4 °C.  
 
Sorbitol (5%) 
A solution of 5% D- Sorbitol was prepared by dissolving 50 g of D-sorbitol in 1 L of 
distilled water. The solution was sterile filtered through a 0.22 µm membrane into 
250 ml autoclaved glass bottles and stored at 4 °C until further use. 
 
Sodium chloride (12%) 
A 12% solution of sodium chloride was prepared by dissolving 12 g of NaCl in 100 
ml of distilled water. The solution was sterile filtered through a 0.22 µm 
membrane into a 100 ml autoclaved glass bottle and stored at 4 °C until further 
use. 
 
Sodium chloride (1.8%) 
The solution was prepared by dissolving 1.8 g of NaCl in 100 ml of distilled water. 
The solution was sterile filtered through a 0.22 µm membrane into a 100 ml 
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Sodium chloride (0.9%) with glycerine (0.2%) 
The solution was prepared by dissolving 0.9 g of NaCl and 0.2 ml glycerine in 100 
ml of distilled water. The solution was sterile filtered through a 0.22 µm 




Freezing medium was prepared by dissolving 1.6 g sodium lactate, 30 mg 
potassium chloride (KCl),   1.38 g sodium dihydrogen phosphate, 57 g glycerine  in 
100 ml distilled water.  The solution was sterile filtered through a 0.22 µm 




PBS was prepared by dissolving 1 tablet in 200 ml of distilled water. The final 
preparation yielded a solution containing 0.01 M phosphate buffer, 0.0027 M KCl 
and 0.14 M NaCl with a pH of 7.4 at 25 °C. 
 
Giemsa stain (10%) 
Giemsa stain was prepared before use by diluting the stain 1:10 in PBS. 
 
2.4.2 Antiplasmodial assays 
 
Malstat 
Malstat was prepared by dissolving 400 µl TritonX100, 4 g L-lactate and 1.32 g Tris 
buffer in 150 ml of distilled water. To this, 22 mg of APAD was added and the pH 
adjusted to 9 with 32% HCl. The final volume was made up to 200 ml with distilled 
water. The solution was stored at 4 °C. 
 
NBT 
A solution of NBT was prepared by dissolving 160 mg of NBT and 8 mg phenazine 
ethosulphate in distilled water to a final volume of 100 ml.  The storage container 
was covered with foil as NBT is light sensitive and stored at 4 °C. 
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SYBR Green lysis buffer 
The lysis buffer was prepared by dissolving 1.6 g of Triton; 0.16 g of saponin;    
0.29 g of EDTA and 1.58 g of Tris in 100 ml water. The lysis buffer was stored at     
4 °C until required. Immediately before use 2 µl of SYBR Green 10 000 × was added 
per ml of lysis buffer. 
 
2.4.3 Detergent mediated assay for β-haematin inhibitors 
 
DMSO: NP-40: water / 10: 20: 70 (v/v) 
The solution was prepared by mixing 14 ml of water with 4 ml of NP-40          
(305.5 µM) and 2 ml of DMSO and used immediately. 
 
NaOH (5 M) 
5 M NaOH was prepared by dissolving 40 g of NaOH pellets in 200 ml of water.  The 
solution was stored at room temperature. 
 
Acetate buffer (1 M) 
The acetate buffer was prepared by weighing 4.1 g of sodium acetate and 
dissolving in approximately 40 ml of water. 2.4 ml of acetic acid was added and the 
solution was diluted to 50 ml with water. The final pH was adjusted to 4.80 with    
5 M NaOH. 
 
Haemin stock solution 
A 25 mM haemin stock solution was prepared by weighing 16.30 mg of haemin 
into a 2 ml Eppendorf tube and dissolved in 1 ml of DMSO. The solution was 
sonicated for 1 min and 178.80 µl was immediately added to 20 ml of 1 M acetate 
buffer.  The solution was vortexed well and used immediately, ensuring the haem 
remained uniformly suspended in the buffer during use. 
 
HEPES buffer pH 7.5 (2 M) 
A solution of 2 M HEPES buffer was prepared by dissolving 47.66 g of HEPES in 80 
ml of distilled water. The pH was adjusted to 7.5 with 5 M NaOH before diluting to 
a final volume of 100 ml with distilled water. The solution was stored at room 
temperature. 
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Pyridine solution in HEPES (50% v/v) 
Buffered pyridine was prepared by mixing 10 ml of pyridine with 4 ml of acetone, 
4 ml of water and 2 ml of 2 M HEPES (pH 7.5). 
 
2.4.4 Transmission electron microscopy 
 
NaOH (1 M) 
A solution of 1 M NaOH was prepared by dissolving 40 g of NaOH pellets in 1000 
ml of water.  The solution was stored at room temperature. 
 
RPMI-1640 (5×) / sorbitol (25%) 
A solution of 5 × RPMI-1640 / 25% sorbitol was prepared by dissolving   1.05 g of 
RPMI-1640 (with glutamine but without NaHCO3) and 5.0 g of D-sorbitol in 15 ml 
of distilled water. The pH was adjusted to 7.4 using 1 M NaOH and diluted to 20 ml 
with distilled water. The solution was sterile filtered through a 0.22 µm membrane 
and stored at 4 °C until further use. 
 
Percoll® (60%) 
A 60% solution of Percoll® was prepared by mixing 6 ml of Percoll® with 2 ml of 
5 x RPMI-1640 / 25% sorbitol and 2 ml of complete medium. The solution was 
stored at 4 °C until further use. 
 
Percoll® (90%) 
A 90% solution of Percoll® was prepared by mixing 9 ml of Percoll® with 1 ml of 
5 x RPMI-1640 / 25% sorbitol. The solution was stored at 4°C until further use. 
 
Glutaraldehyde (5%) 
A stock solution of 50% gluteraldehyde was diluted in a 1:10 ratio with distilled 
water before use. 
 
Glutaraldehyde (2.5%) 
A stock solution 50% gluteraldehyde was diluted in a 1:20 ratio with distilled 
water before use. 
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Osmium tetroxide (OsO4) 
A 4% solution of OsO4 was diluted 1:2 in PBS pH 7.5 immediately before use. 
 
Agarose (4%) 
The solution was prepared by dissolving 0.1 g of low melting agarose in 2.5 ml of 
water with gentle heating.  
 
2.4.5 Pyridine haem fractionation assay (flask method) 
 
Reaction buffer 
Reaction buffer was prepared by dissolving 0.5 g magnesium sulphate 
(MgSO4.7H2O), 7.4 g KCl, 0.58 g NaCl and 6 g HEPES in 1 L of distilled water. The pH 
was adjusted to 7.5 using 1 M NaOH. The solution was stored at room temperature. 
 
Saponin (1%) 
The solution was prepared by dissolving 0.5 g of saponin in 50 ml of reaction 
buffer. The solution was stored at 4 °C until further use. 
 
HEPES buffer pH 7.5 (0.2 M) 
The buffer was prepared by dissolving 4.76 g of HEPES in 80 ml of distilled water. 
The pH was adjusted to 7.5 with 5 M NaOH before diluting to a final volume of 100 
ml with distilled water. The solution was stored at room temperature. 
 
SDS (4%) 
The solution was prepared by dissolving 4 g of SDS in 100 ml of distilled water. 
The solution was stored at room temperature. 
 
NaCl (0.3 M) 
The solution was prepared by dissolving 1.75 g of NaCl in 100 ml of distilled water. 
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Pyridine in HEPES pH 7.5 (25%) 
A buffered solution of pyridine was prepared by mixing 25 ml pyridine with 10 ml 
of 2 M HEPES pH 7.5 and diluting to 100 ml with distilled water. 
 
NaOH (0.3 M) 
The solution was prepared by dissolving 1.2 g of NaOH pellets in 100 ml of water.  
The solution was stored at room temperature. 
 
HCl (0.3 M) 
The solution was prepared by diluting 3 ml of 32% HCl up to 100 ml of water.  The 
solution was stored at room temperature in a dark bottle. 
 
Haematin porcine standard  
A haem standard curve was prepared from a 100 μg/ml standard solution of 
haematin (porcine) in 0.3 M NaOH.  
 
5% SDS 
The solution was prepared by dissolving 5 g of SDS in 100 ml of distilled water. 
The solution was stored at room temperature. 
 
2.4.6 Ferrozine assay 
 
Trichloroacetic acid (11.3%) 
The solution was prepared by dissolving 11.3 g of trichloroacetic acid (TCA) in 100 
ml of distilled water and stored at room temperature. 
 
Ascorbic acid (2%) 
The solution was prepared by diluting 2 g of ascorbic acid and 1.67 ml 
concentrated HCl to a final volume of 100 ml with distilled water. This solution was 
prepared fresh before use and stored at 4 °C. 
 
Ammonium acetate (10%) 
A solution of ammonium acetate was prepared by dissolving 10 g of ammonium 
acetate in 100 ml of distilled water. The solution was stored at room temperature. 
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Ferrozine 
A ferrozine solution was prepared by dissolving 75 mg of neocuproine HCl hydrate 
and 75 mg ferrozine in 20 ml of distilled water. One drop of concentrated sulphuric 
acid was added and the solution was diluted to 25 ml with distilled water.  
 
Ferrous ammonium sulphate standard (Fe standard)  
A standard curve for Fe at a starting concentration of 10 µg/ml iron was prepared 
by accurately weighing 7.023 mg of ferrous ammonium sulphate 
(Fe(NH4)2(SO4)2.6H2O). The solution was dissolved to a final volume of 100 ml 
with distilled water, acidified with 1 drop of concentrated sulphuric acid. This 
standard was prepared fresh before use.  
 
2.4.7 Thin layer chromatography of haem and osmium tetroxide fixed 
haem 
 
Haemin (0.5 mg/ml) 
A solution of haemin was prepared by dissolving 1 mg of haemin in 2 ml of 0.3 M 
NaOH. The solution was prepared fresh before use and stored at room 
temperature. 
 
2.4.8 Haem fractionation assay (24-well plate method) 
 
Glutaraldehyde (0.125%) 
A stock solution of 50 % glutaraldehyde was diluted in a 1:400 ratio with 0.22 μm 
filtered PBS (pH 7.5) before use. 
 
1 × SYBR® green I 
This solution was prepared immediately before and used away from direct light. 1 
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2.5 Methods 
   
2.5.1 Tissue culture of Plasmodium falciparum 
 
The chloroquine sensitive (CQS) strains of Plasmodium falciparum D10 (derived 
from FQC-27, Papau New Guinea) and NF54 (derived from a patient near Schiphol, 
Amsterdam presumed to be of West African origin) obtained from the MR4 were 
used throughout this study.  
 
Thawing of parasites 
Parasites were thawed by slowly adding 1 volume of 12% sodium chloride to 5 
volumes of thawed parasites with constant mixing. After 5 min 10 ml of 1.8% NaCl 
was added and centrifuged for 5 min at 400 rcf. The supernatant was removed; 10 
ml of 0.9% NaCl with glucose was added and allowed to stand for 5 min. The 
solution was centrifuged for 5 min at 400 rcf. After removing the supernatant the 
pellet was placed into culture. 
 
Cryostorage of parasites 
Parasites were prepared for cryostorage in the ring phase by slowly adding 5 
volumes of freezing medium to 3 volumes of PRBCs and allowed to stand for 5 min. 
The solution was transferred into cryotubes and frozen overnight at -80 °C before 
being transferred into liquid nitrogen for long term storage. 
  
Maintaining parasites in continuous culture 
CQS strains of P. falciparum (D10 or NF54) were cultured using a modified method 
of Trager and Jensen.204 Cultures were maintained under sterile conditions in the 
prepared washed O+ human RBCs in complete medium at 2% haematocrit. Every 
day, medium with PRBCs was transferred to sterile 50 ml centrifuge tubes and 
centrifuged at 750 rcf for 5 min.  The supernatant was aspirated and the 
parasitaemia and predominant phase in the remaining PRBC pellet was 
determined by viewing a Giemsa stained blood smear under a light microscope. 
Briefly, a thin blood smear on a glass slide from the culture was fixed to the glass 
with methanol and stained by covering with a thin layer of freshly prepared 10% 
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Giemsa stain for 10 min. The slide was rinsed with tap water and allowed to dry 
before viewing with an oil immersion lens under a light microscope. The 
parasitaemia was determined by counting the number of parasitised erythrocytes 
as a percentage of the total number of cells (erythrocytes and parasitised 
erythrocytes) counted. Trophozoite cultures were diluted to 5% parasitaemia with 
washed O+ human RBCs.  Ring cultures were sorbitol synchronised with 5 x 
volume of 5% sorbitol at 37 °C for ten min as described by Lambros and 
Vanderberg.205  Post synchronisation, cultures were centrifuged at 750 rcf for 5 
min and  the layer of debris corresponding to lysed cells and the associated 
haemozoin (Hz) was carefully removed from the culture by aspiration. Finally 40 
ml of complete culture medium was added to 1 ml of PRBC pellet in a 200 ml flat 
bottomed culture flask and gassed with a mixture of 3% O2, 4% CO2 and N2 for 1 
min and incubated at 37 °C. The cycle was repeated until sufficient material for 
experiments was obtained.  
 
2.5.2 Antiplasmodial assays 
 
Parasite lactate dehydrogenase assay 
In vitro antiplasmodial activity was determined in CQS strains (NF54 or D10) of P.  
falciparum via the parasite lactate dehydrogenase (pLDH) assay using a modified 
method described by Makler et al., which indirectly colourimetrically measures 
Plasmodium lactate dehydrogenase. 206 Lactate dehydrogenase (LDH) present in 
both the parasite and erythrocyte catalyses the conversion of lactate to pyruvate 
during glycolysis, with nicotinamide adenine dinucleotide (NAD) as a co-enzyme 
(Figure 2-1). The activity of NAD in the parasite is indistinguishable from the 
erythrocyte; however the NAD analogue, 3-acetyl pyridine dinucleotide (APAD) is 
selectively and rapidly used by the malaria parasite as a coenzyme instead of NAD 
during glycolysis and forms APADH. Erythrocyte LDH converts lactate to pyruvate 
at a much slower rate in the presence of APAD. During assay development, plates 
are supplemented with Malstat™ reagent containing both APAD and lactate and the 
yellow NBT reagent.  APADH is rapidly formed by viable parasites as the reaction 
proceeds and reduces yellow NBT to its purple formazan salt. The formation of this 
purple formazan product is measured at 620nm and corresponds to parasite 
viability.  
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Figure 2-1: The conversion of lactate to pyruvate in the presence of the coenzyme 
APAD (Malstat™) in the malaria parasite. As APADH is formed yellow NBT is 
reduced to purple formazan. 
 
The assay was carried out by preparing 2 mg/ml solutions of test samples in 100% 
DMSO and storing at -20 °C. On the day of use, samples were diluted in medium to 
a starting concentration of 1000 ng/ml or 100 ng/ml and serially diluted two-fold 
in medium in 96-well plates. All samples were tested in triplicate at ten 
concentrations, with the lowest concentration being 0.2 ng/ml. The blank column 
contained unparasitised erythrocytes at 1% haematocrit. The positive control and 
the drug testing wells all contained PRBCs at 2% parasitaemia and 1% 
haematocrit. The plates were covered with a sterile lid and gassed in an airtight 
chamber with a mixture of 3% O2, 4% CO2 and N2 for 4 min and incubated at 37 °C 
for 48 h. The highest concentration of DMSO to which the parasites were exposed 
was 0.5%. Post incubation the plate was frozen at -20 °C. The plate was thawed 
when required and developed by adding 100 µl of Malstat and 25 µl of NBT to 15 µl 
of the resuspended PRBC pellet. The absorbance of each well on the plate was 
measured at 620 nm using a Modulus™ Microplate Multimode Reader (Turner 
Biosystems). IC50 values were obtained using a non-linear dose-response curve 
fitting analysis via Graph Pad Prism v.4.0 software. 203 
 
SYBR Green I assay 
In vitro antiplasmodial activity was also determined using a modified method of 
the fluorescent SYBR green assay by Johnson et al. 207 SYBR green I is a nucleic acid 
intercalating fluorescent dye with preferential binding affinity for double stranded 
DNA over single stranded DNA or RNA. As mature erythrocytes lack RNA or DNA, 
in vitro parasite growth is measured as a result of the binding and consequent 
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fluorescence of SYBR Green to malarial DNA after 72 h of incubation in the 
presence of an antimalarial agent.  The test samples and plates were prepared as 
described above in section 2.5.2 for the pLDH assay; however the assay was 
started in ring phase of the lifecycle and incubated at 37 °C for 72 h rather than 48 
h. Post incubation the plate was frozen at -20 °C. The plate was thawed when 
required and developed by transferring 50 µl of resuspended PRBCs to the 
corresponding wells of a flat bottomed black 96-well plate. To each well, 50 µl of 
the SYBR Green lysis buffer mix was added and the plate incubated at 37 °C for 2 h. 
The blue fluorescence in each well was measured using the Modulus™ Microplate 
Multimode Reader (Turner Biosystems). IC50 values were obtained using a non-
linear dose-response curve fitting analysis via Graph Pad Prism v.4.0 software. 203 
 
2.5.3  Detergent mediated β-haematin inhibition assay 
 
The inhibition of the Hz formation pathway, where toxic soluble haem is converted 
to non-toxic insoluble Hz crystals remains an efficient, favourable drug target and 
several antimalarials including the quinolines CQ and AQ have been shown to 
inhibit the formation of βH.66 69 208 105 The formation of Hz has been shown to be 
closely associated with neutral lipids in the digestive vacuole of the parasite and 
Hz associated neutral lipids have been shown to mediate βH formation under 
physiological conditions at rates analogous to parasite Hz formation. 75 76 107 This 
process of cellular lipid mediated Hz formation is mimicked synthetically under 
physiological conditions in a robust detergent mediated assay which substitutes 
neutral lipids for the low cost, commercially available lipophilic detergent NP-40. 
102 Under these assay conditions the efficiency of a compound to inhibit the 
formation of βH is evaluated. Unreacted haematin is quantified based on the 
pyridine hemochrome inhibition (Phiβ) method developed by Ncokazi and Egan, 
where pyridine under neutral or mildly basic conditions complexes with only free 
haematin in the presence of βH and is quantified as a pyridine-haematin complex 
at 405 nm. 101 This technique has been applied as a high throughput screening tool 
and has successfully identified several novel scaffolds capable of inhibiting Hz 
formation. 105 103 The assay is carried out by preparing stock solutions of the test 
compounds at known concentration in the range of 5 mM to  20 mM by dissolving 
accurately weighed amounts in DMSO on the day of use. The test compounds were 
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transferred to a 96 well plate and serially diluted in a solution of   10% DMSO / 
20% NP-40 / 70% water to a final volume of 100 µl. All samples were tested in 
triplicate at 11 concentrations. The blank column contained no drug. A freshly 
prepared homogenous suspension of haematin in 1 M acetate buffer pH 4.8 was 
added to all wells, including the blank column, such that the final concentration of 
haematin in all wells was 100 µM. The plate was covered and incubated at 37 °C in 
a water bath for 5 - 6 h. Post incubation, a solution of 50 % pyridine (50% 
pyridine; 20% water; 20% acetone and 10% 2 M HEPES pH 7.5) was added to all 
wells such that the final concentration of pyridine per well was approximately 5%. 
Finally, acetone was added to aid in the dispersion of the haematin. Analysis of the 
plate was carried out at 405 nm using a SpectraMax plate reader after 5 s of 
shaking. The 50% βH inhibitory concentration for each test compound was 
obtained from the blank corrected absorbance values at 405 nm using a sigmoidal 
dose-response curve fitting analysis via Graph Pad Prism v.4.0 software.203 
 
2.5.4 Transmission electron microscopy 
 
TEM with electron energy loss spectroscopy (EELS) by electron spectroscopic 
imaging (ESI) for Fe was performed using a modification of the method previously 
described by Egan et al .30 
 
Enrichment and gluteraldehyde fixing 
Ring stage sorbitol synchronized parasitised red blood cells at 5% parasitemia and 
2% haematocrit were inoculated with a known concentration of test compounds 
and incubated for 24 h at 37 °C.  After the incubation period the trophozoite 
culture was centrifuged at 750 rcf for 5 min and the supernatant removed by 
aspiration. The remaining PRBC pellet was enriched by Percoll® density gradient 
centrifugation using a modified version of the method by Ginsburg et al.86 Briefly, 
500 µl of 60% Percoll® was carefully layered on top of 500 µl of 90% Percoll® in a 
1.5 ml Eppendorf tube. 300 µl of the PRBC pellet was layered on top of the 90% 
Percoll®.  Samples were centrifuged at 10 000 rpm (revolutions per minute) for 
20 min. Post centrifugation the trophozoite infected erythrocytes were seen as a 
band between the 60% and 90% Percoll® layers and transferred into a 15 ml 
centrifuge tube. The parasitised erythrocytes were incubated with 10 ml of 
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complete medium for 10 min at 37 °C then centrifuged at 1200 rpm for 3 min and 
the supernatant discarded. A 10%  Giemsa stained slide was made to confirm the 
presence of an enriched PRBC pellet (Fig. 2-2). The pellet was then washed twice 
with 5 ml of medium. Fixation was carried out by resuspending the enriched pellet 
in an equal volume of 5% glutaraldehyde in PBS pH 7.4 for 10 min at room 
temperature. Following a wash with 1 ml of PBS (centrifuged at 3000 rpm for       
45 s), the cells were re-suspended in 1 ml 2.5% of glutaraldehyde in PBS and left at 
4 C overnight for further fixation.  
 
 
Figure 2-2: Giemsa stained, microscopic images (100⨯ objectification) of 
trophozoite infected red blood cells before (A) and after Percoll® enrichment (B). 
 
Sample dehydration, resin fixing and trimming 
Two washes with 1 ml of PBS were performed before the samples were post-fixed 
with 1% OsO4 in PBS for 1 h, washed once with PBS and three times with distilled 
water and stained with 1% uranyl acetate. Following a further two washes with 
distilled water samples were suspended in a 1:1 ratio in freshly prepared 4% 
agarose and allowed to solidify. Samples were then cut into 1 mm cubes under 
water and dehydrated with aqueous ethanol (30%, 50%, 60%, 70%, 80%, 90%, 
95% for 5 min each, 2  100% ethanol for 10 min each) and twice with acetone for 
10 min each. Acetone was gradually replaced with Spurr’s epoxy resin over two 
days in 2 h incubation periods with 25:75, 50:50 and 75:25. The final infiltration in 
100% resin took place overnight. The blocks were transferred into fresh resin, 
tumbled for the day and allowed to harden for 16 h at 60 C. Blocks were trimmed 
and cut into ultrathin sections, suitable for TEM imaging with a Reichert Ultracut S 
ultratome using diamond knives. Sections were picked up on 200 mesh square 
copper grids stained with 1% uranyl acetate followed by 1% lead citrate in a 
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closed container containing NaOH for 10 min each with 5 distilled water washes in 
between each stain. Samples which underwent ESI for Fe were not subjected to the 
previous staining procedure. 
 
Extraction of Hz crystals 
Hz crystals were extracted from isolated trophozoites as previously.209 
Trophozoites were released from PRBCs by saponin lysis. PRBCs were incubated in 
1% saponin for 2 min, followed by centrifugation at 1500 rpm for 10 min. The 
supernatant was discarded and the pellet washed three times with PBS. A final 
wash was performed with reaction buffer and the pellet was resuspened in 
deionised water acidified to pH 4.6. This suspension was triturated ten times with 
a 26.5 gauge needle to break open the trophozoites, releasing the trophozoite 
cytosol and DVs into solution. The solution was centrifuged at 1300 rpm for one 
minute and the supernatant was discarded. The pellet was resuspended in reaction 
buffer to final volume of 1 ml and 10 µL of DNase I was added to digest any DNA 
released from the trophozoite cytosol. The solution was incubated for 5 min at 37 
°C, followed by centrifugation at 1300 rpm for 1 min. The supernatant was 
discarded and the pellet washed three times with reaction buffer. The isolated DVs 
were resuspended in deionised water and frozen at -80 °C. The pellet was thawed 
to release the Hz from the DV by freeze thaw lysis. The mixture was centrifuged at 
1300 rpm for 1 min and the supernatant discarded. Freeze thaw lysis was repeated 
a minimum of three times to ensure complete lysis of all the DVs. Solutions 
containing Hz crystals were placed on a glow discharged carbon coated grid and 
blotted with filter paper to remove excess solution. Crystals were stained with 1% 
uranyl acetate for 10 min with five distilled water washes in between each stain.   
 
 Performing TEM with EELS 
TEM has far superior resolving capacity than a light microscope capturing features 
as small as a tenth of a nanometer. Used in conjunction with EELS with ESI for Fe, 
the location and distribution of Fe within treated and untreated P. falciparum 
infected cells and also the association of Fe with any identifiable cellular organelles 
was determined. All measurements were performed using a LEO 912 OMEGA or 
Tecnai 20 transmission electron microscope for images collected in Chapter 3 and 
6 respectively. Images were collected using a slit width of 18 eV on a Tiedtz 
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charge-coupled-device camera (1024  1024 pixels) and processed with analySIS 
software from Soft Imaging System using a two window difference method to 
obtain the element-distribution image. Two images were recorded at energies 
before the Fe L3 absorption edge, namely at 658 eV and 688 eV respectively and 
the third was centred around 718 eV. The background image was then predicted 
by extrapolating the two images collected at 658 eV and 688 eV and then 
subtracted from the image collected around 718 eV resulting in an elemental map 
with intensity values proportional to the amount of iron in a particular section.  
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3 MEASURING HAEMOZOIN 
FORMATION IN PLASMODIUM 
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3.1 Introduction  
 
As discussed in Chapter 1, in the trophozoite, during the asexual stage of the 
parasite lifecycle up to 65% of the host RBC Hb is ingested by the parasite and 
transferred to the acidic DV where it is degraded by a series of proteases. 36 38 29 In 
the DV, toxic haem derived from Hb digestion is sequestered into innocuous Hz 
crystals in a parasite-specific pathway essential for survival of the parasite. 24 
A study by Ginsberg et al published in 1998 suggested that only 30% of Hb derived 
haem is converted into Hz and the majority exits the food vacuole where it is 
degraded by glutathione. This glutathione driven haem degradation was 
competitively inhibited by the presence of CQ and AQ outside of parasites and 
increased resistance to CQ was achieved by increasing cellular levels of 
glutathione. The study confirmed a relationship between membrane haem levels 
and the extent of parasite killing in P. falciparum infected erythrocytes, showing an 
increase in toxic membrane associated haem in a time and dose dependent manner 
in the presence of both CQ and AQ. 86 In contrast, a later study of the chemical 
analysis of elemental Fe in isolated D10 trophozoites and DVs showed the majority 
of Fe present in trophozoites was located in the DV (92±6%). Further analysis of 
Hz isolated from DVs showed that 88±9% of the Fe in the DV corresponds to inert 
Hz. This finding was confirmed by 57Fe-Mössbauer spectroscopy performed on 
freeze-dried isolated trophozoites which revealed that more than 95% of the Fe in 
trophozoites was present as Hz, with the spectra of the freeze dried trophozoites 
being identical to that of synthetic βH with the exception of larger background 
scatter in the biological sample.  It therefore follows that the majority of Fe located 
in the DV of the trophozoite is present as Hz. 30 The Hz formation pathway 
unquestionably represents a vital process in the lifecycle of the malaria parasite 
and as such the inhibition of this pathway presents a point of susceptibility 
exploited as a drug target by several clinically relevant antimalarials, including CQ. 
As discussed in Chapter 1, CQ for many years was considered the gold standard in 
antimalarial treatment and it is a well-accepted theory that CQ acts by inhibiting 
the formation of Hz.72 210 Despite being widely accepted, the theory that CQ and 
related quinoline antimalarials inhibit Hz formation within the DV has never been 
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demonstrated in the cell, while the inhibition of the synthetic counterpart of Hz, 
βH, has been demonstrated many times in cell-free systems. 105 184 211 212 69 
This chapter describes a cellular fractionation assay developed to measure haem 
species in isolated P. falciparum trophozoites. In an attempt to determine the 
effects of CQ in the parasite, all major haem species were determined in 
trophozoites isolated from cultures of P. falciparum incubated with increasing 
doses of CQ. The quantification of haem in each fraction was based on the ability of 
neutral aqueous pyridine to selectively form a low spin Fe(III)haem-pyridine 
complex with haem in the presence of Hz.101 This cellular fractionation technique 
was extended to several well-known antimalarials; ART, AQ, LF, MQ, QN and a 
sulfadoxine-pyrimethamine (SP) combination at a single concentration 
corresponding to 2.5 × their IC50 as a measurement of their ability to inhibit Hz. 
With the exception of the antifolate combination of SP, it has been proposed that 
all other compounds are able to interfere with the formation of βH.69 106 178  98 110 213 
In the case of LF, the package inserts of several AMN-LF combination tablets 
indicate that the mechanism of action of LF is through βH inhibition. 214 215 The 
claim is controversial for ART. Haynes et al in 2003 showed that the AMNs do not 
inhibit βH.110 However several studies have implicated the AMNs in βH  inhibition, 
proposing that AMN’s inhibit Hz formation and kill through the consequent  build-
up of toxic haem.179 178   
In the case of CQ, the findings of the haem fractionation assay was enhanced by 
TEM with ESI using EELS for Fe on CQ treated parasitised erythrocytes used to 
demonstrate the differences in the distribution of cellular haem in CQ treated and 
untreated P. falciparum parasites. Previously, TEM with ESI using EELS for Fe 
performed on untreated trophozoite infected erythrocytes showed the presence of 
Fe was localised to Hz crystals within the DV, while the rest of the trophozoite was 
devoid of Fe levels higher than those seen in the erythrocyte.30 Subsequent studies 
have shown that CQ disrupts Hz crystal growth, altering Hz crystal morphology 
resulting in the formation of less uniform crystals in the parasite.107 209 
The haem fractionation assay described in this chapter provides an approach to 
determine parasite Hz inhibition in the presence of antimalarials and hence the 
determination of mechanisms of action of both current and novel antimalarials. 
The method is especially relevant in light of recent screening studies of substantial 
compound libraries which yielded several effective potential therapies effective at 
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the blood stage of P. falciparum.216 The target of several of these drugs could very 
likely be the Hz formation pathway, and perhaps one of these candidates will be 
capable of emulating the success demonstrated by CQ during the mid-1900’s.217  
 
3.2 Materials  
 
All materials used throughout this chapter are listed in chapter 2. Materials were 
of AR grade or higher and used without further purification.  
 
3.3 Sample Preparation 
 
The preparation of all samples used throughout this chapter is described in 
Chapter 2. The water used throughout this work was double distilled deionised 
Millipore® Direct-Q water. 
 
3.4 Methods  
 
3.4.1 Pyridine-Haem fractionation assay 
 
The pyridine-haem fractionation assay described here was based on the method 
developed by Ncokazi and Egan used to determine the cell free ability of a 
compound to inhibit βH formation. 101 The method, abbreviated from here 
onwards as the Ρhiβ (pyridine hemichrome inhibition of β-haematin) is based on 
the pyridine hemochrome method published by Partos in 1922, where haem was 
quantified as a haem pyridine complex.100 Haematin dissolved in aqueous medium 
forms aggregates and as a result displays a relatively weak, broad Soret peak, with 
a maximum absorbance at 389 nm. In contrast the spectrum of the pyridine-
haematin (Fe(III)PPIX) complex exhibits a sharper more intense peak, shifting 15 
nm to an absorption maximum of 404 nm indicative of the monomeric low-spin 
state of the Fe(III)PPIX and well separated from haem aggregates. This pyridine-
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Fe(III)PPIX complex obeys Beers law, a valuable feature, as it makes quantification 
of haem species possible with this method.  The increased peak intensity enhances 
the sensitivity of the assay in comparison to the use of the absorbance of aqueous 
Fe(III)PPIX and ensures linear proportionality of absorbance to concentration. To 
maintain direct proportionality between absorbance and concentration, it was 
found that the pyridine solution must be buffered to pH 7.5 for optimal formation 
of pyridine co-ordinated to the Fe(III)  porphyrin center.  Under basic conditions, 
in the presence of aqueous pyridine it has been shown that the µ-oxo dimer of 
Fe(III)PPIX is induced by pyridine.218 Additionally, it was determined that neutral 
or very mildly basic solutions of 5 - 10% (v/v) pyridine do not react with βH but 
are still able to dissolve and form complexes with haematin. In mixtures of 
haematin and βH, the absorbance at 405 nm upon addition of a fixed volume of 
neutral aqueous pyridine (5% v/v, pH 7.5) increased linearly with increasing 
amount of haematin. The method can therefore be used to selectively quantify 
haematin in mixtures of both βH and haematin as a complex with pyridine. 101 
Here the method was applied to parasite haem, measuring the ability of a 
compound to inhibit Hz formation in P. falciparum cells. All major haem species; 
Hb, free haem and Hz in isolated P. falciparum trophozoites isolated through a 
series of fractionation steps were determined spectrophotometrically as a low-
spin complex with aqueous pyridine at neutral pH (5% v/v, pH 7.5) (Figure 3-1).107 
“Free” haem was defined as haem in the parasite material which can be solubilised 
by 2% SDS and 5% (v/v, pH 7.5) pyridine and is most likely membrane or lipid 
associated haem or weakly and non-specifically associated with SDS solubilisable 
proteins. All spectra were recorded on a Varian Cary 100 UV-vs spetrophotometer. 
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Figure 3-1: A schematic representation of the haem-pyridine fraction assay. A CQS 
strain of P. falciparum was cultured according to a modification of the Trager and 
Jensen method.204 Immature ring stage PRBCs were inoculated with several 
different increasing drug concentrations. After 32 h, mature trophozoites were 
harvested via saponin lysis of erythrocytes and taken through a series of 
fractionation steps. Following hypotonic lysis and centrifugation, Hb was 
measured in the first fraction. The second fraction corresponds to SDS treated 
soluble Hb measured in the supernatant as a low spin haem-pyridine complex. The 
pellet was further treated with SDS and pyridine to solubilise “free” haem in the 
third fraction, measured in the supernatant following centrifugation. The fourth 
fraction corresponds to Hz, measured after solubilising the pellet in NaOH, 
neutralising with HCl and treating with pyridine.107 
 
Incubation  
The phase of highly synchronous ring stage cultures was confirmed by viewing 
10% (v/v) Giemsa stained blood smears under a light microscope with an oil 
immersion lens at 100x magnification. The parasitemia of rings was determined by 
counting a minimum of 1000 cells and the percentage of ring stage infected cells in 
the total number of counted cells was calculated. The ring culture was diluted to 
The Role of Haem in the Mechanism of Action of Antimalarials in Plasmodium falciparum 
  Jill Michelle Combrinck -November 2016  
76 
5% parasitemia with washed O+ human RBCs and 2% haematocrit with complete 
medium to a final volume of 50 ml in a 200 ml flat bottomed culture flask. Each 
prepared flask was inoculated with a specific multiple of the test compounds IC50.  
No more than 100 µl of the drug stock solution diluted in DMSO was added to each 
flask, such that the final concentration of DMSO in the flask was less than 0.5% 
(v/v). No drug was added to the control flask. The flask was gassed with a mixture 
of 3% O2, 4% CO2 and N2 for 1 min and incubated at 37 °C for 32 h.  
 
Harvesting and isolation of trophozoites 
After 32 h of incubation at 37 °C, flasks were removed from the incubator and the 
contents transferred to 50 ml centrifuge tubes. The cultures were centrifuged at 
750 rcf for 5 min and the supernatant as well as any cell debris and associated Hz 
corresponding to a black layer on top of the PRBC pellet was discarded. A 10% 
(v/v) Giemsa stained blood smear of each culture was viewed under a light 
microscope with an oil immersion lens to confirm the presence of trophozoites. 
Trophozoites were isolated by saponin lysis by adding 46 ml of PBS and 2.5 ml of 
1% saponin to a 1 ml pellet of parasitised erythrocytes. The solution was mixed 
well and left to stand for 2 min at 37 °C, followed by centrifugation at 1500 rcf for 
10 min. The supernatant was discarded and the pellet washed 3× with 10 ml of 
PBS to remove all traces of Hb. In between each wash, the supernatant, cell debris 
and associated Hz corresponding to a black layer on top of the PRBC pellet was 
discarded The trophozoite pellet was diluted to a final volume of 1 ml with PBS 
and mixed well using a vortex. A 1:40 dilution of the trophozoite suspension in PBS 
was prepared and used to obtain a final cell count/ml using a haemocytometer. 
The remaining solution was frozen overnight at ˗80 °C. 
 
Cell counting on a haemocytometer 
The number of cells/ml was determined by loading 10 μl of cells from the well 
mixed 1:40 trophozoite dilution prepared above onto a bright-line 
haemocytometer and 5 large squares were counted after 10 min of settling. The 
concentration of cells in each well of the plate was determined using equation 3-1:  
CH = N × F × DF × 10,000   (3-1) 
Where: CH = concentration of cells per ml as determined with haemocytometer  
  N = number of cells counted in five fields 
Chapter 3: Measuring haemozoin formation in plasmodium falciparum in the presence of antimalarials 
Jill Michelle Combrinck -November 2016 
77 
  F = number of fields counted = 5 
  DF = dilution factor = 40 
 
Pyridine-haem fractionation assay 
The trophozoite suspension was thawed and 200 µl aliquots dispensed in triplicate 
into Eppendorf tubes, including a blank of 200 μl PBS. The remaining 400 µl 
sample was reserved for the determination of total Fe by means of the ferrozine 
assay described in section 3.4.2. To each aliquot, 100 µl of water was added and 
sonicated for 5 min. This was followed by 100 µl 0.2 M HEPES buffer pH 7.5 and 
100 µl water and the sample was then centrifuged in a minifuge (14000 rpm) for 3 
min. The spectrum of the supernatant (fraction 1, Figure 3-1) was recorded from 
330 to 800 nm and corresponds to the spectrum of methaemoglobin (Figure 3-2).   
 
Figure 3-2: Absorption spectrum for fraction 1, corresponding to methaemoglobin 
(fraction1). 
 
The supernatant was retained for further processing by adding 100 µl 4% SDS, 
sonicating for 5 min and then incubating at room temperature for 30 min. Finally, 
100 µl of 0.3 M NaCl and 100 µl of 25% pyridine (v/v) were added and the solution 
was diluted to volume in a 1 ml volumetric flask.  The spectrum of the resulting 
Fe(III)haem-pyridine complex (fraction 2, Figure 3-1) was recorded from 330 to 
800 nm and used to determine the fraction of haem present as Hb (spectrum not 
shown). 
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The pellet was further treated by adding 100 µl of water, followed by 100 µl of 4% 
SDS. After vortexing well, the solution was sonicated for 5 min and incubated for 
30 min at room temperature. To this, 100 µl 0.2 M HEPES pH 7.5, 100 µl 0.3 M NaCl 
and 100 µl 25% pyridine were added and centrifuged for 5 min. The supernatant 
was transferred to a 1 ml volumetric flask and diluted to volume with water. The 
spectrum (fraction 3, Figure 3-1) which is characteristic of the Fe(III)haem-
pyridine complex was recorded from 330 to 800 nm to determine the fraction of 
“free” haem (Figure 3-3).  
 
 
Figure 3-3: Absorption spectrum of the “free” haem-pyridine complex (fraction 3). 
 
The absorbance of the resulting pyridine-Fe(III)PPIX complex at the Soret band of 
the spectrum shown in Figure 3-3 was recorded at 405 nm. The remaining pellet 
was treated with 100 µl of water and 100 µl of 0.3 M NaOH. The solution was 
vortexed well, sonicated for 60 min and incubated for 30 min at room temperature.  
To the supernatant, 100 µl 0.2 M HEPES pH 7.5, 100 µl 0.3 M HCl and 100 µl 25% 
pyridine were added and diluted to volume in a 1 ml volumetric flask. The 
spectrum (fraction 4, Figure 3-1) was recorded from 330 to 800 nm for the 
determination of the Hz fraction (Figure 3-4). Where required, solutions of fraction 
4 were diluted with diluent (1 ml 4% SDS, 1 ml NaCl, 1 ml HEPES and 1 ml 25% 
pyridine diluted to volume with water in a 10 ml volumetric flask). 
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Figure 3-4: Absorption spectrum of Fe(III)haem-pyridine complex for Hz (fraction 
4, diluted 3× in diluent). 
 
The percentages of Hb (fraction 2, Figure 3-1), “free” haem (fraction 3, Figure 3-1) 
and Hz (fraction 4, Figure 3-1) for each sample were calculated from the maximum 
absorbance reading for each species as follows: 
Amax for Fe(III)haem-pyridine (fraction 2) = AHb 
Amax for Fe(III)haem-pyridine (fraction 3) = A”free” haem 
D  Amax for Fe(III)haem-pyridine (fraction 4) = AHz (D = dilution factor, Hz) 
ATotal = AHb + A”free” haem + AHz 
% Hb = (AHb/ ATotal)  100 
% “free” haem = (A’free” haem/ ATotal)  100 
% Hz = (AHz/ ATotal)  100 
 
Haem standard curve 
The total haem in each sample was quantified by constructing a haem standard 
curve from a 100 μg/ml haem standard solution of haematin (porcine) in 0.3 M 
NaOH. Dilutions of the standard were carried out in Eppendorf tubes to a final 
volume of 200 µl in triplicate and 200 μl of 0.15 M NaOH was used as a blank.  To 
the blank and each of the standards, 100 μl of the following solutions were added: 
0.2 M HEPES pH 7.5, 4% (w/v) SDS, 0.3 M NaCl, 0.3 M HCl, 25% pyridine in 0.2 M 
HEPES pH 7.5 and diluted to 1 ml with distilled water. The visible spectra of 
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haematin as a Fe(III)haem-pyridine complex was recorded. The amount of haem 
Fe per cell was calculated by dividing the total haem Fe in each fraction by the 
number of cells determined in each fraction. A representative standard curve of 
absorbance versus concentration of haematin is shown below in Figure 3-5. The 
molar extinction coefficient calculated for the assay from a representative 
calibration curve (Figure 3-5) was determined to be 86480 ± 667 M˗1 cm˗1, similar 
to the value of 90 800 M˗1 cm˗1 determined for haem at 404 nm by Asakura et al. 219  
 
 
Figure 3-5: Calibration curve of absorbance at 405 nm vs haematin (µM) of the 
pyridine-Fe(III)PPIX complex.  The molar extinction co-efficient was calculated 
from the slope of the graph to be 86480 ± 667 M˗1 cm˗1. The data represents the 
mean ± SD of three separate experiments. The linear portion of the graph is shown 
for which the correlation coefficient, R2 = 0.962. The graph was plotted using 
GraphPad Prism 4.0 linear regression function. 
 
3.4.2 Ferrozine Assay for Total Fe 
  
Fixed volumes of isolated trophozoites were assayed for total Fe using a 
modification of the ferrozine assay by Carter which colourimetrically measures the 
formation of a ferrozine-Fe(II) complex at 562 nm.220 221 All glassware used in this 
assay was washed with 1% nitric acid before use to remove all traces of metals. A 
100 µl aliquot of the trophozoite suspension harvested and isolated in section 3.4.1 
was accurately diluted to 1 ml with distilled water. Samples were digested using a 
combination of 250 µl 5% SDS, 100 µl 11.4% TCA and 200 µl 30% H2O2, followed 
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by sonicating. Samples were centrifuged for 5 min in a minifuge (14000 rpm) and 1 
ml of the supernatant was transferred into a labelled test tube. To the supernatant, 
1 ml of 2% ascorbic acid was added and the samples were incubated for 5 min at 
room temperature. Post incubation, 800 µl of ammonium acetate and 200 µl of the 
ferrozine colour reagent were added.  The absorbance of each sample was read at 
562 nm in a 1 cm quartz cuvette. A blank consisting of 1 ml of distilled water and a 
series of Fe standards prepared from a stock solution of ferrous ammonium 
sulphate corresponding to 10 µg/ml of Fe was run alongside the samples according 
to the method described above. The molar extinction coefficient calculated for the 
assay from a representative calibration curve shown below in figure 3-6 was 
determined to be 27247±690 M˗1 cm˗1, which agrees well with the original value of 
28000 M˗1 cm˗1 quoted by Carter et al. 220 The total Fe present in each cell was 
calculated by dividing the value obtained for total Fe by the number of cells in each 
sample as determined by the haemocytometer count in section 3.4.3.3. The fraction 
of Fe present as haem was calculated by dividing the value obtained for total haem 
in section 3.4.1 by the total Fe value and converting to a percentage. 
 

























Figure 3-6: Calibration curve of absorbance at 562 nm vs Fe concentration (as the 
Fe+2-ferrozine complex).  The molar extinction co-efficient was calculated from the 
slope of the graph to be 27247±690 M˗1 cm˗1. The data represents the mean ± SD of 
four separate experiments. The linear portion of the graph is shown for which the 
correlation coefficient R2 = 0.997. The graph was plotted using GraphPad Prism 4.0 
linear regression function. 
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3.4.3 Thin layer chromatography (TLC) of haem and osmium tetroxide 
fixed haem 
 
A mixture of 0.5 mg/ml haemin (Cl-Fe(III)protoporphyrin IX) and OsO4, (100 × 
molar excess) was tumbled for a minimum of 1 h before spotting on a silica gel TLC 
plate alongside a solution of untreated haemin (0.5 mg/ml). After thorough drying 
of the spots, the plate was run in a series of solvents mimicking the dehydration 
procedure used when samples are prepared for TEM: 30% EtOH, 50% EtOH, 70% 
EOH, 90% EtOH, 100% EtOH and 100% acetone. The retention factor (Rf) values 
for untreated haemin and OsO4 treated haemin were calculated in each solvent 
system.  
 
3.5 Results and Discussion  
 
3.5.1 Determination of the parasitic growth inhibition IC50 in P. falciparum 
 
The biological IC50 of several clinically relevant antimalarials was determined in a 
CQS strain of P. falciparum, D10 using a modification of the method previously 
published by Makler et al. 206 In the case of PYR the biological IC50 was determined 
using a modification of the SYBR Green assay with a 72 h incubation time. 207 Both 
methods are described in detail in Chapter 2. The IC50 values obtained are 
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Table 3-1: The IC50 values (nM) of several clinically relevant antimalarials in the 
CQS strain D10 determined using the pLDH assay or in the case of PYR and S, a 
modification of the SYBR Green assay.206 207  
Compounds tested Mean IC50 value (nM) Range at 95% CI (nM) 
Chloroquine 15 11 - 25 (n=8) 
Amodiaquine 16 14 - 19 (n=8) 
Quinine 142 90 - 226 (n=6) 
Mefloquine 24 12 - 47 (n=8) 
Lumefantrine 27.1 23.6 – 31.0 (n=8) 
Artesunate 7.6 5.75 – 9.35 (n=3) 
Pyrimethamine 50 14 - 60 (n=4) 
Sulfadoxine ND ND 
ND = not detected. 
 The parasite survival curves were generated using GraphPad Prism 4.0 non-linear 
regression function (sigmoidal dose response equation) as shown in Figure 3-7 for 
AQ in red and PYR in blue.  
 





















Figure 3-7: Representative graphs of parasite survival curves of the 4-
aminoquinoline AQ (red) and the antifolate PYR (blue) in D10 determined using a 
modification of the parasite lactate dehydrogenase assay previously published by 
Makler et al and a modification of the SYBR Green assay with a 72 h incubation 
time respectively.206 207 The curve was generated using GraphPad Prism 4.0 non-
linear regression function (sigmoidal dose response equation). 
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The measured IC50 values summarised in Table 3-1 were used to determine the 
concentrations at which cultures used for the haem fractionation assay would be 
inoculated. PYR and S were included as negative controls to be used in the 
subsequent haem fractionation assay as both have no known effect on the 
formation of βH.105 Both drugs share a similar mechanism of action, known to 
interfere with folate synthesis and both are potent inhibitors of P. falciparum. The 
sulfonamide, S is an analog of p-aminobenzoic acid (PABA) required for the de 
novo synthesis of folate and PYR inhibits dihydrofolate reductase (DHFR), the 
enzyme responsible for converting dihydrofolate to tetrahydrofolate cofactor. 194 
195. The antimalarial activities of these drugs have previously been shown to be 
diminished in the presence of folic acid and PABA in the routinely used culture 
medium and the determination of an accurate biological activity should ideally be 
tested in culture medium with reduced concentrations of PABA, folate and 
hypoxanthine. 194 222 Normal RPMI used in the culture medium preparation 
throughout this thesis contains 1 mg/L each PABA and folic acid, a concentration 
100 fold greater than the physiological concentration of folic acid. 195 Wein et al, 
showed that the IC50 values for PYR measured using RPMI with low concentrations 
of PABA and folate were approximately 6 fold lower than when measured in 
normal RPMI. In addition it was shown that a longer incubation of 72 h, as used in 
the SYBR green assay was required in the case of both normal RPMI and RPMI with 
low PABA and folate concentrations to obtain reliable, reproducible results in 
agreement with microscopically determined biological IC50 values of Giemsa 
stained parasites. 222 The IC50 of PYR was therefore determined using the SYBR 
green assay with a 72 h incubation period and normal RPMI as used in the 
subsequent pyridine-haem fraction assays. However the biological activity of S was 
not detected in any of the assays used, most likely due to the high concentration of 
exogenous PABA competing with S in the normal culture medium used. 223 As a 
result, a combination of S and PYR (SP) was used in the subsequent haem 
fractionation assays with a S concentration corresponding to 16 molar equivalents 
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3.5.2 Haem fractionation assay 
 
Haem fractionation of CQ in D10 
The cell fractionation study described in section 3.4.1 was applied to the 4-
aminoquinoline, CQ to determine the effect of CQ on all major haem species in the 
cell. Briefly, cultures of highly synchronous CQS D10 at 5% parasitemia and 2% 
haematocrit were inoculated at the immature ring stage with increasing doses of 
CQ, corresponding to multiples of the parasite growth IC50 and incubated for a 
period of 32 h. The mature trophozoites were harvested by saponin lysis and 
exposed to a series of cellular fractionation steps where the relative amounts of 
each haem species in the isolated trophozoites was determined as a Fe(III)PPIX-
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Figure 3-8: The fraction of each haem species present in isolated trophozoites is 
shown as a function of the CQ concentration (nM) for (a) %Hz, (b) %“free” haem 
and (c) %Hb. In each case a control with no CQ added is shown in red (0 nM CQ). 
CQ treated samples are displayed in blue and the negative controls PYR and SP in 
black. Asterisks displayed on the graph indicate statistical significance relative to 
the control (95% CI) determined using a two-tailed t-test (* P <0.05; ** P <0.01; *** 
P <0.001). (d) Parasite survival curve for CQ in D10 (red graph) as determined 
using method of Makler et al overlaid with the percentage of “free” haem (blue 
graph) as a function of CQ concentration.206 
 
Figure 3-8 above illustrates the effect of increasing concentrations of CQ on the 
haem species in P. falciparum. A reduction in the fraction of total haem present as 
Hz, with increasing CQ concentration is seen in Figure 3-8a, decreasing from 95% 
in the control to approximately 74% at 90 nM CQ, the highest concentration of CQ 
tested. This reduction in Hz, is accompanied by an increase in toxic “free” haem 
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maximum of 16.6% in CQ treated cells. Undigested Hb within the CQ treated 
trophozoites follows suite increasing to a maximum of 12% at 60 nM CQ as shown 
in Figure 3-8c. Interestingly, a significant rise in Hb occurs only after 45 nM CQ, 
after a significant increase in free haem which appears from 15 nM CQ upwards.  
This observation that significant increased levels of free haem appear before 
undigested Hb suggests that this increase in %Hb is a consequence of higher “free” 
haem levels in the cell, and has been observed in a previous study examining the 
effects of quinolines on endocytosis in a CQS strain of P. falciparum (3D7). In this 
study trophozoites inoculated with CQ concentrations corresponding to five times 
the biological IC50 showed an increase of 283% in Hb levels determined by western 
blotting gel electrophoresis. 125 In contrast to the effect of CQ on the cell, the 
antifolates PYR and the SP combination had no significant effect on the 
percentages of Hz, “free” haem or Hb levels in the cell.   
A shortcoming of the technique is that reliable results were only obtained up to a 
maximum concentration of 90 nM CQ as shown in Figure 3-8. Beyond this 
concentration of CQ, cells were too vulnerable to survive the harvesting process 
and too few parasites survived to obtain reliable measurements. Despite this 
limitation, a clear correlation exists between the increase in “free” haem and the 
parasite survival curve as shown in Figure 3-8d with a decrease in parasite 
survival accompanied by a corresponding increase in toxic “free” haem. CQ 
inhibition of haem degradation in a dose and time dependent manner has 
previously been demonstrated by Ginsburg et al. Although this study confirmed a 
relationship between membrane haem levels and parasite survival, a consequent 
decrease in Hz formation was not demonstrated. 86 The results provide direct 
evidence that Hz inhibition is indeed the mechanism of action of CQ in P. 
falciparum and is likely to be the mechanism for several other quinoline and 
related antimalarials. This prospect is discussed in the following section.  
 
3.5.3 Haem fractionation of clinically relevant antimalarials in D10  
 
A preliminary study to determine the effect of several other quinoline and related 
antimalarials on Hz formation was performed by exposing parasites to a single 
concentration of these antimalarials. The relative quantities of Hz and “free” haem 
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obtained in P. falciparum parasites after 32 h of exposure to ART, AQ,  LF, MQ and 
QN at a single dose of 2.5 × their IC50 values was examined.  
With the exception of the antifolate combination of SP, all other drugs have in the 
past been implicated in the interference of the formation of βH. 69 68 178 98 213 110 The 
βH inhibition dose response curves for LF and S (Figure 3-9d) as determined by 
the detergent mediated βH inhibition assay in section 2.5.3 shows that LF 
effectively inhibits βH (IC50 = 11 µM) and the antifolate S had no effect. Similarly, 
with the exception of the antifolate combination of SP all drugs caused a 
statistically significant decrease in Hz and increase in  “free” haem as  a percentage 
of the total haem in treated trophozoites tested at a single concentration of each 
drug (Figure 3-9a, b) when compared to the untreated control.  Hz inhibition by 
ART has been a widely debated subject. Haynes et al in 2003 showed that contrary 
to several previously published reports proposing that AMNs inhibit Hz formation 
and kill through the consequent  build-up of toxic haem,  the AMNs do not inhibit 
βH.179 178 110 However it can be seen in figure 3-9a, b that ART does cause a 
decrease in percent Hz formation and corresponding increase in percent “free” 
haem in the D10 strain of P. falciparum. With the exception of LF none of the drugs 
showed an increase in percentage “free” haem and decrease in percentage 
haemozoin, statistically comparable to CQ.  
The time consuming nature of the assay means this preliminary study was limited 
to testing percentages of each haem species at a single concentration for each 
antimalarial. Demonstrating that Hz inhibition is a likely mechanism of action for 
these antimalarials required a full dose response study and is addressed in 
Chapters 4 and 5. It is worth noting that a percentage change cannot distinguish an 
absolute from a relative change. Consequently these percentage results are not 
definitive.  
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Figure 3-9: % “Free” haem (a) and %Hz (b) profiles in isolated trophozoites for 
several well-known antimalarials at a single dose corresponding to 2.5 × parasite 
growth IC50 values with the exception of CQ shown at 45 nM and SP at 2.5 × the 
IC50 of PYR and 16 molar equivalents of S relative to PYR. Asterisks displayed on 
the graph indicate statistical significance relative to the control (95% CI) 
determined using a two-tailed t-test (* P <0.05; ** P <0.01; *** P <0.001, n = 3 
except for ART and MQ (n = 5), SP (n = 5) and PYR (n = 7)). (c) The free haematin 
inhibition for LF (blue) and S (red) was determined using the method described in 
section 2.5.3. The inhibition curves clearly indicate that LF inhibits the formation 
of βH with an IC50 value of 11 µM, while S does not. 
 
3.5.4 Ferrozine Assay for Total Fe 
  
The ferrozine assay developed by Carter et al was previously used to determine 
the total Fe content in isolated CQ-sensitive P. falciparum trophozoites. It was 
found that trophozoites (D10 strain) contain 58 ± 2 fg of Fe per cell, of which 95% 
is haem Fe in the form of Hz within the DV.220 30 The method was used here to 
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increasing doses of CQ after a 32 h incubation period. Total haem Fe as determined 
by the pyridine haem fraction assay in untreated and CQ treated cells was 
compared to the total Fe as determined by the ferrozine assay. In CQ treated cells 
the average total haem Fe was 57.8 ± 6.6 fg/cell versus 61.4 ± 6.5 fg/cell haem Fe  
(n = 6, P = 0.38, statistical significance determined using a two-tailed t-test). The 
total haem Fe was statistically indistinguishable from the total Fe content in both 
treated and untreated cells, demonstrating that the overwhelming majority of Fe in 
the parasite is present as haem. 
 
3.5.5 TEM with EELS for Fe in CQ treated D10 
 
The effect of CQ on the distribution of Fe within the parasite was examined by TEM 
with ESI using EELS (Figure 3-10) according to the technique described in Chapter 
2. Previously unpublished images of untreated merozoite and ring stage parasites 
showed these parasites contained very little Fe in comparison to the host RBC. 
With exposure to 30 nM CQ there was very little change seen in the Fe distribution 
in the merozoite and ring stages.  This is in stark contrast to the Fe distribution 
seen in trophozoites (Figure 3-10). Images of untreated trophozoites show a large 
concentration of Fe inside the DV, while the rest of the cell is virtually devoid of the 
presence of Fe. With the exception of Hz Fe within the DV, control parasites at the 
trophozoite stage contain very little Fe relative to the host RBC cytoplasm.  In a 
separate study where Hz crystals extracted from untreated trophozoites were 
examined using TEM, the crystals were shown to consist of single, ordered crystals 
having uniform fringes corresponding to the {100} face of the crystal.107 In contrast 
images of trophozoites treated with 30 nM CQ show large concentrations of Fe in 
areas corresponding to Hz crystals within the DV but also outside the DV in the 
cytosol, concentrated in areas indicated by yellow asterisks in Figure 3-10. This 
cytosolic Fe can be attributed to haem as virtually all Fe in both treated and 
untreated parasites was found to present as haem species. Furthermore, because 
treated parasites contain very little Hb, this haem can most likely be attributed to 
free haem. TEM images of crystals isolated from CQ treated parasites showed less 
uniform crystals at 30 nM and at 60 nM TEM images showed evidence of grain 
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boundaries in the crystals at high magnification, directly signifying that CQ 
disrupts Hz crystallization in the parasite.107 
 
 
Figure 3-10: TEM images with ESI using EELS for Fe of untreated D10 PRBCs and 
PRBCs inoculated with 30 nM CQ prepared as described in Chapter 2. In all images 
RBCs are delineated by a yellow dashed line, parasite by a green dashed line and 
DV by a white dashed line. The Fe distribution measured by ESI using EELS is 
shown in red. The Fe signal in untreated parasites (Figure 3-10 a and b) is localized 
to the Hz crystals in the DV and 2 areas highlighted by yellow asterisks (*) which 
could be attributed to RBC cytosol containing cytostomes (C). The rest of the 
untreated parasite is devoid of detectable Fe. In both the untreated and treated 
PRBC, Fe is readily detected in the RBC cytoplasm. CQ treated parasites show large 
concentrations of Fe in areas corresponding to Hz crystals within the DV and also 
outside the DV in the troph cytoplasm, concentrated in areas indicated by yellow 
asterisks (*). The Fe signal attributed to Hz crystal inside the DV of CQ treated cells 
is not as strong as in untreated cells. This cytosolic Fe can be attributed to haem, as 
virtually all Fe in both treated and untreated parasites was found to present as 
haem species. Additionally, because treated parasites contain very little Hb, this 
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3.5.6 TLC of haem and OsO4 fixed haem 
 
The TEM images in Figure 3-10 were prepared from cells which underwent a 
lengthy process of chemical fixation before TEM images with EELS for Fe were 
captured. Given the significance of the Fe distribution map in these images, the 
possibility that Fe could have been redistributed during preparation was 
considered. Cells were treated with OsO4 which fixes membranes and so haem 
fixation was also considered. A TLC experiment described in section 3.4.3 was 
conducted where haemin (Cl-Fe(III)protoporphyrin IX) and OsO4-treated haemin 
were spotted alongside each other onto a silica gel TLC plate and after drying were 
run in a series of solvents mimicking the dehydration procedure used when 
samples are prepared for TEM (Figure 3-11). The Rf values obtained for untreated 
haemin in each solvent system are summarised in Table 3.5. As opposed to 
untreated haemin, haemin treated with OsO4 remained on the baseline (Rf = 0) in 
all of the solvent systems. This TLC experiment proves that haemin is immobilized 
following exposure to OsO4.   
 
 
Figure 3-11: Image (unedited) of the thin layer chromatogram of haemin and OsO4 
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Table 3-2: Summary of Rf values of haemin in several solvent systems obtained by 
TLC 
Solvent System Rf value: 
Untreated haemin 
Rf value: 
OsO4 – treated haemin 
30% EtOH (aq) 0.85 0.00 
50% EtOH (aq) 0.95 0.00 
70% EtOH (aq) 





100% EtOH  0.98 0.00 
100% acetone 0.98 0.00 
 
In addition to the evidence provided by the TLC experiment, further evidence for 
the OsO4 fixation of haem can be seen by examining the images of untreated 
trophozoites (Figure 3-10). The Fe signal originates strongly from the HZ crystals 
in the DV with no bleeding of Fe into the cytosol which is completely void of Fe. If 
Fe had diffused out during fixation a uniform distribution of Fe would be seen 
throughout the cell. Furthermore, there is a sharp boundary between the Fe 
present in the RBC cytoplasm and the parasite cytosol indicating that Hb Fe does 
not shift during preparation. Similarly the Fe signal corresponding to the edges of 
the Hz crystals in the DV remain sharp and well defined, confirming that Hz Fe iron 
is not redistributed.  
 
3.6 Summary and conclusions: 
This study very strongly supports the proposed mechanism of action of CQ as a Hz 
inhibitor and establishes a standard method to be used for the validation of 
cellular Hz inhibition for other antimalarial compounds. CQ was shown to cause a 
dose-dependent decrease in Hz and related increase in toxic “free” haem in a 
cultured CQS strain of P. falciparum that is directly correlated with parasite 
survival. Statistically relevant increases in Hb appeared only after the appearance 
of significantly higher levels of free haem suggesting a causative link. Furthermore, 
TEM with EELS for Fe show that haem is redistributed from the DV to parasite 
cytosol in CQ treated P. falciparum cells where it most likely interacts with 
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membranous structures such as endoplasmic reticulum in the parasite cytosol. 
Schmitt et al showed that aggregates of haemin in aqueous solution rapidly enter 
and accumulate into lipid bilayers, associating with organelles, causing membrane 
disorder and enhancing permeability leading to eventual cell lysis.51 The resolution 
of the TEM images obtained was not high enough to distinguish association with 
any specific organelles in the parasite cytosol; however as this theory represents a 
possible way of killing the parasite it necessitates further investigation.  
The haem fractionation study was extended to several other antimalarials, ART, 
AQ,  LF, MQ and QN as well as the antifolate PYR and its combination with S (SP) at 
a single dose of 2.5 × their IC50. With the exception of the antifolates it has been 
suggested that these antimalarials share the same mechanism of action as CQ. 
Although controversial for ART, numerous studies have shown that the quinolines 
interfere with the formation of βH at concentrations that correlate with their 
biological IC50 values, suggesting that like CQ they disrupt the formation of 
haemozoin. 69 106 178 213 98 179 110 Nonetheless, QN and MQ have been implicated in 
alternative mechanism of action, targeting cytosolic and membrane targets.129 
Neither QN nor MQ accumulate to the same degree as CQ within the acidic DV and 
while CQ treatment of P. berghei infected mice resulted in decreased Hz 
production, neither QN nor MQ treatment affected Hz production. 79 127 The 
measurement of “free” haem and Hz at a fixed single dose for the antimalarials 
investigated in this chapter provides only an initial screen. A more comprehensive 
study of each of the compounds tested is required before any definitive 
conclusions can be made. 
The method presented here provides valuable information regarding drug 
mechanisms of action, enhancing existing information to aid in the rational 
selection of novel compounds for drug design and development.  The single biggest 
limiting factor of the technique presented in this chapter is the length of time 
required to complete a profile for a single drug at several different concentrations 
as carried out for CQ. The full potential of this technique as a basis for assaying 
parasite Hz inhibition in the presence of antimalarial compounds could only be 
realised if it was adapted to higher throughput method with shorter lead times.  
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The process of cellular lipid mediated Hz formation is mimicked synthetically in a 
detergent-mediated assay using the lipophilic detergent NP-40 as a substitute for 
the neutral lipids. 102 The NP-40 assay has been applied as a high throughput 
screening tool and identified several novel Hz inhibiting scaffolds. 105 104 224 225 This 
laboratory based method for the determination of βH inhibition was translated 
into an equivalent process in laboratory cultured malaria parasites, the “haem 
fractionation assay”.107 The previous chapter described the results of the haem 
fractionation assay used to directly determine Hb, “free” haem and Hz in P. 
falciparum inoculated with increasing concentrations of CQ.  All haem species were 
spectroscopically measured as a Fe(III)haem complex with pyridine, based on a 
previously published method by Ncokazi and Egan in which it was shown that in a 
mixture of βH and haematin, the latter forms a low-spin complex with aqueous 
pyridine (5% v/v, pH 7.5) without disturbing βH.101 As described in Chapter 3, CQ, 
caused a dose-dependent increase in cellular “free” haem (i.e., labile haem that can 
be solubilized with detergent), alongside a decrease in Hz correlated to decreased 
parasite survival in CQS D10 P. falciparum. The data were supplemented by TEM 
images with EELS for Fe of CQ-treated cells and showed a redistribution of Fe from 
the DV into the parasite cytoplasm. 107 The method successfully demonstrated that 
CQ is able to inhibit the cellular formation of Hz, however, due to its protracted 
nature and high demand on parasite starting material, it could not easily be 
extended to other drugs.  
In this chapter a modification of this haem fractionation assay is described. 
Performed in 24-well plates, this modified technique was primarily developed to 
increase output as multiple drug concentrations can be evaluated in one session 
with relatively low amounts of parasite starting material translating to reduced 
material costs. A significant improvement in output over the previous method was 
achieved, producing results for two compounds per week in comparison to the 
original method which produced results for one compound every two months. The 
method was validated against the original haem fractionation assay performed in 
flasks using CQ, described in detail in Chapter 3. Several experiments were carried 
out to assess the robustness of the method with particular reference to the 
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measurement of each haem species at each fractionation step and the possibility of 
cross-contamination of haem species between fractionation steps. This increased 
throughput method was applied to three clinically relevant antimalarials covering 
a broad spectrum of mechanisms of actions: the 4-aminoquinoline AQ which like 
CQ has been shown to inhibit βH formation, the non-βH inhibiting antifolate PYR 
and finally the non-βH inhibiting anti-malarial ATV. 105 184  
Previously cell counts were acquired using a haemocytometer; however the 
technique was tedious and impractical when applied to a large number of samples. 
As a result counting was also performed with a novel flow cytometry method using 
SYBR green I fluorescent staining of isolated cells. 226-228 229 Based on the 
fluorescent binding of SYBR green I to double stranded DNA, the SYBR green I 
fluorescence signal increases over the course of the 48 h lifecycle of the parasite as 
the amount of DNA increases with maturation from early rings to multi-nucleated 
schizonts. 230 SYBR green I was specifically chosen due to its low binding affinity 
for RNA and preference for double stranded DNA over single stranded DNA. 231 
Furthermore, this flow cytometry method provided valuable information about 
morphological changes of cells treated with antimalarials as the stage of the P. 
falciparum cells can be determined from the associated fluorescence of the 
population.   
This chapter describes the development and implementation of this improved 
throughput, modified version of the assay developed in the previous chapter 
allowing for the more rapid determination of haem species in isolated P. 
falciparum trophozoites. The assay was then applied to several clinically relevant 
antimalarials at multiple concentrations.  
 
4.2 Materials  
 
All materials used throughout this chapter are listed in Chapter 2. Materials were 
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4.3 Sample Preparation 
 
The preparation of all samples used throughout this chapter, are previously 
described in Chapters 2 and 3. The water used throughout this work was double 




4.4.1 Haem fractionation assay 
 
The haem fractionation assay is a cellular fractionation technique based on the 
ability of neutral aqueous pyridine to selectively form a low spin haem-pyridine 
complex with “free” haem in the presence of Hz.101 The original method described 
in detail in Chapter 3, was performed in 250 ml culture flasks, testing a single drug 
concentration at a time and performing spectroscopic measurements in a 
cuvette.107 The modified method was performed in 24-well plates, testing several 
drug concentrations, four replicates at a time and using a multiwell plate reader to 
record absorbance values, resulting in a six-fold increase in throughput. The 
original method performed in 250 ml culture flasks is compared to the modified 
24-well plate method in the flow chart, Figure 4-1 below. 
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Figure 4-1: Flow diagram showing the haem fractionation assay: original flask 
method (left) versus increased throughput plate method (right). Immature ring 
stage PRBCs were inoculated with several different increasing drug 
concentrations. After 32 h, mature trophozoites were harvested via saponin lysis 
of erythrocytes. Following hypotonic lysis and centrifugation the supernatant was 
isolated and the SDS treated soluble Hb was measured in the supernatant as a low 
spin haem-pyridine complex. The pellet was further treated with SDS and pyridine 
to solubilize “free” haem, measured in the supernatant following centrifugation. Hz 
was measured after solubilizing the pellet in NaOH, neutralizing with HCl and 
treating with pyridine. 
 
Incubation: 
The parasitaemia of an early ring-stage sorbitol synchronized culture was 
determined from a 10% (v/v) Giemsa stained blood smear under a light 
microscope with an oil immersion lens at 100× magnification. The culture was 
diluted to 5% parasitaemia with washed O+ human RBCs at a 2% haematocrit with 
complete medium. Aliquots of 2 ml were added to each well of a 24-well flat-
bottom cell culture plate (Figure 4-2). Unless indicated otherwise, all drugs were 
tested at five different concentrations corresponding to 0.5×, 1.0×, 2.0×, 3.0× and 
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4.0× their 50% growth inhibition concentration measured in vitro. Drugs were 
diluted in medium from the previously prepared 2 mg/ml stock solution (Chapter 
2, Section 2.5.3) and 20 μl added to each well of the 24-well plate such that the 
final concentrations in each well corresponded to 0.5×, 1.0×, 2.0×, 3.0× and 4.0× 
the parasite growth IC50 of the test compounds. Each concentration was tested as 
four replicates and the highest concentration of drug tested was at 4× IC50, since 
beyond this concentration very few cells remained for harvesting. No drug was 
added to the 4 control wells on each plate.  The plates were gassed in a gas 
chamber with a mixture of 3% O2, 4% CO2 and N2 for 4 min and incubated at 37 °C 
for 32 h (Figure 4-1).  
 
 
Figure 4-2: Setup for a 24-well flat-bottom cell culture plate. Each well contains 2 
ml of PRBCs at 5% parasitaemia and 2% haematocrit. To each well 20 μl of drug 
was added such that the final concentrations in each well corresponded to 0.5×, 
1.0×, 2.0×, 3.0× and 4.0× the biological IC50 of the test drug. Cell counts determined 
using flow cytometry were performed on all 24 wells of the 24-well plate while 
haemocytometer counts were performed on the 6 wells in row A only. 
 
Harvesting: 
After 32 h, excess supernatant as well as any cell debris and associated Hz 
corresponding to a black layer on top of the PRBC pellet was aspirated. Giemsa-
stained thin smears were prepared on glass slides at each concentration tested and 
viewed under a light microscope with an oil immersion lens to confirm the 
presence of trophozoites. Each pellet was resuspended in 1.9 ml PBS (pH 7.5) and 
transferred to a round bottomed deep well 2.2 ml rectangular 96-well plate. These 
new plates ensured maximum sample recovery in subsequent steps and were 
essential for further processing. Trophozoites were isolated by lysing erythrocytes 
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with the addition of 100 μl 1% (w/v) saponin. After 2 min at 37 °C, plates were 
centrifuged at 750 rcf for 15 min. The supernatant was aspirated and the pellets 
washed three times with 0.5 ml PBS (pH 7.5) to remove all traces of erythrocyte 
Hb. The washed pellet, corresponding primarily to isolated trophozoites, was 
resuspended to a final volume of 100 μl with PBS pH 7.5 and accurately transferred 
to a round-bottomed, 96-well 0.5 ml plate referred to as the stock plate. The stock 
plate was used to prepare a second plate for cell counting as described below after 
which it was frozen at ˗80 °C (Figure 4-1). 
 
Preparation of the counting plate and cell fixation:  
 A counting plate was prepared by adding 10 µl of the isolated washed 
trophozoites to the corresponding wells of a flat-bottomed 96-well plate. The cells 
were fixed with 0.125% (v/v) glutaraldehyde in PBS pH 7.5 to a final volume of 
200 μl and refrigerated at 4 °C overnight (Figure 4-1).  
 
Haemocytometer counting:  
Haemocytometer counting was performed on the first row of each plate only, 
corresponding to 6 samples, a control and one at each of the drug concentrations 
tested. The haemocytometer determined cell counts for these 6 samples were 
statistically compared to the cell counts determined by flow cytometry to test for 
agreement. The number of cells/ml was determined by loading 10 μl of cells from 
each well onto a bright-line haemocytometer and five large squares were counted 
after 10 min of settling. The concentration of cells in each well of the plate was 
determined using equation 4-1:  
CH = N  F  DF  10,000   (4-1) 
Where: CH = concentration of cells per ml as determined by haemocytometer  
  N = number of cells counted in 5 fields 
F = number of fields counted = 5 
DF = dilution factor 
 
Flow cytometry counting:   
The cell count in each well of the counting plate was determined using fluorescent 
staining and flow cytometry.226-228 Samples were prepared by diluting 100 µl of 
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cells taken from the counting plate with 800 µl of 1  SYBR® green I in PBS pH 7.5 
and incubating for 30 min in the dark at 37 °C. Next, each sample was spiked with 
100 µl of Trucount™ beads (Becton Dickinson) such that each sample contained a 
known fixed amount of fluorescent beads in a final volume of 1 ml. Samples were 
analysed on a Becton Dickinson FACSCalibur using SSC/FL1 530 nm with 
CellQuestPro software. All samples were analysed using FloJo software version 10 
(Tree Star Inc). The samples were mixed well before use. The concentration of cells 
in the acquisition tube was calculated according to equation 4-2: 
CF = (T/B)  CB   (4-2) 
Where: CF = concentration of cells per ml as determined with flow cytometry  
  T = number of trophozoites gated 
  B = number of fluorescent beads gated 
CB = concentration of fluorescent Trucount™ beads in the acquisition tube 
per ml (calibrated bead count per acquisition is unique to each lot of 
Trucount™ tubes obtained from the supplier)  
Trophozoite gates were established by running isolated trophozoites obtained 
from a highly synchronous trophozoite culture through the process of harvesting 
and flow cytometry analysis as described above. A 10% (v/v) Giemsa-stained slide 
confirmed the presence of trophozoites. The same process was applied to a highly 
synchronous late stage ring culture; however it was difficult to distinguish rings 
from the debris accumulated during the isolation and harvesting procedure in the 
Giemsa-stained slides. The latter population presumed to correspond to rings and 
associated debris was omitted during gating and only intact trophozoites were 
gated and used to determine cell counts. Typically 10,000 events were counted for 
each sample.  Initial gating was performed with unstained cells to account for 
autofluorescence.  
 
Haem fractionation:   
The stock plate was thawed at room temperature and 50 μl of water was added to 
each well. The plate was floated in an ultrasound bath and sonicated for 5 min. 
Each well was resuspended with 50 μl each of 0.2 M HEPES buffer pH 7.5 and 
water. The plate was then centrifuged at 3600 rpm for 20 min. The supernatant in 
each well was transferred to an adjacent set of wells on the same plate with 
extreme care as to avoid disturbing the pellet.  The supernatant was processed 
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further with 50 μl 4% SDS, sonicated for 5 min and then incubated at 37 °C for 30 
min. Finally, 50 μl of 0.3 M NaCl and 50 μl of 25% (v/v) pyridine in 0.2 M HEPES pH 
7.5 were added and 200 μl of the solution was transferred to a flat-bottomed UV-
Star 96-well plate. This fraction corresponds to the Hb fraction (Figure 4-1).  
The remaining pellet containing “free” haem and Hz was resuspended with 50 μl 
water and 50 μl 4% SDS. The plate was sonicated for 5 min and incubated at 37 °C 
for 30 min to solubilize “free” haem. This was followed by the addition of 50 μl 0.2 
M HEPES pH 7.5, 50 μl 0.3 M NaCl and 50 μl 25% pyridine. The plate was 
centrifuged at 3 700 rpm for 20 min. Again, very carefully without disturbing the 
pellet, the supernatant was transferred to an adjacent set of wells on the same 
plate. The supernatant was diluted to a final volume of 400 μl with water. This 
fraction corresponds to the “free” haem fraction (Figure 4-1); 200 l of this 
solution was transferred to the flat-bottomed UV-Star 96-well plate, the same plate 
previously used for the Hb fraction.  
The remaining pellet containing Hz was solubilized in 50 μl of water and 50 μl 0.3 
M NaOH. The plate was sonicated for 15 min and incubated at 37 °C for 30 min. 
Finally, 50 μl each of 0.2 M HEPES pH 7.5, 0.3 M HCl, 25% pyridine and 150 μl 
water were added. This fraction corresponds to the Hz fraction (Figure 4-1); 200 l 
of this solution was transferred to vacant wells in the flat-bottomed UV-Star 96-
well plate containing the Hb and “free” haem fractions. The UV-visible spectra of 
haem as Fe(III)haem-pyridine complex was recorded using a multi-well plate 
reader (Spectramax 340PC, Molecular Devices). The absorbance maxima (Amax) of 
the Fe(III)haem pyridine complex in each well was used to calculate the 
percentage of each haem species in each sample as the final volume for each 
fraction was identical. The calculation for percentage of each haem species in each 
sample is described in equation 4-3 below:  
ATotal = AHb + A”free” haem + AHz       (4-3.1) 
% Hb = (AHb/ ATotal)  100       (4-3.2) 
% “free” haem = (A’free” haem/ ATotal)  100     (4-3.3) 
% Hz = (AHz/ ATotal)  100       (4-3.4) 
Where: Amax for Fe(III)haem-pyridine (Hb fraction) = AHb  
Amax for Fe(III)haem-pyridine (“free” haem fraction) = A”free” haem 
Amax for Fe(III)haem-pyridine (Hz fraction) = AHz   
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Haem standard curve:   
The total amount of haem in each fraction was quantified using a haem standard 
curve prepared from a 100 μg/ml haem standard solution of haematin (porcine) in 
0.3 M NaOH. Serial dilutions of the standard were carried out in a 96-well plate 
with 100 μl 0.3 M NaOH as a blank. Each haematin standard was diluted with 50 μl 
of each of the following solutions: 0.2 M HEPES pH 7.5, 4% (w/v) SDS, 0.3 M NaCl, 
0.3 M HCl, 25% pyridine in 0.2 M HEPES pH 7.5 and water. All measurements were 
performed in triplicate. The visible spectra of haem as Fe(III)haem-pyridine 
complex was recorded in a multi-well plate reader. A calibration curve of was used 
to determine the amount of haem Fe present in each sample (Figure 4-3).  The 
amount of haem Fe per cell was calculated by dividing the total haem Fe in each 
fraction by the number of cells determined in each fraction. For ease of comparison 
with the total cellular Fe reported in Chapter 3, and with a previous study 
conducted by Egan et al in 2002 where the total amount of Fe in isolated 
trophozoites present as Hz was reported, all results are expressed as the amount of 
haem Fe (fg) per cell. 30  






















Figure 4-3: Representative calibration curve of haem Fe (as Fe(III)haem-pyridine 
complex) vs absorbance.  The data represents the mean ± SD of 3 repeats. The 
linear portion of the graph is shown for which the correlation coefficient, R2 = 
0.999. The graph was plotted using GraphPad Prism 4.0 linear regression function. 
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4.5 Statistical analysis 
 
Bland Altman analysis was used to assess the agreement between the original 
haem fractionation method and modified plate method.232 For determination of 
statistical significance of differences in measurements relative to controls, a two-
tailed t-test (95% CI) was used and is displayed on graphs using asterisks (* P 
<0.05; ** P <0.01; *** P <0.001). In all cases data represent a minimum of three 
repeats. All analysis was carried out using GraphPad Prism version 4.0 software. 
203  
 
4.6 Results and Discussion 
 
4.6.1 Cell counting: haemocytometer versus flow cytometer 
 
Cell concentrations required for the determination of the total amount of haem Fe 
per cell (reported in fg/cell) in the original haem fractionation assay were 
determined manually using a haemocytometer. This method was found to be slow 
and tedious when applied to 24 samples per plate and an alternative, more 
efficient method for counting cells was set up using flow cytometry (Section 4.4.1). 
Cell counts using flow cytometry were performed on all wells of each 24-well plate. 
Haemocytometer counts were routinely done on 6 samples in the first row only of 
each 24-well plate for comparison and to establish agreement between the 
methods. In both cases only intact isolated trophozoites were counted. Flow 
cytometry is a faster, less subjective process than haemocytometer counting but is 
not without limitations. The first issue relates to the accurate gating of cells. A gate 
corresponding to trophozoites was established by running isolated trophozoites 
obtained from a highly synchronous trophozoite culture through the process of 
harvesting and flow cytometry analysis as described in methods above. 
Trophozoites were confirmed with a 10% (v/v) Giemsa-stained slide (Figure 4-4A, 
inset). The resulting dot plot is shown in Figure 4-4A and represents a population 
corresponding to primarily trophozoites. The same process was applied to a highly 
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synchronous ring culture and the resulting dot plot of cell material accrued as a 
consequence of the harvesting process, most likely corresponding to both rings 
and cell debris, can be seen in Figure 4-4B. Again, a 10% (v/v) Giemsa-stained slide 
confirmed the presence of accumulated cell debris; however it was difficult to 
distinguish rings from the debris (Figure 4-4B, inset). The trophozoite population 
in Figure 4-4A corresponds to cells of a greater side scatter (SSC) and fluorescent 
intensity (FL1) indicating more complex cells with more nucleic acid in 
comparison to the population of rings and debris with both lower fluorescent 
intensity and SSC in Figure 4-4B. The latter population was omitted during gating 
and only intact trophozoites were gated and used to determine cell counts. Despite 
having established a gate specifically for trophozoites (Figure 4-4A) which 
excludes any rings and cell debris collected during the process of harvesting 
(Figure 4-4B), an overlap exists where cells which appear as larger, more complex 
and mature rings have the same forward scatter (FSC), SSC and fluorescent 
intensity as immature or underdeveloped trophozoites. This overlap is 
demonstrated in Figure 4-4 C, D and E which show the histogram plots of FL1, FSC 
and SSC of the trophozoite population in Figure 4-4A. The areas of overlap as well 
as the smaller population corresponding to rings and debris are indicated on each 
graph. The presence of this overlap can result in an inaccurate trophozoite cell 
count. The second issue is counting aggregates of cells as a single complex cell 
resulting in under-counting, however this was largely overcome by mixing samples 
well during preparation and running the samples at a low flow rate on the flow 
cytometer.  
Despite the limitations associated with both counting methods, it was found there 
was no statistical difference between the means as determined by each counting 
method (unpaired two-tailed t-test, 95% CI) for the untreated controls (Figure 4-
4F). Furthermore, no significant difference between flow cytometry and 
haemocytometer determined counts were seen at any concentration of the four 
drugs tested (Table 4-1).  
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Figure 4-4: Dot plots of SSC vs SYBR green fluorescence (FL1-H)  for samples 
corresponding to populations of primarily isolated trophozoites (A) and isolated 
rings and associated debris (B). The corresponding 10% Giemsa stained smears of 
isolated cells as viewed under 100× magnification are shown as insets. Panels C, D 
and F correspond to FL1, FSC and SSC of the trophozoite population in A. The areas 
corresponding to rings and debris are indicated by blue arrows and areas of 
overlap between the trophozoite population and population corresponding to 
rings and debris are indicated by orange arrows on each graph.  Panel F shows the 
average cell count obtained for control samples using a haemocytometer (blue) vs 
flow cytometry (red). The mean cell count obtained using the haemocytometer did 
not differ significantly from the flow cytometry count (P = 0.88, n = 6, two tailed 
unpaired t-test at 95% CI).  
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Table 4-1: The P-values obtained when the mean count obtained using the 
haemocytometer is compared to mean count obtained using flow cytometry for 
each drug tested at several different concentrations (unpaired, 2 tailed t-test, 95% 
CI). 
CQ (nM) 7.5 15 30 45 90 
P-value 0.92 0.68 0.32 0.89 0.96 
AQ (nM) 12.5 25 50 75 100 
P-value 0.12 0.56 0.056 0.28 0.061 
ATV (nM) 1 2 4 8 16 
P-value 0.75 0.92 0.69 0.83 0.23 
PYR (nM) 25 50 100 150 200 
P-value 0.13 0.12 0.087 0.11 0.86 
 
4.6.2 Assessment of the Robustness of the Assay 
 
The robustness of the assay was addressed with particular reference to the 
specificity of the assay for different haem species in the various fractions. Several 
opportunities for cross contamination were investigated at each of the 
fractionation steps.  
 
Contamination by Hz post synchronisation 
When cultured parasites are synchronized with sorbitol at the ring stage, 
trophozoites present in the asynchronous culture are lysed and Hz is released into 
the culture. To avoid any carry-over of this released Hz into the synchronized 
culture to be used in the subsequent assay, any visible pigmented cell debris was 
removed by aspiration immediately following sorbitolization. To confirm that 
significant quantities of pre-formed Hz did not contaminate the sample a 
synchronous culture was split into 2. One half was subjected to the process of 
harvesting, followed by the haem fractionation assay at the ring stage soon after 
sorbitol treatment. At this stage of the lifecycle early rings would have produced 
little or no Hz.233 Consequently; any haem detected in the Hz fraction arises from 
Chapter 4: Development and optimisation of a multiwell colorimetric assay for the determination of haem 
species in plasmodium falciparum 
Jill Michelle Combrinck -November 2016 
109 
either Hz carried over during the previous round of sorbitol synchronization, or 
from a small fraction of trophozoites that survive sorbitol treatment. The second 
half of the same culture was harvested 24 h later as trophozoites and taken 
through the same process of the haem fraction assay. The resulting absorbance 
spectrum of the Hz haem fraction corresponding to rings (grey) and trophozoites 
(red) is shown in Figure 4-5A. The absorbance spectrum of Hz haem present in the 
ring stage fraction was minimal compared to material isolated from the same 
culture 24 h later at the trophozoite stage. At the maximum, the amount of Hz in 
the ring culture equates to 4.2 ± 0.4% (n = 4) of the Hz haem in the trophozoite 
culture and most likely arose from a small proportion of trophozoites that survived 
sorbitol treatment, still present in the ring culture. Thus, post synchronisation Hz 
cross-contamination was found to be negligible. 
 
Contamination by host RBC Hb post synchronisation 
Host RBC Hb is another potential source of cross-contamination. RBC Hb is the 
dominant form of haem in the total culture at 5% parasitaemia. Trophozoites 
isolated by saponin lysis for the haem fractionation assay are accompanied by 
lysed RBC membranes. The isolated trophozoite pellet could be contaminated with 
Hb if the washing steps described as part of the harvesting protocol in the haem 
fractionation assay are not efficient enough. RBC Hb would therefore not be 
removed and would result in elevated trophozoite Hb readings which could 
potentially carry over into subsequent fractions and elevate the haem values in 
those fractions.  To test this, 2 ml of PRBC at 2% haematocrit (40 l RBC) and 5% 
parasitaemia was spiked with 100 L of packed RBCs. This mixture was then 
subjected to the usual harvesting and haem fractionation assay and Hb (Figure 4-
5B), “free” haem (Figure 4-5C) and Hz haem (Figure 4-5D) were measured. None of 
the fractions showed any significant change in haem levels relative to the unspiked 
control. This demonstrated that cross-contamination by RBC Hb is not significant 
provided that the washing protocol is followed. 
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Figure 4-5: (A) The absorbance spectrum for the Hz haem fraction of isolated 
trophozoites is shown in red and rings in grey. The Soret peak corresponding to 
the ring culture is minimal compared to the strong signal obtained from the 
trophozoite culture. The cross contamination carried over from previous 
synchronisation cycles was determined to be less than 4%.  The same culture was 
used to generate both graphs, with isolations performed 24 h apart using 
approximately 2.5 × 107 cells each time. The Soret band absorbance readings for 
Hb (B), “free” haem (C) and Hz (D) fractions of a sample spiked with 100 µl of 
packed RBCs compared to a control sample containing 40 µl of 5% PRBCs. Both the 
control and spiked sample were from the same culture and contained 107 
parasites. No significant change was seen in the Hb fraction (P = 0.57), “free” haem 
fraction (P = 0.52) and Hz fraction (P = 0.33) of the spiked sample containing 2.5× 
more RBCs compared to the control sample (unpaired two tailed t-test, 95% CI, n = 
6).  
 
Contamination of “free” haem fraction: 
Finally, contamination of the “free” haem fraction by Hz was investigated. The 
“free” haem fraction could potentially be contaminated as a result of the 
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breakdown of Hz during ultrasound treatment in the presence of SDS. Two 
approaches were used to test this. Firstly, the duration of ultrasound treatment 
was increased 3-fold to 15 min. No significant change in free haem levels was 
detected (Table 4-2). Secondly, the pellet containing “free” haem and Hz was 
spiked with isolated Hz prior to addition of SDS and ultrasound treatment. This Hz 
was obtained from the final pellet of a control experiment isolated prior to 
addition of NaOH, doubling the quantity of Hz in the sample. Isolation of “free” 
haem from this spiked sample showed no significant difference relative to an 
unspiked control (Table 4-2). This confirmed that Hz does not contaminate the 
“free” haem fraction.   
 
Table 4-2: The mean absorbance of a control sample compared to a sample 
sonicated for an extra 15 min and a sample spiked with Hz. The P-values indicate 
that the average absorbances do not differ significantly from the control (unpaired 
two tailed t-test, 95% CI, n = 6).  
Sample Description Average Absorbance P-value 
Control 0.024 ± 0.003 N/A 
Sonicated for 15 min 
Spiked with Hz 
0.021 ± 0.001 




4.7 Validation of plate method with CQ 
 
The plate method was validated in CQS D10 P. falciparum inoculated with CQ. A full 
dose response profile was previously described for CQ using the flask method at 
several different concentrations in Chapter 3, allowing for direct comparison of 
results obtained with the established flask method and modified 24 well plate 
method. The effect on all three haem species, Hb, “free” haem and Hz was 
examined and compared to the data obtained with the original flask method 
(Figure 3-8).  
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Haem fractionation profiles: 
The results achieved with the modified plate method paralleled the results 
obtained with the original flask method, producing a dose dependent increase in 
the % “free” haem with corresponding decrease in Hz in CQS P. falciparum 
inoculated with CQ (Figure 4-6). At high concentrations of CQ, corresponding to 
the highest “free” haem levels very few trophozoites survived after the 32-hour 
incubation period. Despite the similar trend, the modified plate method showed a 
more muted response for both the increase in % “free” haem and decrease in % Hz 
(Figure 4-6b, c, e and f). At 45 nM CQ the mean % “free” haem reached with the 
flask method was 15.3%, while the mean % “free” haem obtained with the 
modified plate method was 11.1%, an increase of 11.1% and 7.0% respectively 
above the untreated control. This muted response can be attributed to several 
factors. Firstly a decreased absorbance as a result of reduced starting material 
volumes for each sample, which is in turn associated with larger errors in the plate 
method. Secondly, small but significant sample losses occurred at each 
fractionation step during the transfer and separation of the supernatant and 
pellets. Nonetheless, as in the original flask method, the rise in “free” haem is 
correlated to the decline in the survival curve of the parasite (Figure 4-6g and h).  
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Figure 4-6: Graphs of % Hb (a), % “free” haem (b) and % Hz (c) obtained with the 
original flask method and % Hb (d), % “free” haem (e) and % Hz (f) obtained with 
the higher throughput 24-well plate method in isolated trophozoites with 
increasing concentrations of CQ (nM).  Asterisks displayed on the graph indicate 
statistical significance relative to the control (95% CI) determined using a 2-tailed 
t-test (* P <0.05; ** P <0.01; *** P <0.001).  The parasite survival curve with CQ, 
determined using a modification of the pLDH assay by Makler et al (red graph, left 
axis) is overlaid with the % “free” haem obtained using the original flask method 
(blue graph, right axis) (g) and modified plate method (---- blue graph, right axis) 
(h).206 The parasite survival curve intersects each of the “free” haem curves at a 
point which corresponds closely to both the parasite growth IC50 and the halfway 
point of the increase in each of “free” haem graphs. Both methods show a dose 
dependent increase in % “free” haem and a decrease in % Hz, correlated to 
parasite death, although a more muted response is seen with the 24 well plate 
method. In all cases the scales of the parasite survival graph overlaid with “free” 
haem levels have been adjusted such that the 50% mark on the parasite survival y-
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Bland-Altman analysis was used to compare the new 24-well plate method to the 
established flask method, with respect to the percentage of each haem species 
determined.232 The Bland-Altman method has been widely used in evaluating 
agreement between different methods of measurement and calculates the mean 
difference between two methods of measurement plotted against the mean and the 
95% limits of agreement of the mean differences. 229 230 The criterion for 
agreement between two methods of measurement is that 95% of the differences 
between the two measurements should lie within the 95% limits of agreement and 
results are represented graphically in a Bland-Altman plot. 232 234 235 The Bland-
Altman plots for each of % Hb, % “free” haem and % Hz are shown in Figure 4-7, 
where the difference in the result obtained with the established flask and modified 
plate method for each haem species is plotted against the mean of the result 
obtained with each method. The agreement between the two methods for both % 
“free” haem (Figure 4-7b) and Hz (Figure 4-7c) were good, showing narrow limits 
of agreement in comparison to the means. Hz however does show evidence of 
systematic error, bordering on the limits of the upper 95% limits of agreement for 
the three lowest mean percentages (Figure 4-7c). These borderline data points 
correspond to cells which were dosed at 90 nM CQ (greater than four times the 
IC50 of CQ) and the results are most likely associated with larger errors due to poor 
recovery at high drug concentrations. Hb showed much broader limits of 
agreement between the methods relative to the mean for each set of 
measurements (Figure 4-7a). In addition to the small sample volume used (2 ml), 
Hb is present in very small amounts in mature trophozoites resulting in low 
absorbance values for this haem species. The determination of Hb, specifically in 
the plate method was very often associated with large errors. In view of the good 
agreement for Hz and especially ‘free’ haem, the higher throughput plate method 
was subsequently used for further investigations and extended to several well 
know antimalarials.  
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Figure 4-7: Bland-Altman statistical analysis was used to compare the results 
obtained with the original flask method and the higher throughput plate method. 
The difference in the result obtained with the flask and modified plate method was 
plotted against the mean of the result obtained with each method for % Hb (a), % 
“free” haem (b) and % Hz (c). The dotted lines in each graph represent the upper 
and lower 95% limits of agreement between the two methods. Before analysis, 
outliers were removed using the modified Thompson Tau test (n = 3 at each 
concentration).  
 
Haem Fe per cell: 
The amount of haem Fe per trophozoite (fg/cell) at each dose of CQ was 
determined from flow cytometry derived cell counts (Methods, 4.4.1). Counts of 
isolated trophozoites determined using flow cytometry did not differ statistically 
from those determined using a haemocytometer (Figure 4-6 and Table 4-6). In 
Chapter 3 it was shown that the total amount of haem Fe in CQ-treated isolated 
trophozoites was not statistically different to control trophozoites, isolated using 
the established flask method with haemocytometer cell counting. These results 
were confirmed in the current study where it was found that the total haem Fe in 
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CQ-treated trophozoite cells was statistically indistinguishable from control cells 
(Figure 4-8d). The haem fractionation profiles showing the amount of Hb (Figure 
4-8a), “free” haem (Figure 4-8b) and Hz (Figure 4-8c) Fe per trophozoite with 
increasing CQ concentration followed the same trend as the corresponding  
percentage profiles seen in Figure 4-6d, e and f. Similarly an overlay of the parasite 
survival curve with the amount of “free” haem Fe per trophozoite shows an 
increase in the amount of “free” haem per cell correlated to cell death (Figure 4-8e) 
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Figure 4-8: Haem fractionation profiles for CQ. The amount of Hb (a), "free" haem 
(b) and Hz (c) expressed in terms of the amount of haem Fe (fg) per isolated 
trophozoite with increasing concentrations of CQ (nM). The total haem Fe per cell 
(fg) for the CQ-treated isolated trophozoites was not statistically different to the 
control (d). Asterisks displayed on the graph indicate statistical significance 
relative to the control (shown in red) at the 95% CI, determined using a 2-tailed t-
test (* P <0.05; ** P <0.01; *** P <0.001).  The parasite survival curve with CQ, 
determined using a modification of the p-LDH assay by Makler et al (red graph, left 
axis) is overlaid with the amount of “free” haem Fe (fg) per cell (blue graph, right 
axis) as a function of CQ concentration (nM).206 In all cases the scales of the 
parasite survival graph overlaid with “free” haem have been adjusted such that the 
50% mark on the parasite survival y-axis coincides with the half way mark on the 
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4.8 Antimalarial testing 
 
4.8.1 Amodiaquine  
 
The haem fractionation assay was previously applied to the 4-aminoquinoline AQ 
at a single concentration only using the original flask method in Chapter 3. Closely 
related to CQ, AQ is speculated to share the same the same mechanism of action 
and has been shown to inhibit βH formation with the NP-40 detergent mediated 
βH inhibition assay.105  Preliminary results shown in Chapter 3 for “free” haem 
performed on parasites treated with AQ at 2.5 the parasite growth inhibition IC50 
showed an increase in “free” haem significantly different to the control. A full dose 
response study at several different concentrations of AQ was performed using the 
modified higher throughput 24 well plate haem fractionation assay. The results of 
this study confirmed that AQ, like CQ was a Hz inhibitor, causing a dose related 
increase in “free” haem accompanying parasite death (Figure 4-9a-f). Again as in 
the case of CQ, no statistical difference was found in total haem Fe/trophozoite 
(fg/cell) between the control and AQ-treated samples (Figure 4-9g). This result 
made it possible to use the percentage values of “free” haem (Figure 4-9a) and Hz 
(Figure 4-9b) as a direct indication of the effect of AQ on each of the haem species, 
as was the case for CQ (Figure 4-6d, e, f and 4-8a, b, c). The profiles for the amount 
of “free” haem Fe/trophozoite (fg) and Hz Fe/trophozoite (fg) with increasing AQ 
concentration (Figure 4-9c and d) mirror the profiles obtained with the percentage 
values of the corresponding haem species (Figure 4-9a and b).  
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Figure 4-9: Haem fractionation profiles for AQ. The % “free” haem (a) and % Hz 
profiles (b) with increasing concentrations of AQ (nM) obtained using the modified 
24 well plate haem fraction assay. The trend of increasing “free” haem and 
decreasing Hz with increasing AQ concentrations in isolated trophozoites is 
mirrored in the profiles for the amount of “free” haem Fe (fg/cell) (c) and amount 
Hz Fe (fg/cell) (d). Asterisks displayed on the graph indicate statistical significance 
0
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relative to the control (shown in red) at the 95% CI, determined using a 2-tailed t-
test (* P <0.05; ** P <0.01; *** P <0.001).  An overlay of the parasite survival curve 
determined with AQ using a modified method of Makler et al (red graph, left axis) 
with the % “free” haem (e) ( --- blue graph, right axis) and amount of free haem Fe 
(fg) per cell (f) (˗ ∙ ˗ ∙ blue graph, right axis) in both cases show decreased parasite 
survival is correlated to an increase in “free” haem.206 In all cases the scales of the 
parasite survival graph overlaid with “free” haem have been adjusted such that the 
50% mark on the parasite survival y-axis coincides with the half way mark on the 
“free” haem y-axis. The total haem Fe per cell (fg) for the AQ-treated isolated 




The non βH inhibiting antimalarial PYR, known to interfere with folate synthesis 
was used as negative control in the modified 24 well plate haem fractionation 
assay. 184 105 194 As discussed in Chapter 3, PYR showed no increase in the % “free” 
haem or decrease in % Hz when tested at 2.5 its parasite growth inhibition 
IC50.107 Here, PYR was tested at 5 different concentrations, from 0.5× up to a 
maximum of 4× its parasite growth inhibition IC50 using the 24 well plate haem 
fractionation assay. The haem fractionation profiles for the % of “free” haem and % 
Hz as well the amount of “free” haem and Hz expressed in terms of fg haem Fe per 
isolated trophozoite are shown in Figure 4-10a-d. At higher concentrations of PYR 
corresponding to 3 and 4 IC50, the % “free” haem does show a statistically 
significant increase in % “free” haem compared to the control (Figure 4-10a).  This 
increase in % “free” haem is however not dose related and is not accompanied by a 
decrease in % Hz (Figure 4-10b) which remains constant at all PYR concentrations. 
This statistically significant increase in % “free” haem is not replicated in the PYR 
profile for the amount of “free” haem Fe (fg) per isolated trophozoite, where all 
PYR treated cells were statistically indistinguishable from the amount of free haem 
in the untreated control (Figure 4-10c).  Furthermore, the increase in the amount 
of “free” haem is significant only at the highest doses of PYR where the recovery of 
cells is known to be minimal and associated with a high degree of error. This data 
is consistent with the fact that that PYR is not a βH inhibitor.  
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Figure 4-10: Haem fractionation profiles for PYR.  The profiles for the % “free” 
haem (a) and % Hz (b) with increasing concentration of PYR emulates the profiles 
obtained for the amount of “free” haem Fe (fg) per cell (c) and Hz Fe (fg) per cell 
(d). Asterisks displayed on the graph indicate statistical significance relative to the 
control (shown in red) at the 95% CI, determined using a 2-tailed t-test (* P <0.05; 
** P <0.01; *** P <0.001).  The total haem Fe in untreated isolated trophozoite did 
not differ significantly from PYR treated isolated trophozoites (e). 
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The 24 well plate haem fractionation method was also applied to ATV, an 
antimalarial which like PYR, has a mechanism of action which does not involve βH 
inhibition.98 ATV exerts its antimalarial activity by selectively disrupting 
mitochondrial electron transport in the parasite by inhibiting the essential 
respiratory enzyme complex, cytochrome bc1 without affecting host cell. 198 199 The 
mechanism of action of ATV is confirmed by the fact that ATV resistance coincides 
with mutations in the cytochrome bc1 gene.200 Surprisingly, unlike PYR, ATV 
clearly showed a significant dose dependent increase in % “free”’ haem and 
decrease in % Hz (Figure 4-11a, b). Although the increase was less than that seen 
for both CQ and AQ at the equivalent IC50 values, it was nonetheless significant. 
Further investigation however, revealed statistically significant decreasing total 
haem Fe per trophozoite in ATV-treated cells, showing that treated cells 
accumulated less haem than control cells (Figure 4-11e). This is in contrast to 
results obtained for total haem Fe per trophozoite in CQ (Figure 4-8d), AQ (Figure 
4-9g) and PYR (Figure 4-10e) treated cells, where cells treated with drug showed 
no significant difference to untreated cells. Despite the percentage increase in 
“free” haem with increasing ATV concentration, when the amount of “free” haem 
Fe per trophozoite (fg/cell) was calculated, it was found to remain constant with 
increasing dose, with no significant difference to the control (5.4 ± 1.6 fg Fe/cell), 
at the 95% CI (Figure 4-11c). The amount of Hz haem Fe per trophozoite (fg/cell) 
however decreases significantly in comparison to the untreated control (Figure 4-
11d). The decrease in Hz is likely as a result of decreased Hb uptake and digestion 
secondary to treatment of cells with this drug. This result demonstrates the 
importance of determining the total haem Fe per cell, using cell counts with either 
a haemocytometer or flow cytometry. In the case of ATV, where the total haem Fe 
in treated cells was significantly less than the control (Figure 4-11e), the 
percentage values for each haem species are misleading (Figure 4-11a and b) and 
the amounts of each haem species per cell (Figure 4-11c and d) must be used. This 
approach demonstrated that there was no change in “free” haem and no 
relationship with inhibition of parasite growth in the case of ATV (Figure 4-11f). 
Chapter 4: Development and optimisation of a multiwell colorimetric assay for the determination of haem 
species in plasmodium falciparum 
Jill Michelle Combrinck -November 2016 
123 
 
Figure 4-11: Haem fractionation profiles for ATV. The % “free” haem (a) and Hz 
(b) profiles show a statistically significant dose dependent response to increasing 
ATV concentrations. The amount of “free” haem Fe (fg) per cell shows no dose 
related increase in “free” haem (c) while the amount of Hz Fe (fg) per cell (d) again 
shows a significant dose related decrease in Hz with increasing ATV concentration 
in isolated trophozoites. The total amounts of haem Fe (fg) per cell decreases 
significantly with increasing ATV. An overlay of the parasite survival curve (red 
plot, left axis) with the % “free” haem (black plot, right axis) shows an apparent 
correlation between decreased parasite survival and increased free haem while no 
relationship in fact exists between the amount of “free” haem per trophozoite (grey 
plot, right axis) and parasite survival (f). The biological IC50 of ATV in CQS P. 
falciparum, D10 was determined to be 2.0 ± 0.8 nM using a modified version of the 
pLDH assay by Makler et al. 206 
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4.8.4 Flow cytometry histograms 
 
Flow cytometry histogram overlays (Figure 4-12) corresponding to trophozoites 
isolated after treatment with CQ (blue dotted line), PYR (purple solid line), AQ 
(orange solid line) and ATV (green solid line) at the 2× the parasite growth IC50 of  
each drug were overlaid to compare changes in cell morphology with drug 
treatment, to an untreated control (solid red line).The cells were compared using 
three parameters, forward scatter (FSC) to evaluate change in size (Figure 4-12a), 
side scatter (SSC) to evaluate change in complexity (Figure 4-12b) and SYBR green 
fluorescence (FL1) to evaluate the change in DNA (Figure 4-12c). Cells treated with 
PYR showed very little change in FSC and SSC, but did show a reduction in the 
amount of DNA compared to the control. Cells treated with CQ, AQ and ATV 
showed a similar reduction in all three parameters indicating that cells were less 
complex, smaller and contained less DNA than cells treated with PYR and the 
untreated control.  
 
Figure 4-12: Change in morphology of PYR, CQ, AQ and ATV treated isolated, P. 
falciparum trophozoites. Trophozoites were isolated 32 h post inoculation at the 
ring stage with 2× the parasite growth IC50 of each drug. Flow cytometry histogram 
overlays displaying the change in FSC (a), SSC (b) and FL1 (c) for isolated 
untreated control trophozoites (solid red line), PYR treated isolated trophozoites 
(purple solid line), CQ treated isolated trophozoites (blue dotted line), AQ treated 
isolated trophozoites (orange solid line) and ATV treated isolated trophozoites 
(green solid line).  
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4.9 Summary and conclusions 
 
The successful adaptation of the haem fractionation assay from a very low 
throughput method performed in 250 ml flasks with high demand on valuable 
parasite starting material to a more efficient process was achieved and validated 
using CQ as a model. This higher throughput haem fractionation assay performed 
in 24 well plates, using at most ten million trophozoites was validated against the 
original method using CQ and its robustness was confirmed. 107 Although the 
improved throughput plate method produced more muted sample responses than 
the established flask method, it is capable of reproducing the results obtained with 
the flask method using 24 times less starting material and increasing output by at 
least six-fold. A fluorescent flow cytometry-based technique for the determination 
of cell counts of isolated trophozoites was also developed. This new method of 
determining cell counts produced cell counts which were not statistically different 
to haemocytometer determined cell counts and provided a faster alternative to 
traditional manual methods of cell counting. Flow cytometry histograms allowed 
changes in cell morphology to be compared in terms of size, complexity and the 
amount of DNA present in cells.     
The plate method was subsequently applied to three other established 
antimalarials, AQ, PYR and ATV, providing rapid and valuable insight into the 
mechanistic action of antimalarials and has highlighted the important role which 
haem plays in the action of several drugs.  AQ was shown to inhibit Hz formation, 
while the antifolate PYR and the mitochondrial electron transporter inhibitor ATV 
demonstrated no increase in toxic cellular free haem.  Results with ATV emphasize 
the crucial importance of measuring haem levels per cell, a calculation which 
requires the determination of the cell count in each well of the 24-well plate, rather 
than just percentages of haem species in order to interpret the effects of drugs on 
parasite haem concentrations. This approach is essential in those cases where the 
total haem Fe per cell changes with drug dose. While initial results for ATV showed 
an unanticipated increase in the percentage of “free” haem with increasing ATV 
concentration, the total amount of haem iron per cell was found to be significantly 
less in cells treated with ATV. This corresponds to unchanged free haem per cell 
with increasing ATV concentration.  
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This higher throughput cellular haem fractionation assay can easily be applied to 
novel antimalarials with a significantly decreased lead time, providing a valuable 
tool with which to probe the mechanisms of action of both new and established 
antimalarials. Applied to novel compounds, this method will provide an important 
cellular complement to the existing detergent-mediated βH inhibition assay in 
improving understanding of mechanism of action and in exploring structure 
activity relationships and prospects for rational drug design. 
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5 THE HAEM FRACTIONATION 
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The relationship between haem and several well-known antimalarials is explored 
in detail in this chapter. In Chapter 3, as an initial investigation the percentage of 
haem species in isolated CQS P. falciparum trophozoites inoculated at a single drug 
concentration of each of QN, MQ, LF and ART was determined. All showed an 
increase in the percentage “free” haem and decrease in percentage Hz significantly 
different to the untreated control. However, with the exception of LF, none showed 
an increase in percentage “free” haem or decrease in percentage Hz statistically 
comparable to CQ at the equivalent dose relative to their respective parasite 
growth IC50 values. This investigation was preliminary and to ascertain whether Hz 
inhibition is essential to the mechanism of action, a full dose response study at 
several concentrations of each drug is required. 
 In Chapter 4 the importance of determining the amount of each haem species per 
cell was demonstrated using ATV (Figure 4-11). Cells treated with ATV showed a 
significant dose related decrease in the total haem Fe per cell (Figure 4-11e). 
Therefore, while the percentage of each haem species suggested that ATV acted as 
Hz inhibitor, taking into account the decrease in total haem Fe it was demonstrated 
that ATV has no effect on free haem levels and therefore is unlikely to be a direct 
Hz inhibitor. Classifying a compound as a Hz inhibitor therefore requires 
determination of the amount of each haem species per cell. Throughout this 
chapter a compound is defined as a direct Hz inhibitor when a decrease in the 
amount of Hz per cell is accompanied by an increase in the amount toxic “free” 
haem per cell which can be correlated to the survival of the parasite.  All 
compounds which showed evidence of putative Hz inhibition in Chapter 3 were 
assayed using the higher throughput haem fractionation method described in 
detail in Chapter 4.  
This chapter describes in detail the full haem fractionation profiles for 6 well 
known antimalarials: QN, QD, MQ, LF, PQ and ART. The AMN derivative, 10-dO-
AMN was also tested. The amount of each haem species in drug treated isolated 
trophozoites was determined  and  is supplemented with images of Giemsa stained 
slides and flow cytometry profiles of isolated treated trophozoites highlighting 
Chapter 5: The haem fractionation profiles of several clinically relevant antimalarials 
Jill Michelle Combrinck -November 2016 
129 
differences in cell morphology. The results provide valuable insights, confirming or 
excluding Hz inhibition as the likely mechanism of action of these antimalarials. 
   
5.2 Materials  
 
All materials used throughout this chapter are listed in Chapter 2. Materials were 
of AR grade or higher and used without further purification. 
 
5.3 Sample Preparation 
 
The preparation of all samples used throughout this chapter, are previously 
described in Chapters 2 and 3. The water used throughout this work was double 




The methods used in this chapter, are previously described in Chapters 2, 3 and 4.  
 
5.5   Results and Discussion 
 
5.5.1 Determination of the parasitic growth inhibition IC50 in P. falciparum 
 
The parasite growth IC50 values of the clinically relevant antimalarials investigated 
in this chapter were determined in a CQS strain of P. falciparum, D10 or NF54. The 
D10 strain was used for all initial investigations while the NF54 strain was used for 
subsequent studies after being adopted as the standard CQS strain in the Division 
of Pharmacology. The similarity between the two CQS strains was verified by 
determining parasite growth IC50 values in NF54 for CQ and AQ and comparing it 
to values obtained in D10. The parasite growth IC50 values for CQ and AQ were 
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determined in NF54 to be 11.7 ± 2.7 nM and 18 ±0 .4 nM respectively. These values 
fall into the range of parasite growth IC50 values determined in D10 for CQ and AQ 
to be 11 – 25 nM and 14 – 19 nM (95% CI) respectively (Table 3-1). All parasite 
growth IC50 values were determined using a modification of the pLDH assay 
described in detail in Chapter 2, previously published by Makler et al.206  The 
parasite survival curves were generated using GraphPad Prism 4.0 non-linear 
regression function (sigmoidal dose response equation). 203 
 
Table 5-1: The parasite growth IC50 values (nM) of several clinically relevant 
antimalarials were determined in a CQS strain (D10 or NF54) of P. falciparum. The 
P. falciparum strain used is indicated in brackets next to each compound tested. All 
values were determined using the pLDH assay.206 Results are expressed as the 
mean with the associated standard deviation of several repeat experiments.  





7.6± 1.8 (n=3) 
8.6 ± 2.3 (n=11) 
27.1 ± 3.3 (n=8) 
Quinine (D10) 
Quinidine (D10) 
142 ± 18.8 (n=8) 
40.8 ± 3.9 (n=6) 
Mefloquine (NF54) 
Primaquine (NF54) 
10.43 ± 1.95 (n=4) 
3120 ± 890 (n=4) 
 
The measured parasite growth IC50 values summarised in Table 5-1 were used to 
determine the concentrations at which to inoculate cultures for the haem 
fractionation assay.  The P. falciparum strain in which the parasite growth IC50 was 
determined (indicated in brackets next to each compound tested in Table 5-1) was 




It is widely assumed that QN, QD, MQ and LF investigated here target Hz formation, 
resulting in increased levels of toxic haematin eventually leading to cell death 
through oxidative stress and membrane damage. 51 57 Both the 4-aminoquinolines, 
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CQ and AQ tested in Chapters 3 and 4 unequivocally showed concentration 
dependent increased “free” haem levels and decreased Hz formation correlated to 
cell death and can be classed as Hz inhibitors. Like CQ and AQ; QN, QD, MQ and LF 
all act on the intraerythrocytic asexual stage of the P. falciparum lifecycle and 
several studies have demonstrated a strong relationship between their ability to 
inhibit βH formation and parasite growth inhibition in a CQS strain of P. 
falciparum. 106 107 52 69 101 184 However, unlike the 4-aminoquinolines it is not certain 
that the above mentioned antimalarials primarily target the haem detoxification 
pathway and drug targets other than Hz inhibition have been implicated in the 




The least active arylmethanol tested, QN, was shown to have a parasite growth IC50 
of 142 ± 18.8 nM in a CQS strain of P. falciparum (Table 5-1).  In Figure 3-9 QN was 
shown to cause a significant increase in the percentage “free” haem and decrease 
in percentage Hz in isolated trophozoites treated with 2.5⨯ the parasite growth 
IC50 of QN in comparison to an untreated control. This increase in percentage 
“free” haem of QN treated cells was significantly less than in cells treated with CQ 
(Figure 3-9). The structures of the Fe(III)PPIX complexes formed with both QN and 
QD have been elucidated using single crystal X-ray diffraction. It is proposed that 
the formation of Fe(III)PPIX-QN prevents detoxification of Fe(III)PPIX by inhibiting 
its incorporation into inert Hz crystals within the malaria parasite.118 The 
biologically active stereoisomer of QN, QD (IC50 value of 40.8±3.9 in CQS D10) 
efficiently inhibits βH formation while the stereoisomers 9-epiquinine (9-EQN) 
and 9-epiquinidine (9-EQD), found to be 100 fold less active than QN and QD in a 
CQS strain of P. falciparum have been shown to be very weak inhibitors of βH 
formation. The correlation between biological IC50 and βH formation in this set of 
compounds differing only in their stereochemistry further strengthens the 
argument that Hz inhibition is the mechanism of action of both QN and QD. 66 69 118 
236  
 
Images of Giemsa stained slides of a control population of trophozoites (Figure 5-
1a) compared to QN treated cells (Figure 5-1b) show that QN treated cells had 
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matured to trophozoites smaller than the control population. Flow cytometry 
histogram overlays (Figure 5-1c - e) corresponding to trophozoites isolated after 
treatment with QN (solid green line) or CQ (blue dotted line) at the highest 
concentration tested for each drug showed a larger population of smaller (FSC), 
less complex (SSC) cells present in cultures treated with QN at 5× the parasite 
growth IC50 compared to cells treated at 6× the parasite growth IC50 of CQ (Figure 
5-1d, e). The SYBR Green profiles (FL1, Figure 5-1c) representing the populations 
of CQ and QN treated cells show that QN treated cells contained slightly more DNA 
than CQ treated cells, indicating that decreased complexity cannot be attributed to 
a decrease in the amount of DNA in QN treated cells. Despite the fact that the flow 
cytometry profiles for QN correspond to cells which were treated at a lower 
relative dosage (5× the parasite growth IC50), the change in the morphology of QN 
treated cells, specifically the reduced complexity is more pronounced than CQ 
treated cells at a higher relative dose (6× the parasite growth IC50). The differences 
in cell morphology between CQ and QN treated cells therefore suggest the effects 
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Figure 5-1: Change in morphology of QN treated isolated D10, P. falciparum 
trophozoites. Trophozoites were isolated 32 h post inoculation at the ring stage 
with 5× and 6× the parasite growth IC50 of QN and CQ respectively, corresponding 
to the highest concentration at which both QN and CQ were tested. The image of 
the Giemsa stained slide of the control culture (a) shows the presence of large, 
mature trophozoites, while the image of the QN treated culture (b) shows 
trophozoites which appear smaller than the control (100⨯ objectification). This 
result is confirmed upon examination of the flow cytometry histogram overlays 
displaying the change in fluorescence intensity (FL1) (c), change in FSC (d) and 
change in SSC (e) for isolated untreated control trophozoites (solid red line), CQ 
treated isolated trophozoites (blue dotted line) and QN treated isolated 
trophozoites (green solid line). A clear shift towards cells containing less DNA 
(FL1, c), less complex (SSC, e) and smaller (FSC, d) cells can clearly be seen in QN 
and CQ treated cells compared to untreated control cultures. While plots 
corresponding to the amount of DNA present in CQ and QN treated cells are very 
similar, QN treated cells are smaller (d) and show a greater decrease in cell 
complexity (e) compared to CQ treated cells.  
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Unlike CQ treated P. falciparum, where a significant increase in the amount of 
“free” haem Fe (fg) per cell was seen at 2⨯ the parasite growth IC50 of CQ (Figure 
4-8b), QN produces a statistically significant (P < 0.05) increase in the amount of 
“free” haem and decrease in the amount of Hz Fe in isolated trophozoites only at 
5⨯ the parasite growth IC50 of QN (Figure 5-2b, c). The amount of Hb Fe (fg) per 
cell (Figure 5-2a) shows no significant change with increasing QN concentration, 
however a relatively large amount of scatter in the data makes evaluation difficult.  
Figure 5-2d shows the total haem Fe (fg) per cell decreases systematically, with 
increasing QN concentrations greater than 2.5⨯ the parasite growth IC50, however 
the decrease in the total Haem Fe (fg) per cell is only statistically significant 
relative to the control at the highest concentration of QN tested. An overlay of the 
amount of “free” haem Fe (fg) per cell with the parasite survival curve for QN 
(Figure 5-2e) shows that although the increase in the amount of “free” haem is 
small and not statistically significant relative to the control at lower concentrations 
of QN, the increase in “free” haem does appear to be systematically correlated with 
parasite survival. Therefore while QN does appear to cause Hz inhibition the effect 
is not as pronounced as seen in both CQ and AQ (Figure 4-8, 4-9). The amount of 
“free” haem starts to increase more rapidly at a point where parasite survival is 
low, at approximately 15% parasite survival. It has been speculated that unlike the 
4-aminoquinolines, the quinoline methanols have a drug target other than Hz 
inhibition. 58 79 Treatment of P. berghei infected mice with a range of antimalarials 
showed that while CQ and 4-aminoquinoline derivatives caused a decrease in the 
amount of Hz produced, QN, MQ and PQ showed no effect. 127 In comparison to CQ, 
both QN and MQ have been shown to have a different effect on the endocytic 
pathway.58 CQ was found by Hoppe and co-workers to inhibit trafficking of Hb-
laden transport vesicles resulting in increased Hb accumulation of 283% and the 
TEM images showed an accumulation of Hb transport vesicles in the cell. In 
comparison MQ and QN were shown to inhibit endocytosis resulting in reduced Hb 
accumulation of 83% and 64% respectively. 124 125 In Chapter 4, CQ treated cells at 
3⨯ the parasite growth IC50 showed an increase in Hb levels of 60%. While 
previous studies have shown reduction in the amount of Hb in QN treated cells, 
Figure 5-2a showed no evidence of this, although the scatter in the Hb data for QN 
makes establishment of a firm trend difficult. 124 125  The accumulation of transport 
vesicles in cells treated with high doses of CQ can explain why the flow cytometry 
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histograms of CQ treated cells are greater in both complexity and size compared to 
cells treated with QN (Figure 5-1d, e). QN has been shown to be highly lipophilic, 
binding tightly to serum components and has been shown to bind to phospholipids 
possibly affecting membrane formation and the consequent formation of transport 
vesicles resulting in reduced Hb uptake, while CQ has been shown to have a low 
affinity for phospholipids.237 238 239 57 Despite evidence of βH inhibition and the 
formation of a QN-Fe(III)PPIX complex speculated to be capable of inhibiting Hz 
formation, the results show that classifying QN as a Hz inhibitor is not as definitive 
as is the case for the 4-aminoquinolines CQ (Figure 4-6 and 4-8) and AQ (Figure 4-
9). It is probable that in addition to inhibiting Hz formation accompanied by a 
small dose related increase in “free” haem in the parasite, QN may either have 
other drug targets or the complex is exceptionally active against the parasite, 
possibly accounting for the reported inhibition of endocytosis. 
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Figure 5-2: Haem fractionation profiles for QN in D10, CQS P. falciparum.  The 
profiles obtained for the amount of Hb Fe (fg) per cell (a), “free” haem Fe (fg) per 
cell (b) and Hz Fe (fg) per cell (c) are shown as a function of increasing multiples of 
the parasite growth IC50 of QN. The total haem Fe in untreated isolated trophs did 
not differ significantly from QN treated isolated trophozoites, except at the highest 
concentration (d). An overlay of the parasite survival curve (red plot, left axis) with 
the amount of free haem (fg) per cell (blue plot, right axis) representing the 
amount of “free” haem per cell (fg) shows that “free” haem Fe (fg/cell) increases at 
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A stereoisomer of QN, QD, is a more potent inhibitor of P. falciparum growth with a 
parasite growth IC50 value of 40.8 ± 3.9 nM, compared to 142 ± 18.8 nM for QN in 
CQS D10 (Table 5-1). However, its cardiotoxicity makes it a less desirable 
antimalarial. 78 QD was selected since like QN, it has also been assumed to share a 
similar mechanism of action to CQ and AQ. 54 202 Although the effect of QD on haem 
species in CQS isolated trophozoites was not investigated at a single concentration 
in Chapter 3, it has been shown to inhibit the formation of βH on several occasions. 
52 240 208 69 Like QN, QD has been shown to form a complex with Fe(III)PPIX through 
a three point interaction involving co-ordination, π-stacking and intramolecular 
hydrogen bonding making the haem propionate group of Fe(III)PPIX unavailable 
and consequently preventing  the incorporation of Fe(III)PPIX into Hz. Molecular 
modelling of Fe(III)PPIX complexes with QN, QD and their inactive stereoisomers 
9-EQN and 9-EQD showed a correlation between the ease of formation of the 
intramolecular hydrogen bond in these complexes and both the biological and βH 
inhibition activities in this group of stereoisomers. 117  
 
Flow cytometry histograms (Figure 5-3) corresponding to populations of isolated 
trophozoites inoculated with 4.0× the parasite growth IC50 of QD (solid green line) 
and 3.75 × the parasite growth IC50 of QN (solid orange line) show the profiles for 
the amount of DNA present in cells (Figure 5-3a), the size (Figure 5-3b) and 
complexity (Figure 5-3c) of cells are almost identical. The changes in cell 
morphology of QN and QD treated populations are therefore very similar to each 
other and also differ in the same manner from CQ treated cells (blue dotted line).  
Flow cytometry histogram plots of cells treated with QD at 4.0× the parasite 
growth IC50 compared to cells treated 6.0× the parasite growth IC50 of CQ showed 
that QD treated cells are smaller (Figure 5-3b) and less complex (Figure 5-3c) but 
contain more DNA (Figure 5-3a) than CQ treated cells. As suggested for QN versus 
CQ the increased cell complexity in CQ treated cells compared to QD treated cells, 
can probably be attributed to the accumulation of Hb transport vesicles correlated 
to increased Hb levels in the case of CQ treatment. 124 
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Figure 5-3: Change in morphology of QD treated isolated D10, P. falciparum 
trophozoites. Trophozoites were isolated 32 h post inoculation at the ring stage 
with 4× and 6× the parasite growth IC50 of QD and CQ respectively, corresponding 
to the highest concentration at which both QD and CQ were tested. Flow cytometry 
histogram overlays displaying the change in fluorescence intensity (FL1) (a), FSC 
(b) and SSC (c) for isolated untreated control trophozoites (solid red line), CQ 
treated isolated trophozoites (blue dashed line) and QD treated isolated 
trophozoites (green solid line). QN treated isolated trophozoites inoculated at 
3.75⨯ the parasite growth IC50 of QN is shown for comparison (solid orange line).  
A clear shift towards cells containing less DNA (FL1, c), less complex (SSC, e) and 
smaller (FSC, d) cells can clearly be seen in QD and CQ treated cells compared to 
untreated control cultures.  
 
QD treatment results in a significant decrease of Hb levels from 3× the parasite 
growth IC50 (Figure 5-4a) and a significant dose related decrease in the amount of 
Hz and the total haem Fe (fg) per cell from as low as 0.5× the parasite growth IC50 
of QD (Figure 5-4c, d). A significant increase in the amount of “free” haem from 
1.0× the parasite growth IC50 of QD is seen in Figure 5-4b to a maximum of 35% 
relative to the control.  As in the case of QN, direct Hz inhibition in QD is not as 
obvious as for both CQ and AQ (Figure 4-8, 4-9). An overlay of the parasite survival 
curve for QD (red plot, right axis) with the amount of “free” haem Fe (fg) per cell 
(blue plot, left axis) in Figure 5-4e shows that despite a small increase in “free” 
haem levels in QD treated cells, a dose responsive relationship exists between 
parasite survival and “free” haem levels. QD therefore does appear to behave as a 
Hz inhibitor. However, it is likely that Hz inhibition is not the only effect of QD and 
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given their similar physiochemical properties and similar morphological changes 
after treatment (Figure 5-3), it can be assumed that QD shares the mechanism of 
endocytosis inhibition with its stereoisomer QN, but also has an effect on the 
formation of Hz resulting in significantly higher levels of “free” haem correlated to 
parasite survival. As in the case of QN, the increase in “free” haem is not as 
pronounced as for the 4-aminoquinolines CQ and AQ. Inhibition of endocytosis 
results in decreased Hb accumulation, which in turn reduces the amount of haem 
available for conversion to Hz. Therefore although inhibition of Hz formation and 
the consequent build-up of “free” haem takes place in QD treated cells the 
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Figure 5-4: Haem fractionation profiles for QD in D10, CQS P. falciparum.  The 
profiles for the amount of Hb Fe (fg) per cell (a), “free” haem Fe (fg) per cell (b) and 
Hz Fe (fg) per cell (c) are shown as a function of increasing multiples of the 
parasite growth IC50 of QD.  The total haem Fe in QD treated isolated trophs 
differed significantly from untreated isolated trophozoites, decreasing with 
increasing concentration of QD (d). An overlay of the parasite survival curve 
determined with QD using a modified method of Makler et al (red plot, right axis) 
with the amount of “free” haem Fe (fg) per cell  (blue plot, left axis) shows parasite 
survival decreases with increasing “free” haem in a dose responsive manner (e) 206. 
The left axis displaying the amount of “free” haem Fe (fg) per cell is scaled such 
that the point corresponding to 50% survival (red plot, right axis) on the parasite 
survival curve corresponds to the halfway point in the graph of the amount of 
“free” haem Fe (fg) per cell (blue plot, left axis).  
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MQ was the final quinoline methanol investigated, with a parasite growth IC50 of 
10.43 ± 1.95 nM in NF54 CQS P. falciparum, it is both better tolerated and more 
effective than either QD and QN. In Figure 3-9 MQ was shown to cause a significant 
increase in the percentage “free” haem and decrease in percentage Hz in isolated 
trophozoites treated with 2.5⨯ the parasite growth IC50 in comparison to an 
untreated control. As is the case for the quinoline methanols previously discussed, 
where several studies have demonstrated a strong relationship between βH 
inhibition and parasite growth inhibition, MQ has been shown to efficiently inhibit 
the formation of βH. 101 99 The chemical similarity of MQ to both QN and QD 
indicates that MQ is able to form a complex with Fe(III)PPIX in a manner similar to 
QN and QD through a three point interaction involving co-ordination, π-stacking 
and intramolecular hydrogen bonding, consequently preventing the conversion of 
Fe(III)PPIX to Hz.118 Evidence thus seems to be in favour of classifying MQ as a Hz 
inhibitor. The effect of MQ on the formation of Hz within the parasite is explored 
here.  
Images of Giemsa stained slides of parasites treated with MQ at a concentration 
corresponding to 3.0× the parasite growth IC50 (Figure 5-5b) show that cells 
inoculated with MQ at the ring stage matured to trophozoites, although much 
smaller than the control (Figure 5-5a). Histogram overlays of CQ and MQ treated 
cells at 3.0× the parasite growth IC50 show that cells treated with MQ contained 
less DNA (Figure 5-5c), were much smaller (Figure 5-5d) and less complex (Figure 
5-5e) than CQ treated cells. While treatment of cells with both QN and QD resulted 
in smaller, less complex cells compared to CQ treated cells, neither caused as large 
a reduction in the amount of DNA in cells as seen in MQ treated cells. The dramatic 
changes in the morphology of MQ treated cells indicates that growth of parasites 
treated with MQ is inhibited earlier in the parasite lifecycle and suggests that the 
effect of MQ within the cell is different not only to CQ, but also to QN or QD. 
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Figure 5-5: Change in morphology of MQ treated isolated NF54, P. falciparum 
trophozoites. Trophozoites were isolated 32 h post inoculation at the ring stage 
with 3× the parasite growth IC50 of MQ and CQ. The image of the Giemsa stained 
slides of the control culture (a) shows the presence of large, mature trophs, while 
the image of the MQ treated culture (b) show smaller trophozoites (100⨯ 
objectification). This result was confirmed upon examination of the flow cytometry 
histogram overlays displaying the change in (FL1) (c), FSC (d) and SSC (e) for 
isolated untreated control trophozoites (solid red line), CQ treated isolated 
trophozoites (blue dashed line) and MQ treated isolated trophozoites (green solid 
line). A clear shift towards cells containing less DNA (FL1, c), less complex (SSC, e) 
and smaller (FSC, d) cells can clearly be seen in MQ and CQ treated cells compared 
to untreated control cultures. 
 
The haem fractionation profiles of MQ treated cells in Figure 5-6 show the amount 
of Hb per cell did not change significantly with MQ treatment (Figure 5-6a).  
Similarly the amount of “free” haem per cell showed no significant change 
compared to the control, except for a significant decrease in “free” haem at 3× 
parasite growth IC50 of MQ (Figure 5-6b). The amount of Hz Fe per cell decreases 
in a dose related manner by 44.8 ± 6.1% compared to the control (Figure 5-6c). An 
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overlay of the parasite survival curve for MQ with the amount of “free” haem (fg) 
per MQ treated trophozoite in Figure 5-6e shows no relationship exists between 
the amount of “free” haem Fe (fg/cell) per trophozoite (blue diamonds, right axis) 
and parasite survival (red plot, left axis). MQ therefore does not appear to behave 
as Hz inhibitor, since despite a dose related decrease in Hz, there is no concomitant 
increase in “free” haem correlated to parasite survival. As for QD, MQ causes a dose 
related immediate decrease in total haem Fe in treated cells (Figure 5-6d) most 
likely attributed to decreased Hb uptake by MQ treated parasites. The lipophilicity 
of MQ could contribute towards its ability to inhibit endocytosis by binding 
strongly to lipids and membranes, interfering with vesicle formation and Hb 
uptake.238 57 Cells treated with MQ also show a reduction in the amount of DNA 
compared to CQ treated cells. Both QN and QD treated cells contained more DNA 
than CQ treated cells suggesting that growth of MQ treated cells is inhibited earlier 
in the parasite lifecycle than QN and QD treated cells (Figure 5-5c). Inhibition of 
endocytosis was similarly identified as possible mechanism for QD and QN, 
however in the case of QN and QD this was accompanied an increase in “free” haem 
not seen in MQ treated cells. The differences in cell morphology and haem species 
profiles between CQ, QN and QD compared to MQ treated cells indicate that the 
intracellular targets and the effects of the drugs are different and MQ most likely 
does not directly inhibit Hz formation.  
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Figure 5-6: Haem fractionation profiles for MQ in NF54, CQS P. falciparum.  The 
profiles for the amount of Hb Fe (fg) per cell (a), “free” haem Fe (fg) per cell (b) and 
Hz Fe (fg) per cell (c) as a function of increasing multiples of the parasite growth 
IC50 of MQ. The total haem Fe in untreated isolated trophs shows a dose related 
decrease (significant at 3× parasite growth IC50 of MQ) per cell (d). An overlay of 
the parasite survival curve for MQ (red plot, left axis) with the data points (blue 
diamonds, right axis) representing the amount of “free” haem per MQ treated 
trophozoite (fg) shows no relationship exists between the amount of “free” haem 
Fe (fg/cell) per trophozoite and parasite survival (e).   
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Of all the antimalarials tested in Chapter 3 in a D10, CQS P. falciparum at a 
concentration corresponding to 2.5× the parasite growth IC50, LF was the only drug 
which caused an increase in the percentage “free” haem and decrease in 
percentage Hz comparable to that of CQ (Figure 3.9a, b). LF was shown to produce 
a dose dependent inhibition of the formation of βH using the NP40 mediated βH 
inhibition assay with a βHIC50 value of 11 µM (Figure 3.9d) comparable to AQ with 
an IC50 value of 21 µM. 105 The package inserts of several LF-AMN combination 
therapies including COARTEM and ARCEVA indicate Hz inhibition as the 
mechanism of action of LF. 215 214 The experimental evidence listed above thus 
suggests Hz inhibition as the mechanism of action of LF.  
 
Flow cytometry histogram plots of cells treated with 1× the parasite growth IC50 of 
LF (solid green line) display an immediate dramatic decrease in the amount of 
DNA present in LF treated cells, cell size and cell complexity compared to cells 
treated with CQ (dotted blue line)  at the equivalent IC50 (Figure 5-7a, b, c). The 
flow cytometry histograms of LF treated isolated trophozoites are very similar to 
the flow cytometry histograms obtained for MQ treated trophozoites (solid orange 
line) at the equivalent IC50 indicating a similar effect on the morphology of cells 
after treatment with LF or MQ. A Giemsa stained slide of CQ treated cells at 1× IC50 
shows cultures inoculated with CQ at the ring stage, matured to trophozoites 
(Figure 5-7f) smaller than trophozoites in untreated cultures (Figure 5-7d). LF 
dosed cultures in comparison had very few trophozoites and consisted of mostly 
rings and a large amount of debris (Figure 5-7e). At 4⨯ the parasite growth IC50 
cultures inoculated with LF consisted predominantly of rings and debris (Figure 5-
7g), while CQ treated cultures were comprised of trophozoites (Figure 5-7h). 
Similar to MQ, growth in LF treated cultures therefore seems to have been 
inhibited much earlier in the parasite lifecycle compared to CQ treated cells. 
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Figure 5-7: Changes in morphology of LF and CQ treated D10, P. falciparum shown 
using flow cytometry histogram plots (a - c) and images from Giemsa stained slides 
(d - h) prepared 32 h after inoculation with the drug at the ring stage (100⨯ 
objectification). CQ treated cells are shown for comparison. The histogram plots 
show the change in SYBR green fluorescence intensity (FL1) (a), FSC (b) and SSC 
(c) for isolated untreated control trophozoites (solid red line), 1× IC50 CQ treated 
isolated trophozoites (blue dashed line), 1× IC50 LF treated isolated trophozoites 
(solid green line) and 1× IC50 MQ treated isolated trophozoites (solid orange line) 
shown for comparison. Cells treated with LF even at 1× the parasite growth IC50 
show a dramatic decrease in cell size (FSC), cell complexity (SSC) and the amount 
of DNA present in the cells (FL1) compared to cells treated with CQ at the 
equivalent multiple of the  IC50 (a - c). Images taken from Giemsa stained slides of 
cultures treated at the equivalent multiple of the IC50 of both LF and CQ show that 
CQ treated cells (f, h) mature to larger trophs (blue arrows) while LF treated cells 
(e, g) show the presence of very small stunted trophs (red arrows) and rings 
(yellow arrows).   
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Initial experiments described in Chapter 3 (Figure 3.9) showed the percentage 
increase in “free” haem in LF treated cells differed significantly from the untreated 
control. In Figure 5-8 the haem fractionation profiles for LF are expressed as the 
amount of each haem species per cell at several multiples of the parasite growth 
IC50 of LF.  The amount of Hb Fe (fg) per cell (Figure 5-8a) and the amount of “free” 
haem Fe (fg) per cell (Figure 5-8b) do not differ significantly from the control and 
do not increase with increasing concentration of LF. As observed for MQ, the 
amount of Hz Fe (fg) per cell (Figure 5-8c) shows a dose related significant 
decrease in comparison to the control with increasing concentration of LF. This is 
mirrored in the total amount of haem Fe per isolated trophozoite (fg) which 
decreases significantly in comparison to the control from 1.1⨯ the parasite growth 
IC50 of LF. The initial results in Chapter 3 which suggested LF may be a Hz inhibitor 
are therefore evidently invalidated by the results summarised here. Despite 
decreasing Hz formation with increasing LF concentration there is no associated 
increase in toxic “free” haem and direct Hz inhibition does not appear to the 
mechanism of action of LF. Figure 5-8a shows that Hb Fe levels per cell (fg) do not 
increase significantly in comparison to control cells and although Hz levels 
decrease, it continues to be formed in LF treated cells indicating that Hb 
metabolism and the conversion of “free” haem to Hz is not inhibited with LF 
treatment. Decreased total haem Fe (fg) levels in LF treated cells (Figure 5-8d) as 
well as evidence of inhibited cell growth displayed in flow cytometry histogram 
overlays indicate that growth in LF treated cells is inhibited early in the lifecycle, 
possibly at a stage where Hb uptake is not prolific. An overlay of the parasite 
survival curve for LF with the amount of “free” haem Fe per cell shows no 
relationship exists between the two parameters (Figure 5-8e). Therefore, although 
LF efficiently inhibits the formation of βH, it appears to have an alternative 
mechanism of action, unrelated to haemozoin inhibition in the parasite which halts 
parasite growth earlier in the lifecycle and causes a reduction in total haem Fe 
most likely due to reduced uptake of Hb. This example with LF reiterates the 
importance of determining the per cell profiles for each of the haem species and 
not only the percentages of each. 
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Figure 5-8: Haem fractionation profiles for LF treated isolated trophozoites in 
D10, CQS P. falciparum. The amount of Hb (a) and “free” haem (b) Fe (fg) per cell 
shows no dose related increase in Hb or “free” haem while the amount of Hz Fe (fg) 
per cell (c) does show a significant dose related decrease with increasing LF 
concentration in isolated trophozoites. The total amount of haem Fe (fg) per cell 
decreases significantly with increasing LF from 1.1× parasite growth IC50 of LF (d). 
An overlay of the parasite survival curve (red plot, left axis) with the data points 
(blue diamonds, right axis) representing the amount of “free” haem per cell (fg) 
shows no relationship exists between the amount of “free” haem Fe (fg/cell) per 
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PQ was the only 8-aminoquinline screened using the cellular haem fractionation 
assay. Unlike the previous antimalarials screened, which were all active against the 
intra-erythrocytic stages, PQ is primarily active against the liver stages, and has 
potent gametocidal activity, preventing transmission of malaria. 70 241 242 
Nonetheless, PQ does show inhibition of intra-erythrocytic parasite growth, albeit 
with an IC50 value determined to be 3120 ± 890 nM in NF54, CQS P. falciparum 
determined using a modification of the pLDH assay.206 PQ and other related 8-
amino quinolines have been shown to form relatively weak interactions with “free” 
haem and PQ is incapable of inhibiting the formation of βH. 99 178   
Flow cytometry histogram plots describing the change in morphology of PQ 
treated cells show a reduction in cellular DNA (FL1, Figure 5-9a) and are smaller 
(Figure 5-9b) and have a larger population of less complex cells (Figure 5-9c). 
However, the change in morphology of PQ treated cells is not nearly as pronounced 
as the changes seen in CQ treated parasites at the equivalent parasite growth IC50 
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Figure 5-9: Change in morphology of PQ treated NF54, P. falciparum trophozoites; 
isolated 32 h post inoculation at the ring stage with 3× the parasite growth IC50 of 
PQ and CQ. Examination of the flow cytometry histogram overlays displaying the 
change in (FL1) (a), change in FSC (b) and change in SSC (c) for isolated untreated 
control trophozoites (solid red line), CQ treated isolated trophozoites (blue dashed 
line) and PQ treated isolated trophozoites (green solid line) shows a clear shift 
towards cells containing less DNA (FL1, a), less complex (SSC, b) and smaller (FSC, 
c) cells in PQ and CQ treated cells compared to untreated control cultures. 
 
The haem fractionation profiles for PQ treated cells show that with the exception 
of a slight reduction in the amount of Hz Fe (fg) per trophozoite (Figure 5-10c) and 
the total haem Fe (fg) per trophozoite (Figure 5-10d) at the highest concentration 
of PQ, there is no dose related increase in “free” haem (Figure 5-10b) or decrease 
in Hz. Hb levels in PQ treated cells remained relatively unchanged (Figure 5-10a). 
Furthermore, an overlay of the parasite survival curve for PQ with the amount of 
“free” haem determined in PQ treated cells in Figure 5-10e shows no relationship 
exists between the amount of “free” haem Fe (fg/cell) per trophozoite (data points 
shown as blue diamonds, right axis) and parasite survival (red plot, left axis) in PQ 
treated cells (h).  PQ therefore does not inhibit Hz formation within the parasite. 
This finding is in line with expectation given its inability to inhibit βH inhibition. 
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Figure 5-10: Haem fractionation profiles for PQ in NF54 P. falciparum isolated 
trophozoites.  The profiles for the amount of Hb Fe (fg) per cell (a), “free” haem Fe 
(fg) per cell (b) and Hz Fe (fg) per cell (c) as a function of increasing multiples of 
the parasite growth IC50 of PQ.  The total haem Fe in untreated isolated trophs did 
not differ significantly from PQ treated isolated trophozoites (d). No relationship 
exists between the amount of “free” haem Fe (fg/cell) per trophozoite (data points 
shown as blue diamonds, right axis) and parasite survival (red plot, left axis) in PQ 
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5.5.4 The Artemisinins 
 
The capacity of a compound to inhibit Hz formation within the parasite is surmised 
from its ability to inhibit the formation of βH from haemin or haematin under 
laboratory conditions which normally favour βH formation. Several studies have 
shown that both ART and 10-dO-AMN do not to interfere with the formation of βH. 
However, the mechanism of action and the role of haem in the mechanism of action 
of this drug class remains a widely debated topic. 2 110 98 Here, the effect of ART and 





Loup et al showed that ART was not capable of inhibiting the formation of βH from 
haemin in the presence of acetate at pH 5 (18 h incubation, 37 °C).178 However, a 
preliminary study described in Chapter 3 to determine the effect of several 
clinically relevant antimalarials on Hz formation at a single drug concentration, 
corresponding to 2.5× the parasite growth IC50 showed ART caused an increase in 
the percentage “free” haem and a decrease in percentage Hz significantly different 
to the control (Figure 3-9a, b).  A full dose response profile performed at several 
concentrations of ART was carried out to investigate the preliminary findings in 
Chapter 3.  
 
Examination of images of Giemsa stained glass slides of infected PRBCs at 3× 
parasite growth IC50 of ART show that cells matured to the trophozoite stage 
(Figure 5-11b). The trophozoites appear smaller and less mature than the 
corresponding control (Figure 5-11a); however they contain the same amount of 
haem Fe as the control cells (Figure 5-12d). Parasite viability measured using the 
pLDH assay showed that treatment with ART is effective at killing the parasite, 
resulting in 10.2% survival at 3× parasite growth IC50 after a period of 48 h. The 
appearance of smaller trophozoites on the Giemsa stained slide images was 
confirmed by flow cytometry histogram plots. In the case of ART, the most reduced 
shift in treated cells was in SSC (Figure 5-11e), followed by the FL1 signal 
corresponding to SYBR green fluorescence (Figure 5-1c) and a small reduction in 
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FSC (Figure 5-11d). This indicates cells were less complex, appeared to contain less 
DNA and were slightly smaller in comparison to the control. A histogram overlay of 
trophozoites treated with 3× the parasite growth IC50 of CQ showed, CQ treated 
cells contained less DNA, were smaller and less complex than cells treated with 3× 
the parasite growth IC50 of ART (Figure 5-11c - e). The findings above are 
interesting considering that AMNs are distinguished by their ability to act on all 
stages of the P. falciparum lifecycle, from recently formed rings to schizonts. 159 160 
In a recent study determining the speed of action and stage specificity of a number 
of established antimalarials both CQ and ART were classed as fast acting 
antimalarials, displaying activity against both ring and schizont stages. 
Interestingly inoculation for a period of 24 h with either CQ or ART showed that CQ 
was more effective at inhibiting parasite growth at concentrations ≤ 3× the 
parasite growth IC50.120 The uptake of the AMN derivative, artemisone was shown 
to be highest at the immature ring stage, agreeing with several other studies which 
have shown that in the P. falciparum lifecycle, the ring stage is most susceptible to 
the effects of AMNs. 243 244 245 More recently, Klonis et al showed that AMNs are less 
active against mid ring stages of infection and most effective in young rings (2 – 4 h 
post invasion).171 The effects or ART suggest that inoculation was performed at a 
stage where rings were more mature (older than 4 h) and the effect of the drug 
was attenuated, resulting in maturation to trophozoites. The timing of the 
inoculation in the haem fractionation assay could therefore be important in 
determining whether any trophozoites are obtained in order to measure haem 
species and also on the effectiveness and action of the drug. Indeed, inoculation 
earlier in the lifecycle could result in a more dramatic change in parasite growth or 
even complete inhibition at the ring stage. 
The Role of Haem in the Mechanism of Action of Antimalarials in Plasmodium falciparum 
  Jill Michelle Combrinck -November 2016  
154 
 
Figure 5-11: Changes in morphology of D10 P. falciparum trophozoites treated 
with ART. Images of control trophozoites and trophozoites isolated 32 h post 
inoculation at the ring stage with ART at 3× the parasite growth IC50 are shown 
using Giemsa stained slides (100⨯ objectification). The image of the Giemsa 
stained slide of the control culture (a) shows the presence of mature trophs and 
some schizonts, while the image of the ART treated culture (b) shows trophozoites, 
the majority of which appear smaller than the control. This result was confirmed 
upon examination of the flow cytometry histogram overlays displaying the change 
in fluorescence intensity (FL1) (c), change in FSC (d) and change in SSC (e) for 
isolated untreated control trophozoites (solid red line), CQ treated isolated 
trophozoites (blue dashed line) and ART treated isolated trophozoites (green solid 
line). Interestingly, cells treated with CQ at the equivalent parasite inhibitory 
concentration show a more pronounced decrease in all 3 measured parameters 
(FL1, FSC and SSC) compared to ART treated cells, most notably the FL1 and SSC 
parameters. In the case of ART, only the size appears to be smaller while, FL1 and 
SSC appear almost identical to the control. 
 
In Chapter 3, Figure 3-9, a significant increase in the percentage “free” haem and 
decrease in percentage Hz was seen in isolated trophozoites treated with a single 
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concentration of ART corresponding to 2.5× the parasite growth IC50. The current 
study conducted at several multiples of the parasite growth IC50 of ART and 
expressed as the amount of each haem species per cell (fg) shows that ART does 
not inhibit Hz. No significant increases in Hb (Figure 5-12a), “free” haem (Figure 5-
12b) or decrease in Hz (Figure 5-12c) was observed at any ART concentration and 
the total haem Fe (fg) per cell (Figure 5-12d) remains constant at all concentration 
of ART tested. Additionally an overlay of the amount of haem Fe (fg) per cell with 
the parasite survival curve for ART (Figure 5-12e) shows no relationship between 
the parasite survival and the change in “free” haem levels. ART therefore does not 
appear to inhibit Hz formation in the parasite, producing no increase in toxic “free” 
haem that can be correlated to parasite survival in the presence of ART. The result 
is not surprising given that studies have shown that several AMNs, including ART 
do not inhibit βH formation. 110 178  
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Figure 5-12: Haem fractionation profiles for ART in D10, CQS P. falciparum.  The 
profiles for the amount of Hb Fe (fg) per cell (a), “free” haem Fe (fg) per cell (b) and 
Hz Fe (fg) per cell (c) are shown as a function of increasing concentration of ART. 
The total haem Fe in untreated isolated trophs did not differ significantly from ART 
treated isolated trophozoites, despite a slight decrease in total haem Fe per cell at 
higher ART concentrations (d). An overlay of the parasite survival curve (red plot, 
left axis) with the data points (blue diamonds, right axis) representing the amount 
of “free” haem per cell (fg) shows no dose response relationship between the 
amount of “free” haem Fe (fg/cell) per ART treated trophozoite and parasite 








































































































































Chapter 5: The haem fractionation profiles of several clinically relevant antimalarials 




10-DO-AMN was specifically chosen for investigation because despite being a 
highly effective antimalarial it has been previously shown to have no chemical 
interaction with haem. 10-dO-AMN was negative for βH inhibition when screened 
with both the so called “haem polymerisation inhibitory activity” assay (HPIA, 
acetic acid at pH 2.7 for 18 h at 37 °C) and the β-haematin inhibitory activity assay 
(βHIA, DMSO-acetate buffer at pH 5.0 for 18 h at 37 °C).110 Despite lack of activity 
in both the HPIA and βHIA and the inability to bind to Fe(III)PPIX, 10-dO-AMN 
remains a potent antimalarial.  
 
Giemsa stained slides of 10-dO-AMN treated parasites (Figure 5-13b) show that 
despite the presence 10-dO-AMN at 3× the parasite growth IC50, cells mature to the 
trophozoite stage. Once more, as in the case of ART the trophozoites appear 
smaller and less mature than the corresponding control but contain the same 
amount of haem Fe as the control cells (Figure 5-13a). As explained in the case of 
ART, this could be as a result of the time point at which the inoculation was 
performed in the parasite lifecycle.  
 
 
Figure 5-13: Changes in morphology in NF54, P. falciparum trophozoites treated 
with 10-dO-AMN. Trophozoites isolated 32 h post inoculation at the ring stage with 
10-dO-AMN at 3× the parasite growth IC50 are shown using Giemsa stained slides 
with an untreated control shown for comparison (100⨯ objectification). The image 
of the Giemsa stained slide of the 10-dO-AMN treated culture image (b) shows 
smaller trophozoites in comparison to the control (a).  
 
The haem fractionation profiles (Figure 5-14), show that Hz formation in the 
parasite was not inhibited in the presence of 10-dO-AMN. No significant increase in 
The Role of Haem in the Mechanism of Action of Antimalarials in Plasmodium falciparum 
  Jill Michelle Combrinck -November 2016  
158 
Hb (Figure 5-14a) or decrease in Hz (Figure 5-14c) was seen with increasing drug 
concentration and with the exception of a significant change in “free” haem at 3× 
the parasite growth IC50, no dose related increase in “free” haem per cell was seen 
(Figure 5-14b). The total amount of haem Fe (fg) per cell remained relatively 
unchanged with increasing 10-dO-AMN concentration, exhibiting a single 
significant increase at 2× the parasite growth IC50 of 10-dO-AMN, (Figure 5-14d). 
Furthermore no dose dependent relationship was seen between “free” haem levels 
and parasite survival (Figure 5-14e). The results presented here show that 10-dO-
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Figure 5-14: Haem fractionation profiles for 10-dO-AMN in NF54, CQS P 
falciparum.  The profiles for the amount of Hb Fe (fg) per cell (a), “free” haem Fe 
(fg) per cell (b) and Hz Fe (fg) per cell (c) are shown as a function of increasing 
concentration of 10-dO-AMN. The total haem Fe per cell (fg) in untreated isolated 
trophs did not differ significantly from 10-dO-AMN treated isolated trophozoites 
(d). An overlay of the parasite survival curve and the amount of “free” haem Fe per 
cell shows that no relationship exists between the amount of “free” haem Fe 
(fg/cell) (data points shown as blue diamonds, right axis) and parasite survival 
(red plot, left axis) in 10-dO-AMN treated cells (e).   
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5.6 Summary and Conclusion 
 
Seven antimalarials were investigated in this chapter using the modified higher 
throughput haem fractionation assay to determine if they inhibited Hz as a 
mechanism of action.  The results have been supplemented with flow cytometry 
profiles and images of Giemsa stained slides which provided additional 
information detailing the change in morphology of treated parasites.  
The aryl methanols, QN, QD, MQ and LF have all been shown to inhibit the 
formation of βH in a manner which some studies suggest correlates with the 
parasite survival IC50 implicating Hz inhibition as the mechanism of action of these 
drugs. 106 105 107 52 69 72 101 108  Treatment of parasites at the ring stage with each of 
the aryl methanols resulted in much smaller and less complex cells in comparison 
to CQ treated cells at the equivalent multiple of the parasite growth IC50. This 
suggests that the effects of these drugs within the parasite are different to CQ, 
especially in the case of LF and MQ. Cells treated with LF and MQ, in addition to 
being smaller and less complex also showed a reduction in the amount of DNA 
present in cells suggesting that growth was inhibited earlier in the lifecycle than in 
CQ, QN or QD treated cells.  
Cells treated with the quinoline methanols, QN and QD shared similar effects to 
each other. Isolated trophozoites showed a dose related increase in “free” haem 
levels which could be correlated to parasite survival. However, the increase in 
“free” haem levels was not nearly as pronounced as the levels seen in cells 
inoculated with the 4-aminoquinolines CQ and AQ discussed in Chapter 4. The 
increased levels of “free” haem in QN and QD treated cells were accompanied by a 
decrease in Hz and a decrease in the total amount of haem Fe. This was more 
pronounced in the case of QD, where an immediate dose related significant 
decrease in the total haem Fe per cell was seen. The latter effect was also produced 
in the final 2 compounds, MQ and LF, where in both cases an immediate reduction 
in both the amount of Hz and total haem Fe per cell occurred. However unlike QN 
and QD, neither MQ nor LF induced a measurable increase in “free” haem in 
treated cells correlated to parasite survival. Both LF and MQ showed a reduction in 
the amount of DNA present in cells suggesting that growth was inhibited much 
earlier in the parasite lifecycle compared to QN or QD treated cells. Previous 
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studies have shown that while CQ treatment of P. falciparum results in increased 
levels of Hb accompanied by accumulation of Hb laden transport vesicles, QN and 
MQ treatment inhibited endocytosis reducing the amount of Hb taken up by 
treated cells. 124 125 Therefore, while QN and QD appear to exert some degree of Hz 
inhibition, all four aryl methanols evaluated appear to have an alternative 
mechanism of action possibly involving the inhibition endocytosis, resulting in 
reduced Hb uptake.  
The 8-amino-quinoline, PQ and the two AMNs, ART and 10-dO-AMN can be 
grouped together as the outcomes for these three compounds were very similar. 
Flow cytometry histogram plots and images of Giemsa stained slides showed that 
the morphology of the cells treated with these compounds changed in comparison 
to untreated cells but not to the degree which cells treated with CQ changed. In 
general CQ treated cells were smaller, less complex and contained less DNA.  
Application of the haem fractionation assay to all three compounds showed that 
none of the compounds inhibited the formation of Hz in treated parasites. No dose 
related change in the levels of Hb, “free” haem or Hz in comparison to the control 
was seen and the total amount of haem Fe per cell remained unchanged at all 
concentrations of drug tested. An overlay of the parasite survival curve for each of 
PQ, ART and 10-dO-AMN with the amount of “free” haem produced in treated cells 
shows no relationship exists between the two parameters. The results are not 
surprising given that all 3 compounds did not inhibit the formation of βH and while 
the exact mechanism of action of the AMNs remains unknown, PQ is known to 
possess activity against the liver stage and against mature gametocytes. 99 110 178 
Direct Hz inhibition does not therefore appear to be the mechanism of action for 
these antimalarials. However the assay cannot disprove the presence of small 
quantities of highly toxic haem-ART complexes which some authors have proposed 
play a role in the mechanism of action of the AMNs. 51 176 175 177 The haem 
fractionation assay on its own, therefore cannot totally exclude the role of haem in 
the mechanism of action in the AMNs.  
The application of the haem fractionation assay to six clinical and one 
experimentally effective antimalarial in this chapter demonstrates the insight the 
technique can provide as a valuable contribution in understanding the mechanism 
in existing and novel antimalarials focussing on Hz inhibition as target.  In the next 
The Role of Haem in the Mechanism of Action of Antimalarials in Plasmodium falciparum 
  Jill Michelle Combrinck -November 2016  
162 
chapter the assay will be applied to several novel βH inhibiting compounds 
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In this chapter the haem fractionation assay was applied to six novel compounds 
shown to have favourable antimalarial properties. The compounds were derived 
from scaffolds identified in a high-throughput screening (HTS) campaign 
conducted on a library of 144 330 compounds belonging to the Vanderbilt 
University Institute of Chemical Biology (VUICB) chemical library to identify novel 
βH inhibiting scaffolds using the NP-40 mediated assay. The results of this HTS 
found 530 βH inhibiting “hits” of which 73 showed activity below 5 µM in a CQS 
strain of P. falciparum. Compounds belonging to the quinoline scaffold comprised 
the majority of “hits” in the screen. Having been extensively investigated in the 
previous chapters, no compounds belonging to the quinoline scaffold were 
selected for investigation. Of the 14 scaffolds identified in the HTS, the benzamide 
chemotype had the second highest βH inhibiting hit rate, surpassed only by the 
quinolines and made up 10% of the hits. Three of the novel compounds 
investigated in this chapter belong to this scaffold. The final three compounds 
selected for investigation were chosen from the triarylimidazole (TAI) scaffold. 
This scaffold displayed favourable βH inhibiting activity and most of the βH 
inhibiting “hits” also displayed favourable parasite inhibitory activity. 104 246 247 All 
six compounds selected were biologically active against a CQS strain of P. 
falciparum and five of the six compounds selected were potent inhibitors of βH 
formation. The cellular haem fractionation assay was performed to validate that 
inhibition of βH seen in the majority of the selected compounds translates to the 
inhibition of Hz formation within the P. falciparum infected RBC resulting in 
parasite death. Whereas previously the relationship between the inhibition of βH, 
biological activity and the inhibition of Hz formation in the parasite using the haem 
fractionation assay has been limited to the study of βH inhibiting quinolines, the 
extension of the study to these novel βH inhibiting antimalarials provides the 
opportunity to gain insight into the mechanism of βH inhibition and its translation 
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6.2 Materials  
 
All materials used throughout this chapter are listed in Chapter 2. Materials were 
of AR grade or higher and used without further purification. The novel compounds 
tested in this chapter were synthesised and characterised by Dr Katherine Wicht 
and reported elsewhere. 246 
 
Table 6-1: A list of compounds tested in the pyridine haem fractionation study. 
Compound Scaffold Molecular formula *Percentage purity 
KW2 Benzamide C12H7N4O5 99.3% 
KW15 Benzamide C24H23N2O2 99.3% 
KW17 Benzamide C22H21N4O2 99.4% 
TSI_3 Triarylimidazole C23H21N2O2 98.5% 
TSI_6 Triarylimidazole C21H16N3O2 98.8% 
TSI_12 Triarylimidazole C25H25N2O4 98.0% 
*Percentage purity determined by HPLC. 
 
6.3 Sample Preparation 
 
The preparation of all samples used throughout this chapter, are previously 
described in Chapters 2 and 3. The water used throughout this work was double 
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6.5 Results and Discussion 
 
6.5.1 Selection of novel antimalarials for the cellular haem fractionation 
assay 
 
Three compounds from the benzamide scaffold and three from the TAI scaffold 
were selected for testing using the haem fractionation assay (Figure 6-1).  Both 
scaffolds have previously been investigated for antimalarial activity.103 104 
Phenylbenzamides have shown antimalarial activity against CQS 3D7 and one 
monobenzamide has been identified as a kinase inhibitor and subsequently 
optimised for solubility and parasite selectivity. 211 248 The TAI scaffold has 
previously been identified as a “hit” in a HTS campaign of several thousand 
compounds, screened specifically for antiprotozoal activity as haem detoxification 
protein (HDP) inhibitors.249 More recently several TAIs were identified as 
promising antimalarial leads in a HTS of almost two million compounds in the 
Glaxo Smith Kline chemical library for activity against CQS 3D7.216 TAI’s capable of 
βH inhibition have also been shown to have early stage gametocyte activity.103 The 
structures of the compounds selected for the cellular haem fractionation assay 
along with the 50% parasite inhibitory concentrations determined in the CQS 
NF54 strain and the 50% βH inhibitory concentrations are shown in Figure 6-1. 
The compounds selected covered a broad range of parasite inhibitory 
concentrations ranging from 0.6 µM to 14.8 µM. The range of parasite growth IC50 
values in the sample set could provide insight as to how differences in “free” haem 
levels affect parasite activity. With the exception of one benzamide, KW15 which 
showed no βH inhibitory activity, all had similar βH IC50 values ranging from 13.0 
µM to 18.7 µM, more active than the βH IC50 of CQ of 31.5 ± 0.5 µM. The single non 
βH inhibiting antimalarial, KW15, served as a negative control in this study.  
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Figure 6-1: The six compounds chosen for assessment of Hz parasite inhibitory 
activity derived from the benzamide and TAI scaffolds are shown above. The 
parasite growth IC50 values (µM) were determined in a CQS strain of P. falciparum, 
NF54 using a modification of the pLDH assay described in Section 2.5.2. The βH 
IC50 value (µM) for each compound was determined using the NP-40 detergent 
mediated βH inhibition assay described in Section 2.4.3. The parasite growth IC50 
value (µM) and βH IC50 value (µM) for CQ is listed for comparison. *All βH 
inhibition values listed in Figure 6-1 were determined by Katherine Wicht.246  
  
A significant correlation between the inverse of parasite activity and the inverse of 
βH inhibition activity in compounds selected from the benzamide and TAI scaffolds 
is shown in Figure 6-2. This significant correlation suggests the mechanism of 
action of these compounds can be attributed to Hz inhibition in the parasite. A 
similar relationship was demonstrated by Wicht et al between the inverse of the 
βH inhibition IC50 and the inverse of the parasite growth IC50 for several benzamide 
analogues showing a positive correlation (r2 = 0.68, P < 0.0001); again suggesting 
that Hz inhibition is the expected mechanism of action. 247  
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Figure 6-2: A plot of the inverse of the βH IC50 vs the inverse of the parasite 
growth IC50 shows a significant linear relationship exists between the parasite 
growth IC50 and βH IC50 for the TAIs and benzamides selected for testing (r2 =0.86, 
P = 0.022). Data are displayed as the mean with the associated SEM of 3 repeat 
measurements. The benzamide, KW15 was omitted from the plot as it did not 
exhibit any βH inhibition activity.  
 
6.5.2 The haem fractionation profiles of benzamide and triarylimidazoles 
 
The haem fractionation assay was performed to confirm that Hz inhibition was the 
mechanism of action for all compounds which tested positive for βH inhibition 
using the NP-40 mediated assay. The novel compounds derived from the 
benzamide and TAI scaffolds are structurally distinct from the quinolines 
previously studied and provide a unique opportunity to gain insight into the Hz 
inhibition pathway in an alternative scaffold.  
 
6.5.2.1 The Benzamide scaffold 
 
By contrast to KW15 which had no βH inhibitory activity, both KW2 and KW17 
showed dramatic increases in “free” haem levels accompanied by decreased levels 
of Hz correlated to parasite survival (Figure 6-3). Compound KW15 served as a 
negative control. Biologically active, with an parasite growth IC50 value of 8.1 ± 0.5 
µM, KW15 showed no inhibition of βH (βH IC50 > 1000 µM) and also no inhibition 
of Hz or build-up of “free” haem in the parasite. Therefore despite being 
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Chapter 6: Novel non-quinoline Hz inhibiting antimalarials 
Jill Michelle Combrinck -November 2016 
169 
biologically active against P. falciparum, KW15 most likely exerts activity via a 
mechanism other than Hz inhibition within the Plasmodium infected RBC. The 
antiplasmodial activity of a monobenzamide has previously been linked to kinase 
inhibition and it is possible that KW15 shares a similar mechanism of action.248 
KW2 and KW17 produced maximum “free” haem levels of 48.3 ± 1.8 and 39.1 ± 5 
fg haem Fe per cell respectively, higher than any of the Hz inhibiting antimalarials 
previously tested, including the highly effective Hz inhibiting antimalarial CQ 
which reached at most 8.8 ± 0.8 fg of “free” haem Fe per cell (Figure 4-8). An 
overlay of the parasite survival curve for KW2 and KW17 with the amount of “free” 
haem produced in the presence of each drug (Figure 6-3 c and i) showed that 
decreased parasite survival corresponds to an increase in “free” haem. In the case 
of both KW2 and KW17 the graphs intersect at or close to the 50% parasite 
inhibitory concentration reinforcing the relevance of the relationship between 
decreasing parasite survival and increasing “free” haem levels. Conversely, the 
negative control KW15 showed no relationship between parasite survival and free 
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NF54 parasite IC50  (µM) = 4.5 ± 1.0

































































































NF54 parasite IC 50  (µM) = 8.1 ± 0.5
ßH IC50  (µM) > 1000
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NF54 parasite IC50  (µM) = 0.6 ± 0.1
ßH IC50  (µM) = 6.8 ± 0.1
 
Figure 6-3: The haem fractionation profiles of the benzamide derivatives KW2 (a, 
b, c), KW15 (d, e, f) and KW17 (g, h, i) showing the amount of “free” haem Fe per 
cell (a, d, g)  and Hz Fe per cell (b, e, h) with increasing drug concentration. An 
overlay of the parasite survival curve with the amount of “free” haem is shown in c, 
f and i for each of KW2, KW15 and KW17 respectively. In the case of KW2 (c) and 
KW17 (i) the scales of the parasite survival curve overlaid with “free” haem levels 
have been adjusted such that the 50% mark on the parasite survival y-axis 
coincides with the half way mark on the “free” haem y-axis. A dose related increase 
in “free” haem and decrease in Hz related to parasite survival is seen for KW2 and 
KW17. Asterisks displayed on the graph indicate statistical significance relative to 
the control (shown in red) at the 95% CI, determined using a 2-tailed t-test (* P 
<0.05; ** P <0.01; *** P <0.001).   
 
The change in morphology of cells after treatment with 3× the parasite growth IC50 
of CQ, KW2, KW15 and KW17 is represented in the flow cytometry histogram 
overlays in Figure 6-4. Cells treated with the benzamide KW15 (solid dark purple 
line), which exhibited no evidence of Hz inhibition (Figure 6-3d – f) showed no 
change in the amount of DNA (Figure 6-4a), size (Figure 6-4b) or complexity 
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(Figure 6-4c) compared to the control (solid red line). The benzamides KW2 (solid 
green line) and KW17 (solid purple line) which produced high “free” haem Fe 
levels of 43.7 ± 1.7 and 34.3 ± 4.5 fg per cell at 3× parasite growth IC50 showed a 
reduction in the amount of DNA (Figure 6-4a) and the complexity of the cells 
(Figure 6-4c) but very little change in the size of the cells compared to the control. 
In comparison to CQ, the flow cytometry profiles of KW2 and KW17 were almost 
identical with the exception of the FSC parameter which showed that cells treated 
with CQ had a larger population of smaller cells. Treatment with the benzamides 
KW2 and KW17 which produced “free” haem levels of up to 5.5⨯ more than in CQ 
treated cells therefore resulted in a larger proportion of bigger cells and cells 
which were very similar in complexity and amount of DNA as cells treated with CQ. 
The results obtained here differ from flow cytometry histogram plots of cells 
treated with the aryl methanols in Chapter 5 which showed treated cells were less 
complex and in most cases smaller than cells treated with CQ.  
 
 
Figure 6-4: Change in morphology of isolated P. falciparum trophozoites treated 
with 3× the parasite growth IC50 of KW15, KW17, KW2 and CQ. Flow cytometry 
histogram overlays displaying the change in FL1 (a), FSC (b) and SSC (c) for 
isolated untreated control trophozoites (solid red line), CQ (blue dotted line), 
KW15 (solid dark purple line), KW17 (solid purple line) and KW2 (solid green 
line) treated isolated trophozoites. While very little shift in any of parameters was 
seen between the control and KW15, the profiles of KW2, KW17 and CQ treated 
cells are very similar.   
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6.5.2.2 The Triarylimidazole scaffold 
 
All three TAIs tested showed evidence of Hz inhibition (Figure 6-4). As seen in the 
benzamides, TSI_3 and TSI_12 produced unusually high levels of “free” haem 
corresponding to maximum levels of 36.9 ± 6.0 and 46.4 ± 3.0 fg of “free” haem Fe 
per cell respectively. By contrast, TSI_6 produced at most 17.4 ± 1.4 fg of “free” 
haem Fe per cell. Although higher, this result is comparable to AQ which produced 
at most 13.1 ± 2.1 fg of “free” haem Fe per cell. The increase in “free” haem in each 
case is accompanied by a decrease in Hz. In all three cases an overlay of the 
parasite survival curves with the amount of “free” haem (Figure 6-4c, f and i) 
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NF54 parasite IC50  (µM) = 3.6 ± 0.01
ßH IC50  (µM) = 14.6 ± 0.2





















































































































NF54 parasite IC 50  (µM) = 14.8 ± 1.8
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NF54 parasite IC 50  (µM) = 1.2 ± 0.2
ßH IC50  (µM) = 13.8 ± 0.4
 
Figure 6-5: The haem fraction profiles of the TAI derivatives TSI_3 (a, b, c), TSI_6 
(d, e, f) and TSI_12 (g, h, i) showing the amount of “free” haem Fe per cell (a, d, g)  
and Hz Fe per cell (b, e, h) with increasing drug concentration. An overlay of the 
parasite survival curve with the amount of free haem is shown in c, f and i for 
TSI_3, TSI_6 and TSI_12 respectively. In all cases the scales of the parasite survival 
curve overlaid with “free” haem levels has been adjusted such that the 50% mark 
on the parasite survival y axis coincides with the half way mark on the “free” haem 
y-axis. A dose related increase in “free” haem and decrease in Hz related to 
parasite survival is seen in all of the TAI derivatives. Asterisks displayed on the 
graph indicate statistical significance relative to the control (shown in red) at the 
95% CI, determined using a 2-tailed t-test (* P <0.05; ** P <0.01; *** P <0.001).  
 
Flow cytometry histogram profiles of CQ and TAI treated cells in Figure 6-6 show a 
reduction in all three parameters evaluated (FL1, FSC and SSC) in comparison to 
the untreated control. Unlike the flow cytometry profiles of benzamide treated 
cells (Figure 6-4), where a definite trend of larger cells as complex as CQ treated 
cells could easily be identified, the effect of the TAIs on cell morphology differ with 
each derivative tested and no single trend could be established with the TAI 
treated cells. Cells treated with TSI_6 showed a marked reduction in DNA in 
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comparison to cells treated with CQ at the equivalent parasite growth IC50. Both 
TSI_3 and TSI_6 showed a marked reduction in cell size as well as a decrease in the 
fraction of complex cells in the population. As seen in the benzamides (Figure 6-4), 
the flow cytometry profiles of TSI_12 were very similar to CQ at the equivalent 
parasite growth IC50 in all parameters evaluated. Although Hz inhibition along with 
increased levels of free haem was established as the likely mechanism of action for 
all TAIs, the effect of each TAI evaluated on the morphology of the parasite appears 
to be different. 
Figure 6-6: Change in morphology of isolated P. falciparum trophozoites treated 
with each of 3× the parasite growth IC50 of TSI_3, TSI_6, TSI_12 and CQ. Flow 
cytometry histogram overlays displaying the change in fluorescence intensity 
(FL1) (a), change in FSC (b) and change in SSC (c) are shown for isolated untreated 
control trophozoites (solid red line), CQ treated isolated trophozoites (blue dotted 
line) TSI_3 (solid green line), TSI_6 (solid orange line) and TSI_12 (solid purple 
line). 
6.5.3 Towards understanding high “free” haem levels 
A compound was considered to be a Hz inhibitor when the following three criteria 
were met: an increase in “free” haem, an accompanying decrease in Hz and a 
decrease in parasite survival that could be correlated to the increase in “free” haem 
and decrease in Hz. All five compounds which tested positive for βH inhibition 
(KW2, KW17, TSI_3, TSI_6 and TSI_12) were found to inhibit Hz formation within 
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the P. falciparum infected RBC, confirming the biological relevance of the NP-40 βH 
inhibition assay. Interestingly all five compounds produced higher levels of “free” 
haem (Figure 6-7a and b) and lower levels of Hz than seen in any of the Hz 
inhibiting antimalarials previously tested. In the case of KW2 the amount of “free” 
haem Fe reached within the parasite was ~35 - 40 fg higher than the highest 
amount of “free” haem reached within CQ and AQ treated cells.  The vastly different 
levels of “free” haem Fe between the Hz inhibiting 4-aminoquinolines and 
specifically KW2, KW17, TSI_3 and TSI_12 suggests that Hz inhibition in these non-
quinoline antimalarials follows a different mechanism. The ability of the parasite to 
reach high levels of “free” haem Fe while still exhibiting reasonable parasite 
survival suggests the toxicity of the “free” haem produced is lower than that 
produced in CQ and AQ treated cells. Compounds belonging to the quinoline 
scaffold require only a small increase in “free” haem to induce parasite death 
signifying that the ultimate effect of the quinolines is more effective at killing the 
parasite. The relationship between parasite growth IC50 and βH IC50 with change in 
“free” haem levels is shown in Figure 6-7c and d respectively. A significant 
correlation exists between the parasite growth IC50 and the change in “free” haem 
levels. Thus high levels of “free” haem are produced by compounds with high 
parasite growth IC50 values. The highly effective Hz inhibiting antimalarial CQ 
shown in Figure 6-7c for comparison produces the smallest increase in “free” haem 
but is the most biologically active antimalarial. The relationship is counterintuitive, 
as less biologically effective compounds produce higher levels of “free” haem 
known to be toxic to the parasite resulting in cell death. One explanation could be 
that the resulting complex formed between “free” haem and these novel 
compounds is less toxic than “free” haem alone or “free” haem-CQ complex. This 
concept requires further investigation and can only be firmly established with the 
inclusion of more data acquired from Hz inhibiting compounds. It must be noted 
that the positive relationship between the change in “free” haem levels and the 
parasite growth IC50 only exists with the exclusion of TSI_6 as this TAI had a high 
parasite growth IC50 value of 14.8 μM but a small change in “free” haem of 5.9 fg 
haem Fe at 1⨯ the 50% parasite inhibitory concentration. TSI_6 therefore does not 
conform to the relationship of less biologically effective compounds producing 
higher levels of “free” haem. Interestingly TSI_6 was the only compound which 
caused a significant reduction in the amount of DNA per cell suggesting that aside 
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from Hz inhibition this compound has an additional, possibly nonspecific cytotoxic 
effect on the cell. No significant relationship was observed between the 50% βH 
inhibition concentrations and the change in “free” haem at 1⨯ 50% parasite 
inhibitory concentration (Figure 6-7d).  Therefore although the NP-40 assay 
successfully identified all Hz inhibitors in the sample set it did not predict the level 
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Figure 6-7: The amount of “free” haem produced in cells inoculated with 0.5×, 
1.0×, 2× and 3× the parasite 50% inhibitory concentration of CQ, KW2 and 
KW17(a) and CQ, TSI_3, TSI_6 and TSI_12 (b). The Hz inhibiting quinoline, CQ is 
shown for comparison. The amount of “free” haem produced in the presence of the 
benzamide and TAI derivatives are considerably higher than in CQ treated cells at 
the equivalent parasite inhibitory concentration with KW2 producing the highest 
amount of free haem Fe (fg) per cell. The benzamide, KW15 was omitted from the 
plot as it did not exhibit βH inhibition activity. Graph c shows that a significant 
relationship exists between the 50% parasite inhibitory concentration and the 
change in “free” haem at 1⨯ parasite inhibitory concentration (r2 = 0.97, P =0.002). 
Both KW15 and TSI_6 (data point shown in green) were omitted from the plot. 
KW15 was omitted as it showed no Hz inhibition and TSI_6 as it had a high 
parasite growth IC50 value of 14.8 μM and small change in “free” haem of 5.9 fg at 
1⨯ the 50% parasite inhibitory concentration. The inclusion of TSI_6 eliminates 
the significant correlation (P= 0.997).  No significant correlation was seen between 
the 50% βH inhibition concentration (d) with the  change in “free” haem at 1⨯ 
50% parasite inhibitory concentration (r2 = 0.15,  P = 0.44). Again KW15 was 
omitted from the plot.   
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To further investigate the phenomenon of unusually high levels of “free” haem, one 
compound was selected for further investigation. The benzamide KW17 was 
chosen on account of its high levels of “free” haem and because it exhibited the 
most potent biological activity amongst the compounds chosen in either scaffold 
with a parasite growth IC50 of 0.6 ± 0.1 µM in the NF54 strain. TEM with EELS for 
Fe was performed on cells treated with 2× the parasite growth IC50 of KW17 and 
highlighted the morphological changes in KW17 treated cells compared to 
untreated cells and cells treated with CQ at 2× the parasite growth IC50 of CQ  
(Figures 6-8 and 6-9). Samples were prepared as previously described in Section 
2.4.4 from NF54 cultures inoculated with 2× the parasite growth IC50 of KW17 or 
CQ at the ring stage. The amount of “free” haem in isolated trophozoites derived 
from these cultures corresponded to 30.6 ± 3.0 fg haem Fe, 3.5 fold higher than CQ 
treated trophozoites at the equivalent parasite growth IC50 (Figure 6-8a). Several 
morphological changes between the control cell (Figure 6-8b), the CQ treated cell 
(Figure 6-8c) and the KW17 treated cells (Figures 6-8d, e and 6-9a) were observed. 
The first was the presence of an enlarged DV in KW17 treated cells, most evident in 
Figures 6-8e and 6-9a. The second was that Hz formation within the DV was 
disrupted.  The TEM images of KW17 treated cells clearly show the presence of 
apparently “non-crystalline” Hz, possibly corresponding to aggregated haem 
confined to the DV. Unlike the tightly packed Hz crystals in DV of the untreated 
control (Figure 6-8b) and CQ (Figure 6-8c) treated cells, the Hz crystals in the DV 
of KW17 treated cells were loosely distributed within the DV, mostly at the 
periphery of the enlarged DV (Figures 6-8d, e). A distinct shadow could be seen 
surrounding each crystal in KW17 treated cells, not observed in untreated cells 
(Figure 6-8b) and very slightly in CQ treated cells (Figure 6-8c). In comparison, Hz 
crystals in the DV of the untreated PRBC (Figure 6-8b) were uniform in shape, 
ordered, sharp crystals. Previous studies have showed that treatment with 30 nM 
CQ (corresponding to 2× the 50% parasite inhibitory concentration) produced less 
ordered crystals and at 60 nM CQ. TEM of extracted Hz clearly shows disruption of 
Hz formation with obvious grain boundaries visible between multiple small 
crystals making up Hz 107. TEM images of extracted Hz crystals treated with 2× the 
50% parasite inhibitory concentration of CQ (Figure 6-9c) and KW17 (Figure 6-9d) 
respectively are shown with insets magnifying a portion of the crystal. While the 
crystals of the CQ treated cell are not as regularly shaped as the untreated control, 
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the extracted CQ treated Hz crystals in Figure 6-9c exhibit a repetitive pattern with 
areas of non-uniform interaction at points where two crystals overlap. The inset 
corresponding to a magnified portion of extracted CQ treated Hz (Figure 6-9c) 
shows lattice fringes are clearly visible, indicative of a crystal structure. KW17 
treated extracted material in Figure 6-9d appears to be amorphous with no distinct 
order. The inset in Figure 6-9d showing a magnified portion of the material 
corresponding to Hz extracted from KW17 treated cells appears amorphous and 
shows no evidence of lattice fringes as seen in Hz of CQ treated cells. Finally a large 
number of vesicles, highlighted by yellow and orange asterisks (*,*) were observed 
in KW17 treated PRBC images (Figure 6-9a, b). The vesicles were primarily seen in 
the DV, some of which contained Fe (*) concentrations greater than Fe levels in the 
RBC and parasite cytosol. Similar transport vesicles are seen in much smaller 
numbers in the image of the untreated PRBC (Figure 6-8b) and have also been 
identified in large numbers in the TEM of CQ treated PRBCs, attributed to the 
accumulation of Hb containing transport vesicles. However in both cases these 
transport vesicles were found outside of the DV 124. Further work is required to 
elucidate the role of these vesicles in KW17 treated cells and whether they play a 
role in the extraordinary high levels of “free” haem obtained with this compound.  
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Figure 6-8: TEM of PRBCs treated with KW17. Graph (a) shows the increase in 
“free” haem (left y-axis) and decrease in Hz (right y-axis, dotted bar graphs) in 
KW17 treated cells (green bar graphs), and CQ treated cells (blue bar graphs) at 2× 
the 50% parasite growth inhibition dose compared to an untreated control (red 
bar graphs). TEM images of untreated (b) and CQ treated PRBCs (c) shown for 
comparison with KW17 treated PRBCs. TEM images of KW17 treated PRBCs (d, e) 
display an enlarged DV and “non-crystalline” loosely distributed amorphous 
electron dense material. C = cytostome; RBC = red bool cell; RBCM = red blood cell 
membrane; P = parasite cytosol; PM = parasite membrane; DV = digestive vacuole; 
DVM = digestive vacuole membrane; Hz = Haemozoin; SK = surface knobs.  
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Figure 6-9: TEM images of KW17 treated PRBCs (a) display an enlarged DV, “non 
crystalline” loosely distributed amorphous electron dense material and a large 
number of vesicles throughout the parasite. The Fe distribution measured by ESI 
using EELS for Fe is shown in white (b). The Fe signal in vesicles is highlighted by 
yellow asterisks (*) while vesicles devoid of Fe are highlighted by an orange 
asterisks (*).  In all images the DVM is delineated by a white dashed line. Hz 
crystals extracted from CQ treated PRBCs (c) with inset of magnified crystals 
displaying lattice fringes. Hz crystals extracted from KW17 treated PRBCs (d) with 
inset of magnified extracted Hz crystals. DV = digestive vacuole; DVM = digestive 
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6.6 Summary and Conclusion 
 
In this chapter, six derivatives of two non-quinoline scaffolds; the benzamide and 
TAI scaffolds identified by HTS as having promising βH inhibiting and parasite 
inhibitory activity were tested using the haem cellular fractionation assay. The 
relationship between βH inhibition, parasite inhibitory activity and Hz inhibition in 
the P. falciparum parasite has been explored in relation to these two scaffolds. βH 
inhibition does not always translate into Hz inhibition as the primary mechanism 
of action of the drug. In Chapter 5, the βH inhibiting antimalarial LF determined to 
have a βH IC50 value of 11 µM (Figure 3.9d) did not inhibit Hz formation in CQS P. 
falciparum. Although Hz inhibition may still theoretically be able to occur, LF most 
likely also has an alternative more effective mechanism of action occurring at a 
stage in the lifecycle where Hz inhibition is not possible. Of the six novel 
compounds selected for investigation, five tested positive for βH inhibition with βH 
IC50 values approximately half those of CQ. All five of these compounds 
subsequently tested positive as inhibitors of Hz formation within the P. falciparum 
infected RBC, confirming the biological relevance of the NP-40 assay with 
reference to the benzamide and TAI scaffolds. This relationship was strengthened 
by the inclusion of the negative control, KW15. This non βH inhibiting antimalarial 
(βH IC50 > 1000 µM) showed no inhibition of Hz formation within the parasite. The 
results of this investigation indicate that βH inhibition for the benzamides and 
TAIs translates into Hz inhibition.  However no correlation exists between the βH 
IC50 value and the amount of free haem produced (Figure 6-5d). The βH inhibition 
NP-40 assay therefore accurately predicts whether a compound will inhibit 
haemozoin but does not predict the degree of Hz inhibition seen within the 
parasite. 
The most notable effect of the benzamide and TAI analogues was the exaggerated 
levels of “free” haem produced in P. falciparum infected RBCs. High levels of “free” 
haem have previously been reported for the benzamide and TAI scaffolds. In 
separate studies performed using the haem fractionation assay described in 
Chapter 3, Sandlin et al identified three different benzamides and one TAI from the 
VUICB chemical library which produced levels of “free” haem 51% above the 
control. These “free” haem levels were the highest amongst all other βH inhibiting 
Chapter 6: Novel non-quinoline Hz inhibiting antimalarials 
Jill Michelle Combrinck -November 2016 
185 
scaffolds identified, including several quinolines. The quinolines represented the 
largest percentage of βH inhibiting hits in the HTS and produced very small but 
significant increases in “free” haem correlated to parasite death.104 Similarly, Fong 
et al in another HTS campaign of active antimalarial compounds in the Medicines 
for Malaria Venture (MMV) Malaria Box identified ten βH inhibiting hits of which 
two were benzamides and three were TAIs. Again it was shown that treatment 
with these compounds resulted in the highest “free” haem levels amongst all 
scaffolds identified 103. Findings presented in this chapter as well as previous 
studies have therefore shown that the amount of “free” haem required to achieve 
the equivalent level of toxicity and associated parasite survival was much higher in 
the TAI and benzamide scaffolds than in βH inhibiting quinolines. 
TEM with EELS for Fe of KW17 treated parasites was undertaken to provide 
morphological clues to explain the high levels of “free” haem. A significantly 
enlarged DV containing a large number of vesicles as well as disrupted Hz 
formation was observed. The presence of these vesicles as well as the enlarged DV 
could account for the flow cytometry profiles of KW17 treated cells which were as 
complex as and larger than cells treated with CQ. Most significant was the 
appearance of the Hz in KW17 treated cells compared to control and CQ treated 
cells. Structured, sharp Hz crystals were seen in both the control and CQ treated 
cells compared to the “non-crystalline” amorphous material which has been 
attributed to aggregated haem confined to the DV.  
 
High levels of free haem and distinct morphological differences in treated cells 
indicate that the benzamides and TAIs clearly have a different toxicity to the 
parasite compared to quinolines. Although the exact mechanism of Hz formation 
and inhibition is not known, recent evidence indicates that CQ inhibits Hz 
formation through interaction with growing Hz crystals resulting in termination of 
growth and increased levels of toxic “free” haem. Haem cellular fractionation 
studies with CQ and other Hz inhibiting quinolines have shown that very small but 
significant increases in “free” haem are required to cause parasite death. CQ, with a 
50% parasite inhibitory concentration of 11.0 nM in NF54 causes an approximate 
two fold maximum increase in “free” haem above the untreated control. The graph 
of parasite growth IC50 vs the change in “free” haem in Figure 6-5c shows that the 
higher the parasite growth IC50, the more “free” haem produced in the presence of 
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the drug within the parasite. Therefore the highly effective Hz inhibiting 
antimalarial CQ produces the smallest increase in “free” haem whereas the less 
biologically effective benzamides and TAIs produce high amounts of “free” haem 
while still exhibiting reasonable parasite survival. This phenomenon suggests that 
the toxic effect of the “free” haem produced in the presence of these novel 
compounds is attenuated possibly through the formation of haem-drug complexes 
which are less harmful to the parasite than “free” haem itself, possibly because of 
low solubility. Therefore in addition to inhibiting Hz crystal growth through 
interaction with Hz crystals, the TAI and benzamide derivatives could also form 
complexes with Fe(III)PPIX, diminishing the effect of the toxic “free” haem and 
allowing extraordinarily high levels of “free” haem to be reached within the 
parasite. All benzamide and TAI compounds investigated here had βH inhibition 
values 2 - 3 fold more effective than CQ. The ability to inhibit βH therefore does not 
translate directly into parasite activity or biological effectiveness, but rather 
possibly into the ability to favourably form complexes with Fe(III)PPIX which 
could be less toxic than “free” haem thereby reducing the biological effectiveness 
of the compounds. Future work is certainly required to provide more insight into 
the formation of these high “free” haem levels, beginning with identifying the 
composition of the “non-crystalline” electron dense material seen in the DV as well 
as the role played by the vesicles identified in the DV of KW17 treated PRBCs.  
Chapter 7: Conclusion and further studies 
Jill Michelle Combrinck -November 2016 
187 






















The Role of Haem in the Mechanism of Action of Antimalarials in Plasmodium falciparum 




CQ is no longer routinely administered as the standard treatment for P. falciparum 
malaria, having been replaced by WHO recommended AMN combination therapies. 
The rapid acting AMNs are administered with a partner drug of alternate, longer 
acting mechanism of action and in several cases this partner is a quinoline.2 The 
emerging threat of resistance to the AMNs, which manifests as reduced clearance 
rates places extra pressure on the partner drug, eventually resulting in the 
emergence of multidrug resistance. In keeping with the most recent WHO “Global 
Technical Strategy for Malaria 2016 – 2030” which aims to curb and eventually 
eliminate the global spread of malaria, the need for the development of new drugs 
remains necessary.2 Even though CQ is no longer recommended for malaria 
treatment due to the emergence of CQ resistance, the long running success of CQ 
means it remains a drug to emulate. CQ resistance has been attributed primarily to 
mutations in the parasite transmembrane protein PfCRT, resulting in reduced CQ 
accumulation and therefore does not directly affect Hz formation in the parasite.129 
Recently it was found that administering a double dose of CQ in children younger 
than 5 years infected with CQR P. falciparum strains resulted in an approximate 
five-fold increase in CQ efficacy. 250 Furthermore, CQ analogues continue to be 
effective against CQ resistant strains of P. falciparum.251 The Hz formation pathway 
therefore remains a desirable target for the development of new antimalarials. 
Being unique to the parasite this vital pathway represents a point of vulnerability 
in the parasite lifecycle. Monitoring the inhibition of βH production in the presence 
of drugs has provided an abiotic means of measuring inhibition of the Hz formation 
pathway. The recently developed NP-40 assay, which uses a synthetic neutral lipid 
blend to mimic the lipid environment assumed to be the conditions under which 
Hz is formed in the parasite, showed a strong correlation between parasite growth 
inhibition and the ability of a compound to inhibit the formation of βH . 102 105 
Although biologically relevant, this assay nonetheless does not always 
unequivocally show that Hz inhibition occurs within the cell.  
In this project, a cellular haem fractionation assay was developed to directly 
determine the amounts of Hb, “free’” haem and Hz in drug treated isolated 
trophozoites. Aqueous soluble Hb, “free” haem corresponding to haem that is 
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labile, most likely membrane bound and soluble in the presence of SDS, and finally 
Hz soluble in base, was determined through a series of fractionation steps in 
isolated trophozoites. Based on a method developed by Ncokazi and Egan, each 
haem species was spectrophotometrically quantified as a Fe(III)haem complex 
with aqueous pyridine at near neutral pH (5% v/v, pH 7.5).101 The method was 
originally applied to CQ treated cells and performed in 250 ml culture flasks. The 
determination of each haem species in isolated trophozoites, inoculated 32 h 
earlier with different concentrations of CQ, showed a decrease in the percentage of 
Hz and increase in the percentage of “free” haem with increasing CQ concentration. 
CQ was therefore classed as a Hz inhibitor as it demonstrated a dose related direct 
inhibition of Hz and a build-up of toxic “free” haem resulting in the death of CQ 
treated P. falciparum parasites. An increase in the percentage Hb, most likely 
corresponding to undigested RBC cytosol in transport vesicles was observed 
following a significant increase in the percentage “free” haem. The appearance of 
statistically higher levels of Hb after significant increases in the percentage “free” 
haem suggests a causative link, a result of the downstream effects of increased 
“free” haem (or haem-CQ complex) levels in the parasite. The observation agrees 
with previous studies which showed a build-up of undigested Hb and the 
accumulation of Hb transport vesicles at high CQ concentrations, possibly 
attributed to the disruption of Hb metabolism by proteases and the failure to 
deliver Hb in transport vesicles to the parasite DV for digestion. 121 122 124 125 The 
results were supplemented by TEM images of CQ treated PRBCs in conjunction 
with EELS for Fe. In comparison to the control, haem Fe had been redistributed 
outside the DV into the parasite cytosol, where due to its lipophilic nature, haem 
most likely interacts with lipid rich membranes and organelles causing eventual 
cell death. 51 57 
Having established the cellular haem fractionation assay in 250 ml flasks, it was 
applied to several other clinically relevant antimalarials. The percentage of each 
haem species at a single drug concentration corresponding to 2.5⨯ the parasite 
growth IC50 was determined for each of LF, MQ, AQ, QN, ART, PYR and SP. With the 
exception of the antifolates PYR and the SP combination, all species showed some 
degree of Hz inhibition. However, with the exception of LF, none showed inhibition 
comparable to CQ. The study, conducted at a single concentration of each drug, 
provided only a glimpse into the full effect of haem on the parasite with drug 
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treatment.  A comprehensive dose response investigation was required to explore 
the results obtained as part of this initial investigation. This was important in light 
of the fact that in addition to Hz inhibition, several other mechanisms of action 
have been proposed for the antimalarials investigated. The quinoline methanols 
have been associated with reduced DV accumulation, reduced Hz formation and 
inhibition of endocytosis calling into question Hz inhibition as the major 
mechanism of action. 79 127 124 125 While haem association with AMNs has been 
demonstrated in several studies, Hz inhibition as the mechanism of action of AMNs 
remains a widely debated topic with several conflicting opinions. 178 252 98 
High demands on parasite starting material and the length of time required to 
complete a full dose response study on a single compound were the biggest 
limiting factors of the original assay performed in 250 ml flasks as described in 
Chapter 3. It was therefore adapted to a higher throughput method performed in 
24-well plates, containing at most ten million trophozoites per well, significantly
improving the output and reducing the amount of parasite starting material 
required. Whereas previously results for a single compound were obtained after 2 
months the newer method shortened output time to 2 compounds per week. 
Although the new higher throughput cellular haem fractionation assay was 
associated with a loss in sensitivity, the results obtained with CQ in the original 
flask method was successfully reproduced in the higher throughput 24-well plate 
method. The new method was validated using CQ and was found to be robust. In 
addition to CQ the method was also applied to AQ, ATV and PYR. An extra facet of 
the newer higher throughput 24-well plate cellular haem fractionation assay was 
the inclusion of flow cytometry-based cell counting. In addition to determining the 
concentration of cells assayed, flow cytometry provided information about changes 
in morphology of drug treated cells. Cell counting enabled results to be expressed 
as the amount of each haem species per cell rather than in percentage terms. The 
importance of this step became apparent when it was determined that treatment 
of cells with the mitochondrial electron transport inhibitor ATV, caused a dose 
dependent reduction in the total amount of haem Fe per cell. Initial results 
expressed as a percentage gave the appearance that ATV was a Hz inhibitor, 
resulting in an unexpected increase in the percentage “free” haem and decrease in 
percentage Hz. However, taking into account the dose related reduction in total 
haem Fe levels it was found that the “free” haem levels per cell remained 
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unchanged with increasing concentration of ATV. ATV almost certainly does not 
inhibit Hz formation within the parasite since it does not inhibit βH formation. In 
cases where the total haem Fe per cell changes with drug dose it was essential to 
express each haem species as the amount of Hb, “free” haem and Hz Fe per cell to 
accurately interpret the effects on parasite haem concentrations. Similar to CQ, AQ 
was shown to inhibit Hz formation with a dose related increase in “free” haem 
correlated to decreased parasite survival. The antifolate PYR showed no evidence 
of Hz inhibition, demonstrating no increase in the amount of toxic cellular “free” 
haem or decrease in the amount of Hz Fe per cell.  
Having successfully adapted the haem fractionation assay to a higher throughput 
technique, the method could then be applied to six additional clinically relevant 
antimalarials: QN, QD, MQ, LF, PQ and ART as well as the novel AMN 10-dO-AMN. 
Based on the results of this comprehensive investigation as well as results 
previously obtained for CQ, AQ, ATV and PYR, compounds can be classified into 
three groups (with several subdivisions within each group) according to the 
degree of Hz inhibition exhibited within the parasite (Table 7-1).  Group A can be 
defined as compounds which exhibit direct Hz inhibition and can be further 
subdivided by defining three subgroups of Hz inhibition. The 4-aminoquinolines, 
CQ and AQ are classified under group A-1, as compounds which exhibit typical 
direct Hz inhibition. CQ and AQ both showed a dose related increase in “free” haem 
levels, correlated closely to decreased parasite survival, accompanied by a dose 
related decrease in Hz.  The aryl methanols investigated have all been shown to 
inhibit of βH formation and several studies have correlated this βH inhibition with 
parasite growth IC50 suggesting a causative link.69 106 52 101 105 However inhibition 
of βH did not translate into Hz inhibition in all cases. While both QN and QD 
exhibited Hz inhibition with an accompanying increase in “free” haem which could 
be correlated to parasite survival, the effect was not nearly as pronounced as in 
cells inoculated with CQ and AQ.  The increased levels of “free” haem in QN and QD 
treated cells were accompanied by a decrease in Hz and a decrease in the total 
amount of haem Fe, the latter effect being more pronounced in the case of QD. Both 
QN and QD can be grouped under class A-2 as compounds which show reduced 
levels of Hz inhibition in comparison to CQ accompanied by a dose related 
reduction in total haem Fe. Neither MQ nor LF caused an increase in “free” haem 
levels, however, both drugs caused an immediate reduction in both the amount of 
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Hz and total haem Fe per cell. Hz inhibition did not therefore appear to be the 
mechanism of action for MQ or LF and both compounds can be classified under 
group B as compounds which do not directly inhibit Hz formation but cause a dose 
related decrease in total haem Fe. Comparison of the cell morphology of CQ treated 
cells, with cells treated with QN, QD, MQ and LF showed CQ treated cells were 
generally larger and more complex. Cells treated with LF and MQ also showed a 
reduction in the amount of DNA, suggesting cell growth was inhibited earlier in the 
lifecycle than CQ, QN and QD treated cells. The results suggest that the effect of QN, 
QD, MQ and LF are different to the effects of CQ in the cell.  While QN and QD 
appear to exert some degree of Hz inhibition, all four aryl methanols evaluated 
appear to have an alternative mechanism of action possibly involving the 
inhibition of endocytosis, resulting in reduced Hb uptake. The findings agree with 
previous studies which have shown that QN and MQ treatment inhibited 
endocytosis reducing the amount of Hb taken up by treated cells. 121 124 125 Similar 
to PYR, the non-βH inhibiting antimalarials PQ, ART and 10-dO-AMN had no effect 
on the Hz inhibition pathway.  All four compounds can be classified under group C-
1, as non βH inhibiting antimalarials which show no dose related change in the 
levels of Hb, “free” haem or Hz in comparison to the control. The total amount of 
haem Fe per cell remained unchanged at all drug concentrations in all four 
compounds. The morphology of the cells treated with PYR, PQ, ART and 10-dO-
AMN changed in comparison to untreated cells but in general were larger, more 
complex and contained more DNA than cells treated with CQ. ATV can be classified 
under group C-2. Similar to the non-βH inhibiting antimalarials previously 
mentioned, ATV did not appear to inhibit Hz formation, however treatment of cells 
with increasing concentrations of ATV did cause a dose responsive decrease in 
levels of Hz and total haem Fe. Furthermore in comparison to CQ treated cells, the 
morphology of ATV treated cells showed a slight reduction in cell size and 
complexity and the amount of DNA present. The result that compounds in group C 
do not inhibit Hz formation is not surprising. PQ is known to possess potent 
activity against mature gametocytes in P. falciparum and to eliminate hypnozoites 
in P. vivax, PYR is a known antifolate and ATV is known to disrupt mitochondrial 
electron transport in parasites. However the exact mechanism of action of the 
AMNs is not fully understood.  The presence of small quantities of highly toxic 
haem-AMN adducts which some authors have proposed play a role in the 
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mechanism of action of the AMNs cannot be either verified or excluded within the 
tolerance of the assay. Although the AMNs did not exhibit Hz inhibition, the cellular 
haem fractionation assay on its own, cannot unequivocally exclude the role of 
haem adducts in the mechanism of action of the AMNs. 99 110 178 51 176 177 175  
The cellular haem fractionation assay was also applied to six novel antimalarials 
belonging to the benzamide (KW2, KW15 and KW17) and Triarylimidazole or TAI 
(TSI_3, TSI_6 and TSI_12) non-quinoline chemotypes. Five of the six novel 
compounds selected inhibited βH formation with a βH IC50 twice as active as CQ. 
All five βH inhibiting compounds tested positive as inhibitors of Hz formation 
within the P. falciparum infected RBC, confirming the biological relevance of the 
NP-40 assay with reference to the benzamide and TAI scaffolds. The single non βH 
inhibiting antimalarial (βH IC50 > 1000 µM), KW15, showed no inhibition of Hz 
formation within the parasite and was classified accordingly under group C-1 in 
Table 7-1. The most notable effect of the benzamide and TAI analogues was the 
exaggerated levels of “free” haem produced in P. falciparum infected RBCs. TEM 
with EELS for Fe of KW17 treated parasites showed a significantly enlarged DV 
containing a large number of vesicles and evidence of disrupted Hz formation was 
observed. Structured, well-defined Hz crystals were seen in both the control and 
CQ treated cells, compared to “non-crystalline” material with amorphous 
appearance which was attributed to aggregated amorphous haem confined to the 
DV. Haem cellular fractionation studies with CQ and other Hz inhibiting quinolines 
have shown that small but significant increases in “free” haem are required to 
cause parasite death. CQ, with a 50% parasite inhibitory concentration of 11.0 nM 
in NF54 causes an approximate two fold maximum increase in “free” haem above 
the untreated control. High levels of “free” haem and distinct morphological 
differences in benzamide and TAI treated cells indicate they have a different 
toxicity to the parasite compared to the quinolines. The amount of “free” haem 
required to reach the equivalent level of toxicity and associated parasite survival 
was much higher in the TAI and benzamide scaffolds than in βH inhibiting 
quinolines. Surprisingly, a positive relationship was observed between the parasite 
growth IC50 and the change in “free” haem. The higher the parasite growth IC50, the 
more “free” haem produced in the presence of the drug within the parasite. 
Therefore the highly effective Hz inhibiting antimalarial CQ produces the smallest 
increase in “free” haem whereas the less biologically effective benzamides and 
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TAIs produce high amounts of “free” haem. This phenomenon suggests that the 
toxic effect of the “free” haem produced in the presence of these novel compounds 
is attenuated, possibly through the formation of haem-drug complexes which are 
less harmful to the parasite than “free” haem itself or haem-CQ complexes. 
Therefore in addition to inhibiting Hz crystal growth through interaction with Hz 
crystals, the TAI and benzamide derivatives could also form complexes with 
Fe(III)PPIX, diminishing the effect of the toxic “free” haem and allowing 
extraordinarily high levels of “free” haem to be reached within the parasite. All 
benzamide and TAI compounds investigated here had βH inhibition values 2 - 3 
fold more effective than CQ. The ability to inhibit βH therefore does not translate 
directly into parasite activity or biological effectiveness, but rather into the ability 
to favourably form complexes with Fe(III)PPIX which could be less toxic than 
“free” haem thereby reducing the biological effectiveness of the compounds. All 
five βH inhibiting novel compounds can be classified under a group A-3 as 
compounds which exhibited Hz inhibition with unusually high levels of “free” 
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Table 7-7-1: Summary of the outcomes of the cellular haem fractionation assay 
performed on clinically relevant and novel antimalarials with a proposed 
classification system. All compounds classified under Group A exhibited varying 
degrees of Hz inhibition. Compounds classified under Group B have been shown to 
inhibit βH formation but do not directly inhibit Hz formation. Compounds 
classified under Group C have no impact on βH formation or Hz inhibition. In all 
cases, comparisons are made with respect to the results obtained with the 








increase in “free” 
haem 




Fe(fg)  per cell 
A 
A1 CQ, AQ Yes Yes 
Slight decrease in 
cell size, 
complexity and 
amount of DNA 
No 
A2 QN, QD Yes 
Yes. Very small 
increase in level of 
“free” haem in 
comparison to CQ. 
Decreased cell size 
and complexity 





KW2, KW17 Yes 
Yes. Very large 
increase in level of 
“free” haem in 
comparison to CQ 
Bigger population 





Yes.  Very large 
increase in level of 
“free” haem in 
comparison to CQ 
No specific trend No 
B MQ, LF, Yes No 
Decreased cell 
size, complexity 
and amount of 
DNA 
















C2 ATV No No 
Slight Decrease in 
cell size, 
complexity and 
amount of DNA 
Yes. 
 
In this project a cellular fractionation assay for the determination of Hb, “free” 
haem and Hz in a CQS strain of Plasmodium falciparum was developed and applied 
to a diverse group of sixteen clinically relevant antimalarials and novel compounds 
active against Plasmodium falciparum. The method provided direct evidence which 
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confirmed or excluded Hz inhibition as a likely mechanism of action for all 
compounds investigated. While CQ and AQ were classified as archetypical Hz 
inhibitors that caused a significant build-up of “free” haem, it was found that 
several compounds investigated increased “free” haem levels to varying degrees. 
In comparison to CQ, QN and its stereoisomer QD caused increased “free” haem to 
a lesser degree. This was accompanied by a reduction in total haem Fe, exhibiting 
an alternative mechanism in addition to haemozoin inhibition, possibly as a 
downstream effect of haemozoin inhibition or as a direct effect of the drug itself. 
Five novel compounds belonging to the benzamide and TAI series were found to 
cause exaggerated levels of “free” haem correlated to decreased parasite survival 
suggesting that the “free” haem produced was of diminished toxicity. Several non-
βH inhibiting compounds including two AMNs, ATV, PYR, ART and PQ did not 
inhibit Hz formation. However LF and MQ, both of which inhibit the formation of 
βH, surprisingly also did not appear to inhibit Hz formation since they caused no 
increase in “free” haem. Similar to QN and QD they showed a reduction in total 
haem Fe, attributed reduced uptake of Hb. Therefore, while the haem fractionation 
assay was developed initially as a means to directly identify haemozoin inhibitors, 
the outcomes have provided valuable insights into the nuances of Hz inhibition, a 
process which is still being studied in an attempt to design new drugs capable of 
mimicking the past success of Hz inhibiting antimalarials such as CQ.  
 
7.2 Further studies 
 
The direct in-cell demonstration of CQ as a Hz inhibitor was a major milestone in 
this study. The relationship between increased levels of toxic “free” haem and 
decreased parasite survival in conjunction with TEM imaging techniques showing 
redistribution of haem out of the DV into the parasite cytosol provided evidence of 
Hz inhibition. However, the direct downstream consequences of increased “free” 
haem levels resulting in cell death were not identified. Interestingly, baseline levels 
of “free” haem were found to be present in untreated cells at approximately 4 fg of 
haem Fe per cell. In a PRBC corresponding to a volume of 90 fL this equates to a 
concentration of 796 µM of “free” haem. This concentration is far above that which 
has been shown to have adverse effects on the cell and therefore to maintain this 
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high concentration of “free” haem in the cell it is likely to be present mainly as an 
insoluble precipitate within the DV rather than soluble toxic “free” haem.55 
Presumably, treatment with Hz inhibitors leads to a small increase in soluble haem 
leading to parasite death.  
Schmitt et al, have demonstrated that aggregates of haemin in aqueous solution 
rapidly enter and accumulate into lipid bilayers, associating with organelles and 
enhancing permeability leading to eventual cell lysis. Fe(III)PPIX identified in the 
parasite cytosol, most likely present as the anionic form of haematin would behave 
in a manner similar to haemin as described by Schmitt et al. It was anticipated that 
evidence of “free” haem association with membranes and organelles in the cytosol 
would be obtained from the TEM EELS images collected, however the image 
resolution was not sufficient to distinguish association with any specific organelles 
in the parasite cytosol. The determination of possible association with specific 
organelles is a rational next step in concluding the investigation of the effects of CQ 
induced “free” haem within the cell and requires further investigation. In this 
regard, the use of more powerful imaging techniques with superior resolving 
capabilities is required. While studies using TEM have proved useful in 
demonstrating the location of haem in drug treated cells and changes in cell 
morphology, lengthy fixation of isolated cells in resin and the high cost of image 
processing limits the application of the technique. The use of Cryo-TEM would 
eliminate several fixation steps and could be expected to produce better resolved 
images. An alternative to TEM imaging would be the introduction of a haem 
fluorescent marker. Used in conjunction with commercially available fluorescent 
sensors known to associate with specific organelles, a haem fluorescent marker 
could track the pathway of labile haem microscopically in cells. While this type of 
fluorescent sensor is not yet available, several studies have made use of GFP based 
haem fluorescent sensors to investigate the dynamics of haem in live cells. 253 254 255 
Encoding P. falciparum with a haem fluorescent sensor such as recently developed 
and applied to yeast cells by Hanna et al may prove useful in a wide variety of 
applications relating to Hz inhibition. However this requires the modification of 
the genome of a CQS strain of P. falciparum to express the haem fluorescent protein 
in specific compartments within the parasite. Used in conjunction with confocal 
microscopy, flow cytometry and the wide variety of commercial available 
fluorescent trackers for organelles within P. falciparum this application may be 
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able to quantify haem levels as in the cellular haem fraction assay and additionally 
identify possible specific associations with organelles in individual cells.   
Hz inhibition has been implicated as the mechanism of action of LF and MQ, both of 
which strongly inhibit the formation of βH. Despite such evidence that MQ and LF 
could act as Hz inhibitors, neither caused increased “free” haem levels in the 
malaria parasite. Both compounds displayed reduced levels of total haem Fe, 
attributed to reduced uptake of Hb. The findings agree with several studies which 
have shown that MQ treated cells inhibit endocytosis reducing the amount of Hb 
taken up by treated cells. 121 124 125 Furthermore flow cytometry profiles of SYBR 
green stained trophozoites treated with LF and MQ showed reduced levels of DNA 
suggesting growth was inhibited earlier in the parasite lifecycle than each of CQ, 
AQ, QN and QD treated cells. Inoculation of cells with LF or MQ at the ring stage 
therefore appears to kill cells by a mechanism other than Hz inhibition. However 
evidence suggests that Hz inhibition could still be a possible mechanism of action. 
Inoculating parasites with LF or MQ, later in the lifecycle at the trophozoite stage 
rather than early ring stage would determine if more than one stage specific 
mechanism of action or different effects from the same drug are possible. This type 
of experiment might prove useful in cases where Hz inhibition was expected and 
not seen, perhaps due to alternative or secondary mechanisms of action of the 
drugs involved.  
Finally, further work is required to elucidate the mechanism behind exaggerated 
levels of “free” haem seen with the five novel benzamide and TAI compounds 
tested in Chapter 6. The amount of “free” haem required to reach equivalent levels 
of toxicity was much higher in cells treated with the benzamide and TAI 
derivatives than CQ treated cells. Furthermore TEM images of cells treated with 
the benzamide KW17, showed an enlarged DV containing “non-crystalline” 
material corresponding to Hz. A large number of vesicles were observed 
throughout the parasite some of which were shown to contain Fe. The ability to 
reach high levels of “free” haem was attributed to the formation of a Fe(III)PPIX-
drug complex between haem and the novel compounds tested, attenuating the 
effect of toxic “free” haem. The identification of these Fe(III)PPIX-drug complexes 
in the parasite, possibly associated with the large number of vesicles seen in TEM 
images of cells treated with the benzamide KW17 is required to validate this 
explanation. Furthermore, the extraction and identification of the “non-crystalline” 
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material corresponding to Hz seen in TEM images within the DV might provide 
more insight into the mechanism of Hz inhibition observed with these novel 
compounds. 
 
Even in the face of successful AMN combination therapies studying the mechanism 
of action behind the quinolines, especially CQ remains relevant. To emulate the 
success of CQ which was both clinically effective and cost effective would go a long 
way in curbing the spread malaria which is of greatest concern in countries which 
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